Motif ID	Motif Logo	Scanned Score Distribution	Frequency of Motif	Replicability Score	Evolutionary Conservation Score	Gene Targets	Gene Ontology of CpGMM targets
CG_h9laurent_promoter_p_RM_12_64_24			4	0.75	3.74E-04	EIF4EBP2, HHEX	eukaryotic initiation factor 4E binding [MF]
CG_h9laurent_promoter_p_RM_12_89_15			3	0.75	2.32E-04	ZMYM4, PSEN1, DCLK2, TENC1, ATF4, SPSB1, RASA2, BRSK2	intracellular signal transduction [BP], regulation of cell morphogenesis [BP], intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [BP]
CG_h9laurent_promoter_p_RM_12_43_10			3	0.5	3.34E-04	WRNIP1, SIRT1	DNA synthesis involved in DNA repair [BP]
CG_h9laurent_promoter_p_RM_14_333_5			2	0.25	4.58E-04	FPGS, B4GALT7, AHCYL1	tetrahydrofolylpolyglutamate synthase activity [MF], xylosylprotein 4-beta-galactosyltransferase activity [MF], one-carbon metabolic process [BP]
CG_h9laurent_promoter_p_RM_18_7_8			2	0.25	4.45E-04	NLGN1, PBX3	regulation of respiratory gaseous exchange by neurological system process [BP]
CG_h9laurent_promoter_p_RM_12_200_7			2	0.25	3.00E-04	POLA1, RAD50, TELO2	3'-5' exonuclease activity [MF], chromosome, telomeric region [CC]
CG_h9laurent_promoter_p_RM_12_511_15			3	0.5	2.69E-04	SOCS5, EPB49, CBLC	epidermal growth factor receptor binding [MF], negative regulation of epidermal growth factor-activated receptor activity [BP], actin filament capping [BP]
CG_h9laurent_promoter_p_RM_20_11_1			1	0.25	1.18E-04	FGF2, TPI1	substantia nigra development [BP], glyceraldehyde-3-phosphate metabolic process [BP], triose-phosphate isomerase activity [MF]
CG_h9laurent_promoter_p_RM_14_254_7			2	0.5	3.42E-04	GMPS, ATIC	purine ribonucleoside monophosphate biosynthetic process [BP]
CG_h9laurent_promoter_p_RM_14_331_8			2	0.25	2.85E-04	NOS3, GDF7, PRNP, SAE1, AP2M1, MET, INHBB, NEO1, DAG1, ABL1, ARID3A	membrane raft [CC], actin monomer binding [MF], ATP-dependent protein binding [MF], axon guidance [BP], response to external stimulus [BP], branching morphogenesis of an epithelial tube [BP]
CG_h9laurent_promoter_p_RM_12_11_10			3	0.5	1.84E-04	DYRK2, PPP1R3G	positive regulation of glycogen biosynthetic process [BP]
CG_h9laurent_promoter_p_RM_12_80_19			2	0.25	2.85E-04	ACOT1, ACOT4	palmitoyl-CoA hydrolase activity [MF]
CG_h9laurent_promoter_p_RM_12_82_12			4	0.75	2.69E-04	SMAD5, HABP4, STXBP5, VEGFA, STXBP5L, TIMP1	platelet degranulation [BP], exocytosis [BP], erythrocyte differentiation [BP]
CG_h9laurent_promoter_p_RM_12_457_19			4	0.75	3.91E-04	FOXK2, PNRC2, FAM120B, ZNF236, CDKN1A, EIF5, SOX8, CHAF1A, EIF5B, FZD7, TADA2B, L3MBTL3, KDM4C, NEO1, CDK5R1, FOXF2, CAMTA1, TCF25, SRP72, ATOH8, POU3F2, ACVRL1, TRIM28, RQCD1, EFNA2, RPS28, GTF2H4, SNAPC2, SKIL, EP300, KCNH3, IRF5, ARID1B, TCF7L1, ZBTB42, FOXD3, PTF1A, HLF, ZMIZ1, NFIX, RBPJ, ZNF771, RECK	blood vessel maturation [BP], chromo shadow domain binding [MF], regulation of transcription, DNA-dependent [BP], ephrin receptor signaling pathway [BP], sequence-specific DNA binding transcription factor activity [MF], transcription, DNA-dependent [BP], tissue development [BP], embryo development [BP], gene expression [BP], RNA metabolic process [BP], negative regulation of gene expression [BP]
CG_h9laurent_promoter_p_RM_12_432_21			1	0.25	3.46E-04	CUL4A, PRDM2, RBX1, DOT1L, TAOK2, MAP3K3	activation of MAPKK activity [BP], Cul4A-RING ubiquitin ligase complex [CC], histone-lysine N-methyltransferase activity [MF]
CG_h9laurent_promoter_p_RM_14_149_24			2	0.25	5.42E-04	PTPLAD1, FOXO3, RCOR1, MAFF, NFX1, CEBPG, RALGAPB, NR2F1, ADRA2C, BRPF3, EN2, ZIC2, CABLES1, SIPA1L3, MTA1, DGKE, ITGB3, GREM1, RAC1, TXLNG, MLLT10, ARNT2, HABP4, ADCY2, EMX2, TLX1, PRDM2, PDPK1, ARHGAP44	wound healing [BP], epithelial cell morphogenesis [BP], platelet activation [BP], sequence-specific DNA binding transcription factor activity [MF], blood coagulation [BP], vascular endothelial growth factor receptor 2 binding [MF], protein heterodimerization activity [MF], GTPase activator activity [MF], cell-matrix adhesion [BP]
CG_h9laurent_promoter_p_RM_14_193_13			5	0.5	2.60E-04	PHRF1, ENPP1, CLN5	sequestering of triglyceride [BP], vacuolar lumen [CC], RNA polymerase binding [MF]
CG_h9laurent_promoter_p_RM_12_120_15			4	0.5	3.81E-04	ABCG1, CDK13, MSH2, DUSP5, MYO9B, CDH1, DUSP14, FGFR3, RCC1	cochlea development [BP], regulation of mitosis [BP], MAP kinase tyrosine/serine/threonine phosphatase activity [MF], ADP binding [MF]
CG_h9laurent_promoter_p_RM_12_344_29			3	0.5	2.88E-04	DYRK2, ECE2, MAP2K5, DGKZ, PMPCA, ASXL3, COMMD1, ATP8A2, IRAK3, CNOT6, CLIC6, TSSK3, WRN, RHOU, SRR, STK4, RIMKLA, THAP3, RNF187, PIAS4, PALM, RNF4, SHISA9, RNF213, CDKN1A	protein autoubiquitination [BP], dendritic spine membrane [CC], metal ion binding [MF], magnesium ion binding [MF], negative regulation of NF-kappaB transcription factor activity [BP], D3 dopamine receptor binding [MF]
CG_h9laurent_promoter_p_RM_12_26_12			1	0.25	2.30E-04	ACVRL1, NLGN3, MAP4K4, STK4, HPN, KCNN1, MARK3, SPEG, RTN4RL2, RIOK3	protein serine/threonine kinase activity [MF], cell surface [CC], calcium-activated potassium channel activity [MF]
CG_h9laurent_promoter_p_RM_12_562_11			3	0.5	3.25E-04	LMNA	nuclear envelope organization [BP]
CG_h9laurent_promoter_p_RM_12_390_10			4	0.5	4.90E-04	SUN1	nuclear matrix anchoring at nuclear membrane [BP]
CG_h9laurent_promoter_p_RM_14_84_14			3	0.25	3.79E-04	ACVR1B, RNF169, HMGA1, SMARCD1, ING2, ACVR2A	response to DNA damage stimulus [BP], activin binding [MF], inhibin binding [MF], activin-activated receptor activity [MF], transforming growth factor beta-activated receptor activity [MF], nucleosome disassembly [BP], positive regulation of activin receptor signaling pathway [BP], transmembrane receptor protein serine/threonine kinase activity [MF], regulation of cellular senescence [BP]
CG_h9laurent_promoter_p_RM_12_589_16			2	0.25	2.54E-04	HTRA2, IGF1R	pentacyclic triterpenoid metabolic process [BP], inactivation of MAPKK activity [BP]
CG_h9laurent_promoter_p_RM_12_157_14			1	0.25	2.85E-04	GPX4, ME2, DOLPP1	malate dehydrogenase (decarboxylating) activity [MF], dolichyldiphosphatase activity [MF], phospholipid-hydroperoxide glutathione peroxidase activity [MF]
CG_h9laurent_promoter_p_RM_12_185_20			2	0.5	3.25E-04	NOLC1, RRP36, RRP1	rRNA processing [BP]
CG_h9laurent_promoter_p_RM_12_229_14			3	0.5	2.66E-04	TGFB2, PLCB3, SMARCB1, OSGIN2, PKD2, PIK3CD, SPHK1, GATA3, CTNNB1, INHBB, INADL, ING5, KAT6B, RALB, RASA2, MAEA	cell death [BP], cell cycle [BP], germ cell development [BP], cellular response to fluid shear stress [BP], oocyte development [BP], negative regulation of cell cycle [BP], mast cell differentiation [BP], MOZ/MORF histone acetyltransferase complex [CC], intracellular signal transduction [BP]
CG_h9laurent_promoter_p_RM_12_442_11			1	0.25	3.30E-04	ID2	negative regulation of DNA binding [BP]
CG_h9laurent_promoter_p_RM_12_16_15			4	0.75	2.76E-04	SYNDIG1, HLA-F, HLA-E, HLA-A	MHC class I receptor activity [MF], early endosome membrane [CC], phagocytic vesicle membrane [CC], integral to lumenal side of endoplasmic reticulum membrane [CC], MHC class I protein complex [CC], antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent [BP], ER to Golgi transport vesicle membrane [CC]
CG_h9laurent_promoter_p_RM_14_293_8			2	0.25	3.07E-04	BMP2, FOS, PSEN1, FZR1, PSMD11, ARHGEF1, FOXL1, NELL1, GPR3	negative regulation of axonogenesis [BP], ubiquitin-dependent protein catabolic process [BP], cell proliferation [BP], S phase of mitotic cell cycle [BP], SMAD protein signal transduction [BP], negative regulation of ubiquitin-protein ligase activity [BP], positive regulation of Wnt receptor signaling pathway by BMP signaling pathway [BP], Cajal-Retzius cell differentiation [BP], positive regulation of ossification [BP], negative regulation of cell cycle [BP], visceral mesoderm-endoderm interaction involved in midgut development [BP], regulation of meiosis [BP], positive regulation of bone mineralization [BP]
CG_h9laurent_promoter_p_RM_16_42_4			2	0.25	3.01E-04	PNRC2	deadenylation-independent decapping of nuclear-transcribed mRNA [BP]
CG_h9laurent_promoter_p_RM_14_15_18			3	0.25	4.01E-04	PLXNA1, PLXNA3	semaphorin receptor complex [CC], semaphorin receptor activity [MF]
CG_h9laurent_promoter_p_RM_14_200_10			3	0.5	2.95E-04	IGF1R, ATAD3C, PKN3, NTRK1, ATP11B, CHD3, DHX30, DGKZ	ATP binding [MF]
CG_h9laurent_promoter_p_RM_12_374_14			4	0.75	3.71E-04	TCEB3, CAB39, AIMP2, MSN, EP400, RHOT1, RHOT2, SMARCA2, SOX1, RARA, PPP1R1B, DMBX1, NR2F2, RAI1, GPR124, ZIC2, CAMTA1, MORF4L1, GABPB2, B3GNT4, TCF7, ACVRL1, RAC1, TSHZ1, HOXD1, TRRAP, BAMBI, DAG1, MERTK, TBL1X, ABHD6, FGF2, PRDM12, ZNF526, GALNT10, RPL10A, RGCC, PDPK1, ZNF37A, CCDC85B, ZNF771, PHF16	regulation of transcription, DNA-dependent [BP], NuA4 histone acetyltransferase complex [CC], negative regulation of endothelial cell proliferation [BP], cellular component movement [BP], histone acetylation [BP], cell migration [BP], chondroblast differentiation [BP], histone acetyltransferase complex [CC], RNA metabolic process [BP], histone H4 acetylation [BP], apoptotic cell clearance [BP], negative regulation of blood vessel endothelial cell migration [BP], regulation of endothelial cell migration [BP], regulation of endothelial cell proliferation [BP], histone H2A acetylation [BP], endothelial cell migration [BP], lymphatic endothelial cell differentiation [BP], negative regulation of cell migration [BP], regulation of transcription from RNA polymerase II promoter [BP], regulation of cell migration [BP], gene expression [BP], kinase binding [MF], cellular protein metabolic process [BP], mitochondrion transport along microtubule [BP], transcription, DNA-dependent [BP], cell motility [BP], negative regulation of endothelial cell migration [BP]
CG_h9laurent_promoter_p_RM_12_539_8			3	0.5	3.40E-04	LMX1B, CEBPG, FOXF2, ZNF397, HNRNPAB	sequence-specific DNA binding transcription factor activity [MF]
CG_h9laurent_promoter_p_RM_12_471_20			1	0.25	2.63E-04	SLC25A26, SKIL, HTRA2, TALDO1, FAS	S-adenosyl-L-methionine transport [BP], lymphocyte homeostasis [BP], pentacyclic triterpenoid metabolic process [BP], sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [MF], S-adenosyl-L-methionine transmembrane transporter activity [MF], response to toxin [BP]
CG_h9laurent_promoter_p_RM_12_519_13			2	0.25	2.80E-04	RYR2, CACNA1C, NCS1, CACNG8	voltage-gated calcium channel activity [MF], calcium channel activity [MF], calcium channel complex [CC], cell communication by electrical coupling involved in cardiac conduction [BP], regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [BP]
CG_h9laurent_promoter_p_RM_18_5_3			2	0.25	4.17E-04	B3GALT6, AP2M1	clathrin coat of coated pit [CC], clathrin adaptor complex [CC], galactosylxylosylprotein 3-beta-galactosyltransferase activity [MF], clathrin-coated endocytic vesicle membrane [CC]
CG_h9laurent_promoter_p_RM_12_189_14			1	0.25	2.65E-04	ZIC2, EPHB2	retinal ganglion cell axon guidance [BP]
CG_h9laurent_promoter_p_RM_12_499_13			3	0.5	3.25E-04	RASSF3, FCHO1, AGRN, TNFRSF14, MDH2, C2orf88, SEPT7, SPTBN4, OPRL1, HTRA2, CCKBR, CACNA1D, PLEKHH2, KCNK3, RAB18, SLC50A1, DIO3, EFR3A, NKAIN2, SCN8A, EFNA2, CD40, LY96, CTNS, AKAP5, CA9, NAA35, WNT1, SLC5A2, PRRT2, ITM2C, PDE6C, OPRD1, GPR114, SLC1A1, ASAP2, PRSS41	plasma membrane [CC], clustering of voltage-gated sodium channels [BP], adult walking behavior [BP], adult locomotory behavior [BP]
CG_h9laurent_promoter_p_RM_14_32_7			2	0.25	3.51E-04	AKAP13, ADCY2, SMPD2, NR4A1	nerve growth factor receptor signaling pathway [BP]
CG_h9laurent_promoter_p_RM_18_8_21			4	0.25	4.58E-04	ZFX, GDF7, HIPK1, ZXDB, TNRC6A, FAM50A, PPP4C, KDM2A, MTMR3, MTMR1, DHX9, TRIM28, TRIM24, ZNF362, KCNF1, BRSK2, DR1, ARID1A, TCF7L1, RUNX2, PTEN, ATMIN, XPO7, CARM1, PDS5B, HABP4, POLR1C, SEPT7, KLHDC2, CDC16, TSPYL2, UBAP2L, MKL2, EN2, ZIC2, XPOT, TTC3, KCNQ5, MLLT10, CUX1, TLK2, ZNF618, HOXD10, POLE4, AGO4, ALKBH5, GGNBP2, KDM1A, KDM1B, AFTPH, DYRK2, FZD1, FGF18, DUSP9, MVP, POMP, NLGN1, WAC, KAT2B, TRIOBP, ID4, ADRB1, BASP1, PHF17, KCNC1, BIRC7, SOX8, PRELID1, FMR1, RAB5A, SOX1, CAND1, BHLHE22, NPAS2, KCNK2, GPR124, UBE2Z, KCNS2, POU3F2, NR4A3, CASC3, CHD7, ZBED4, ZNF711, NFIX, ILF3, FBXO18	brain development [BP], generation of neurons [BP], positive regulation of heart growth [BP], nucleus [CC], delayed rectifier potassium channel activity [MF], phosphatidylinositol-3-phosphatase activity [MF], histone demethylase activity (H3-dimethyl-K4 specific) [MF], demethylase activity [MF], histone acetyltransferase complex [CC], neuron differentiation [BP], regulation of neuron differentiation [BP], synaptic vesicle clustering [BP], chromatin organization [BP], nervous system development [BP], neurogenesis [BP], micro-ribonucleoprotein complex [CC], positive regulation of transcription, DNA-dependent [BP], central nervous system development [BP], locomotor rhythm [BP], chromatin modification [BP], Ada2/Gcn5/Ada3 transcription activator complex [CC], histone demethylase activity [MF], protein demethylation [BP], nucleoplasm [CC], voltage-gated potassium channel complex [CC]
CG_h9laurent_promoter_p_RM_14_230_6			3	0.25	2.78E-04	PDPK1, UBE2D1, FNDC1, EPO, HSP90AB1	regulation of transcription from RNA polymerase II promoter in response to hypoxia [BP], response to salt stress [BP], cellular response to hypoxia [BP], hyperosmotic response [BP]
CG_h9laurent_promoter_p_RM_12_239_16			3	0.5	2.33E-04	SERPINF2, SHROOM2, GPR124, SCNN1D, CDK5R1, UBC, PAFAH1B1, MALT1, TACC1	protease binding [MF], ligand-gated sodium channel activity [MF], microtubule cytoskeleton organization [BP], brain development [BP], central nervous system development [BP], layer formation in cerebral cortex [BP], regulation of microtubule-based process [BP]
CG_h9laurent_promoter_p_RM_12_155_12			5	0.5	3.97E-04	TRRAP	histone deubiquitination [BP]
CG_h9laurent_promoter_p_RM_12_313_10			3	0.5	2.48E-04	SCAF8, PHRF1, GCKR, SPEN, TYMS, MAPK7, SKI, SIRT1	enzyme binding [MF], triglyceride homeostasis [BP], mitogen-activated protein kinase binding [MF], RNA polymerase binding [MF], nucleotide binding [MF]
CG_h9laurent_promoter_p_RM_12_570_25			4	0.75	3.90E-04	PPP2R1A, ZRANB1, VBP1, PLK1, CLIC4, ZNF696, ARF6, UBE2L3, CHAT, NLRC5, SOX2, SIX3, SOX1, SMARCA4, SWSAP1, POLI, ZMIZ2, HNRNPM, FNIP2, ZBTB10, HIC1, NFE2L3, KLHDC2, NDST3, BMP2K, NR2F2, ZNF783, ZNF341, SOBP, FOXF1, ARPC2, CDCA8, DMTF1, KLF2, B3GALT6, ATP6V0E1, RNF4, BUB3, KIAA1967, HNRNPA3, ZBTB9, CAMK4, PRKAA2, POU4F2, CCRN4L, ZNF584, HEXIM2, ZNF302, PSMA8, TYRO3, SREK1, PRDM13, BRSK1, DR1, PLXNA1, ADCYAP1R1, TCF7L1, MTG1, ZBTB42, HS3ST3B1, UBC, SRRD, COQ7, ZNF549, CTCF, ZNF292, BPTF	neurogenesis [BP], heparan sulfate proteoglycan biosynthetic process [BP], rhythmic process [BP], negative regulation of cyclin-dependent protein kinase activity [BP], negative regulation of transcription from RNA polymerase II promoter [BP], endosome [CC], nucleus [CC], intracellular membrane-bounded organelle [CC], SUMO polymer binding [MF], vacuolar acidification [BP]
CG_h9laurent_promoter_p_RM_12_517_14			2	0.5	3.40E-04	ZFP42, FOXC1, ZMIZ1	in utero embryonic development [BP]
CG_h9laurent_promoter_p_RM_12_319_14			4	0.5	3.39E-04	AIP, SMC4, PDE4A	regulation of protein kinase A signaling cascade [BP], kinetochore organization [BP]
CG_h9laurent_promoter_p_RM_12_598_12			2	0.25	2.70E-04	EPB49, VIL1	actin filament depolymerization [BP], lysophosphatidic acid binding [MF], actin filament capping [BP]
CG_h9laurent_promoter_p_RM_12_88_24			3	0.5	3.01E-04	ADCY1, SLC24A4, KCNN1, GNAL, GCGR, SPTBN4, SPTBN1, KCNC1, KCNJ12	spectrin [CC], adenylate cyclase-activating G-protein coupled receptor signaling pathway [BP], potassium ion transport [BP]
CG_h9laurent_promoter_p_RM_12_115_7			2	0.25	3.27E-04	PGS1, SMS, PQLC2, SOX17, MOCS3	CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity [MF], cardiogenic plate morphogenesis [BP], URM1 activating enzyme activity [MF], lysine transport [BP], spermine synthase activity [MF], inner cell mass cellular morphogenesis [BP], enzyme active site formation via L-cysteine persulfide [BP], amino acid homeostasis [BP], regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification [BP]
CG_h9laurent_promoter_p_RM_12_574_31			3	0.5	3.40E-04	DGKA, SPHK1	diacylglycerol kinase activity [MF]
CG_h9laurent_promoter_p_RM_12_331_28			2	0.25	3.00E-04	SMOC1	regulation of osteoblast differentiation [BP]
CG_h9laurent_promoter_p_RM_12_7_12			2	0.5	2.82E-04	CHD2, C12orf52, MET, PKN1, PTF1A, SMAD6, ZNF865, CNTNAP1, ZAR1, INHBB, NEO1, CDK5R1, ABL1, CATSPER4, ARID3A	neurogenesis [BP], regulation of transcription, DNA-dependent [BP], axon guidance [BP], response to laminar fluid shear stress [BP], multicellular organismal development [BP], cell differentiation [BP], regulation of transcription from RNA polymerase II promoter [BP]
CG_h9laurent_promoter_p_RM_12_434_8			3	0.5	2.82E-04	ADM, RYR2	positive regulation of heart rate [BP]
CG_h9laurent_promoter_p_RM_12_196_5			1	0.25	3.57E-05	FGFR3, CAV1, NAT8L	positive regulation of canonical Wnt receptor signaling pathway [BP], aspartate N-acetyltransferase activity [MF]
CG_h9laurent_promoter_p_RM_12_413_18			5	1.0	2.93E-04	ASB1, FOXE1, ISL2, NR4A1, TDRD7, PPARD, OSTF1, SHROOM2, CUX2, COL5A1, FOXF1, FOXF2, ZNF236, HLF, PTF1A, HEY2, LZTR1, NFIC	intracellular [CC], sequence-specific DNA binding transcription factor activity [MF], camera-type eye morphogenesis [BP], sequence-specific DNA binding [MF], lens morphogenesis in camera-type eye [BP], eye morphogenesis [BP]
CG_h9laurent_promoter_p_RM_14_71_6			1	0.25	4.21E-04	ENDOG	response to antibiotic [BP]
CG_h9laurent_promoter_p_RM_14_73_4			3	0.25	5.59E-04	SUV39H1	chromatin silencing at rDNA [BP]
CG_h9laurent_promoter_p_RM_14_66_8			2	0.25	3.35E-04	CHRNB1, PODXL2, INHBB, TSPAN4, NRG3, BAI1	negative regulation of hepatocyte growth factor biosynthetic process [BP], integral to plasma membrane [CC]
CG_h9laurent_promoter_p_RM_12_226_8			1	0.25	3.13E-04	TRAF2, CCRL1, TNFRSF11A, TRPM4	tumor necrosis factor-mediated signaling pathway [BP], chemotaxis [BP], regulation of T cell cytokine production [BP]
CG_h9laurent_promoter_p_RM_16_5_14			3	0.25	4.50E-04	EPHX2, TSC2, FOXG1, LMO4, CUX1, BMPR2, SKI, FOXC1, BMP6	cell proliferation [BP], lymphangiogenesis [BP], SMAD protein signal transduction [BP], embryo development ending in birth or egg hatching [BP], nose development [BP], dephosphorylation [BP], neural tube closure [BP], regulation of transcription from RNA polymerase II promoter [BP]
CG_h9laurent_promoter_p_RM_12_493_25			3	0.75	4.04E-04	SIRT1, UTP18, ALDH1A3, NOC4L	NAD+ binding [MF], rRNA processing [BP]
CG_h9laurent_promoter_p_RM_12_393_21			3	0.5	3.79E-04	CDKN1B, RBPJ, STK11, RPS6KB2, FOXO3, PHLPP1, ADCY1	phosphatidylinositol-mediated signaling [BP], negative regulation of epithelial cell proliferation involved in prostate gland development [BP], endocardium morphogenesis [BP], fibroblast growth factor receptor signaling pathway [BP]
CG_h9laurent_promoter_p_RM_12_248_10			2	0.5	2.94E-04	NYAP1	neuron projection morphogenesis [BP]
CG_h9laurent_promoter_p_RM_12_301_8			4	0.5	2.89E-04	DRD5, TRIM28, LRRFIP1, RASL11A, IKZF1, DNASE1L2, NPAS4, JDP2, SP5, SS18L1, ZNF485, BARX2, RABGAP1, PRDM2, RGCC, MYC, LMX1B, CBX3, DRD4, LHX2	positive regulation of DNA biosynthetic process [BP], dopamine neurotransmitter receptor activity [MF], regulation of transcription, DNA-dependent [BP], transcription, DNA-dependent [BP], sequence-specific DNA binding [MF], centromeric heterochromatin [CC], dopamine binding [MF], DNA binding [MF], nuclear euchromatin [CC]
CG_h9laurent_promoter_p_RM_12_90_21			2	0.5	4.34E-04	LRRK2, P2RX2	neuromuscular junction development [BP]
CG_h9laurent_promoter_p_RM_12_37_19			3	0.5	2.94E-04	GRIN1, IDUA, INHA	inhibin A complex [CC], L-iduronidase activity [MF], propylene metabolic process [BP]
CG_h9laurent_promoter_p_RM_12_186_12			5	0.75	2.82E-04	RGS20, LIME1, LLGL1, PSEN2, TBCD, PIK3CD, CRHBP, CD4, RIN3, PDPK1, CLPSL1, ADORA2A	T cell receptor signaling pathway [BP], axon [CC], positive regulation of catalytic activity [BP], enzyme activator activity [MF], GTPase activator activity [MF], synaptic transmission, dopaminergic [BP]
CG_h9laurent_promoter_p_RM_12_252_19			3	0.5	3.59E-04	CISD1, WRNIP1, LANCL2, ATP8B2, SKIL, SKI, RNF213, PRDM16	negative regulation of transforming growth factor beta receptor signaling pathway [BP], catalytic activity [MF], SMAD binding [MF], protein homotrimerization [BP], regulation of cellular respiration [BP], ATP catabolic process [BP], ATPase activity [MF]
CG_h9laurent_promoter_p_RM_14_52_2			2	0.25	2.33E-04	TRMT61A	tRNA (m1A) methyltransferase complex [CC]
CG_h9laurent_promoter_p_RM_14_75_5			2	0.25	2.71E-04	EGLN2, OGFOD1, CCNE1, RPA1, TFDP1, ST3GAL3	N-acetyllactosaminide alpha-2,3-sialyltransferase activity [MF], oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors [MF], L-ascorbic acid binding [MF], G1/S transition of mitotic cell cycle [BP]
CG_h9laurent_promoter_p_RM_12_527_24			4	0.5	2.27E-04	MLPH, FOXD3	RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription [MF], melanocyte differentiation [BP]
CG_h9laurent_promoter_p_RM_16_9_3			2	0.25	3.98E-04	EGR1, SRD5A3	positive regulation of glomerular metanephric mesangial cell proliferation [BP], polyprenol catabolic process [BP]
CG_h9laurent_promoter_p_RM_12_256_11			3	0.5	3.26E-04	SYNM, DAG1, SORBS3	vinculin binding [MF]
CG_h9laurent_promoter_p_RM_14_244_17			3	0.25	3.53E-04	MAVS, CDK1	positive regulation of protein import into nucleus, translocation [BP]
CG_h9laurent_promoter_p_RM_12_350_10			2	0.5	2.75E-04	HABP4, ID4, TBX1, CTNNB1	negative regulation of oligodendrocyte differentiation [BP], tongue morphogenesis [BP], regulation of secondary heart field cardioblast proliferation [BP], sarcomere [CC]
CG_h9laurent_promoter_p_RM_12_566_23			2	0.25	3.68E-04	VIL1, ACSF3, BCL2L11, FAHD1	cytoplasmic actin-based contraction involved in cell motility [BP], malonate catabolic process [BP], lysophosphatidic acid binding [MF], malonyl-CoA synthetase activity [MF], BIM-BCL-xl complex [CC], fumarylpyruvate hydrolase activity [MF], acylpyruvate hydrolase activity [MF], BIM-BCL-2 complex [CC], acetylpyruvate hydrolase activity [MF]
CG_h9laurent_promoter_p_RM_12_356_16			3	0.5	3.99E-04	POLA1, PDLIM5, ZAR1, ISL1, RAD9A, EGFR, RAP1B, ABCA7, CRTC3, POLR1E, FBXO6, PANX1, KCNA5, GNAI1, PPP1R7, JMY, WASF3, CHRNB1, CACNA1C, CACNA1D, EML4, RELT, MCU, ZNF346, DLGAP4, IRX5, NRBF2, TROAP, RAP2B, KCNJ12, RAP2A, HEATR2, OXT, GNB2, CSNK1G2, AGAP1, FPGS, ADSSL1, NPM1, ZMIZ1, DUSP12, BBS9, MLLT4, SMARCB1, BRSK2, CAMSAP3, RNF187, RUNX2, ADRB1, BANF2, ARHGAP33, KLHDC8B, RNF4, ID4, KLHL24	neurological system process [BP], Rap protein signal transduction [BP], synaptic transmission [BP], alpha-actinin binding [MF], cytoplasm [CC], negative regulation of urine volume [BP], insulin secretion [BP], regulation of atrial cardiac muscle cell membrane repolarization [BP], calcium channel activity [MF], positive regulation of interleukin-1 alpha production [BP], actinin binding [MF], cell-cell signaling [BP], regulation of heart rate [BP], high voltage-gated calcium channel activity [MF], Tat protein binding [MF], regulation of insulin secretion [BP], regulation of heart contraction [BP]
CG_h9laurent_promoter_p_RM_12_322_28			2	0.5	4.54E-04	SFI1, SLC9A3R1, NSG1, COL5A1, PPARA, IGF1R	phosphatase binding [MF], proteoglycan binding [MF], dopamine receptor binding [MF], negative regulation of protein kinase B signaling cascade [BP]
CG_h9laurent_promoter_p_RM_12_466_13			6	0.75	3.68E-04	RGS20, SPATS2L, BRSK2, MICALL1, MACF1, USP10, UBE2E3, AHSA1, BASP1, OPRD1, SH2D4A, PCMTD2	establishment or maintenance of cell polarity [BP], cytoplasm [CC]
CG_h9laurent_promoter_p_RM_12_549_10			2	0.25	2.74E-04	B4GALNT3, MAF1, PLXNA1, GMCL1, TPGS1, PRDX5, EBF4, B4GALNT4	multicellular organismal development [BP], N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity [MF], RNA polymerase III regulatory region DNA binding [MF], negative regulation of transcription from RNA polymerase III promoter [BP]
CG_h9laurent_promoter_p_RM_14_127_9			2	0.25	2.61E-04	LRP5, SLC12A2	branching involved in mammary gland duct morphogenesis [BP]
CG_h9laurent_promoter_p_RM_16_60_19			3	0.5	3.81E-04	ADORA2A, ARHGAP10, INPPL1, KHDRBS3, OXT	regulation of norepinephrine secretion [BP], response to amphetamine [BP], positive regulation of renal sodium excretion [BP], SH3 domain binding [MF], eating behavior [BP]
CG_h9laurent_promoter_p_RM_12_482_20			1	0.25	1.79E-04	MCU, PPOX	oxygen-dependent protoporphyrinogen oxidase activity [MF], protein complex oligomerization [BP], uniporter activity [MF]
CG_h9laurent_promoter_p_RM_14_291_14			2	0.25	3.37E-04	OLFML2A, TGFBR1, COL9A3, TIMP1, PRDM16	palate development [BP], extracellular matrix organization [BP], extracellular structure organization [BP]
CG_h9laurent_promoter_p_RM_14_267_11			3	0.5	2.92E-04	TYRO3, CORO1A	phosphatidylinositol 3-kinase binding [MF]
CG_h9laurent_promoter_p_RM_12_288_12			2	0.25	2.95E-04	TIMP1, OXT, ISL1, FOSL2, NPAS3, COL9A3, ONECUT3, NR2F1, CUX1, STAT5A, ZIC2, FOXF1, LHX9, EMX2, P2RX4, HSF1	maternal behavior [BP], transcription regulatory region DNA binding [MF], positive regulation of prostaglandin secretion [BP], sequence-specific DNA binding transcription factor activity [MF], sequence-specific DNA binding [MF], transcription regulatory region sequence-specific DNA binding [MF], cardiac muscle cell myoblast differentiation [BP], extracellular matrix organization [BP]
CG_h9laurent_promoter_p_RM_12_346_5			2	0.25	3.30E-04	CCDC64, UBC, ISCU	hypothalamus gonadotrophin-releasing hormone neuron development [BP], nitrogen fixation [BP], Golgi to secretory granule transport [BP]
CG_h9laurent_promoter_p_RM_14_358_12			4	0.5	3.66E-04	ARL8B, TGFBR1, RIPK1, PIM3, PLK1	spindle midzone [CC], protein serine/threonine kinase activity [MF]
CG_h9laurent_promoter_p_RM_12_546_25			2	0.25	3.60E-04	ARHGEF10, C12orf52, EPN2, ADRA2C, UBC, P2RY1, SKI, NEURL1B	myelination in peripheral nervous system [BP], negative regulation of norepinephrine secretion [BP], Notch signaling pathway [BP]
CG_h9laurent_promoter_p_RM_12_193_15			2	0.25	2.15E-04	MYO6, TPM4	filamentous actin [CC]
CG_h9laurent_promoter_p_RM_14_131_12			3	0.5	3.27E-04	TGFBR1, HHEX, NELFB, MACF1, ID2, ZIC2, SMYD2, PPARA, LCOR, PTPRM, MYB, HOXC8	skeletal system morphogenesis [BP], B cell differentiation [BP], negative regulation of transcription from RNA polymerase II promoter [BP], retinal ganglion cell axon guidance [BP], negative regulation of transcription, DNA-dependent [BP], positive regulation of Wnt receptor signaling pathway [BP], negative regulation of gene expression [BP], transcription from RNA polymerase II promoter [BP]
CG_h9laurent_promoter_p_RM_14_54_2			2	0.25	3.72E-04	CRTAP	peptidyl-proline hydroxylation to 3-hydroxy-L-proline [BP]
CG_h9laurent_promoter_p_RM_12_312_11			2	0.25	3.58E-04	PHPT1, LHPP, CCNE1, LANCL2	catalytic activity [MF], phosphohistidine phosphatase activity [MF], kinase activity [MF]
CG_h9laurent_promoter_p_RM_12_488_25			3	0.75	3.62E-04	TLL1, FGFRL1, BLOC1S3, NOG, HOXD11, PI4K2A, YAP1, INHA	notochord development [BP], BLOC-1 complex [CC], embryonic skeletal joint morphogenesis [BP], skeletal system development [BP]
CG_h9laurent_promoter_p_RM_16_32_2			2	0.25	3.35E-04	SPATA18	mitochondrion degradation by induced vacuole formation [BP]
CG_h9laurent_promoter_p_RM_12_500_13			4	0.75	3.15E-04	TGFBR1, CHRNB1, SIVA1, STUB1, BMPR1B, SKI, DNAJA3	negative regulation of transforming growth factor beta receptor signaling pathway [BP], SMAD binding [MF], postsynaptic membrane organization [BP], activation-induced cell death of T cells [BP], transforming growth factor beta-activated receptor activity [MF], transforming growth factor beta receptor activity, type I [MF], transmembrane receptor protein serine/threonine kinase activity [MF]
CG_h9laurent_promoter_p_RM_14_372_26			2	0.25	4.07E-04	BHLHE22, KL, IRX5	retinal bipolar neuron differentiation [BP], vitamin D binding [MF]
CG_h9laurent_promoter_p_RM_14_142_12			4	0.75	3.30E-04	FSTL3, SKI	negative regulation of activin receptor signaling pathway [BP]
CG_h9laurent_promoter_p_RM_12_66_18			4	0.75	3.94E-04	HIC1, TRIM71, SMAD4, RXRA, EN2, IRX5, HLF, AGO1, CEBPG	negative regulation of translation involved in gene silencing by miRNA [BP], sequence-specific DNA binding [MF]
CG_h9laurent_promoter_p_RM_14_93_8			2	0.25	3.75E-04	CHST11, GATA6	polysaccharide localization [BP], negative regulation of transforming growth factor beta2 production [BP], smooth muscle cell differentiation [BP]
CG_h9laurent_promoter_p_RM_14_385_17			5	0.75	3.74E-04	RASSF5, CARM1, MAFK, DPH3P1, CPQ, SKI, UGP2, DGKZ, NT5M, KDM2A, ENPP1, POU3F3, CISD3, UBE2E1, HMGA1, E4F1, LCOR, PAX2, SART1, PHLPP1, ZEB1, SQSTM1, SNRPD3, GALNT10, DNAJA4, VPS18, IRF9, PSMD13, ADARB1, MLPH, ITGA3	metanephric distal convoluted tubule development [BP], metal ion binding [MF], nucleoplasm [CC], metanephric DCT cell differentiation [BP], transcription from RNA polymerase II promoter [BP], regulation of transcription from RNA polymerase II promoter [BP]
CG_h9laurent_promoter_p_RM_12_133_8			2	0.5	7.69E-05	IRAK3, BMPR1B, UNCX, AP1AR, ARHGEF10	positive regulation of macrophage tolerance induction [BP], regulation of Arp2/3 complex-mediated actin nucleation [BP], cartilage condensation [BP], positive regulation of GTP catabolic process [BP]
CG_h9laurent_promoter_p_RM_12_411_11			3	0.75	3.68E-04	YWHAH, GRK4, ADRBK2, PGM5, CXADR	G-protein coupled receptor kinase activity [MF], intercalated disc [CC]
CG_h9laurent_promoter_p_RM_12_580_12			2	0.25	4.10E-04	POU4F3, PAX2, POU3F3	vestibulocochlear nerve development [BP], metanephric DCT cell differentiation [BP], metanephric distal convoluted tubule development [BP]
CG_h9laurent_promoter_p_RM_12_1_17			2	0.5	2.15E-04	PGD	D-gluconate metabolic process [BP]
CG_h9laurent_promoter_p_RM_12_378_24			3	0.5	3.52E-04	DEPTOR, ID1, CDKN1B	negative regulation of kinase activity [BP], negative regulation of protein kinase activity [BP], response to antibiotic [BP]
CG_h9laurent_promoter_p_RM_16_27_3			2	0.25	5.15E-04	CHD7, FOXO3	nose development [BP], embryo development [BP]
CG_h9laurent_promoter_p_RM_16_8_40			2	0.25	4.19E-04	AMOTL1, RYR2, RRP1B, ZNF236, FOXG1, PPRC1, HOXC5, VAPA, TACC1, ZNF592, USP9X, TBX4, EXOSC2, COL19A1, BCR, EHMT1, CEBPB, KLF11, JMY, ASXL1, ASXL3, EGR1, UNCX, PKNOX1, BRPF1, CDK5R1, ZIC3, KCNIP3, NRTN, KLF2, SLC44A1, SLC6A8, POGK, TRIM24, DIXDC1, CELSR2, TRRAP, PAPPA, CUX1, CREB1, GMEB1, FGFR3, ABCG1, ZFYVE27, BMP2, SNAPC2, RNF2, ARID1A, NOG, ID2, CCNY, ATL1, INSM1, SPEN, BMPR2, MAF1, LMO4, DAZAP1, NAB1, HIVEP1, FOXC1, BPTF	brain development [BP], nuclear chromatin [CC], anterior/posterior pattern specification [BP], choline transmembrane transporter activity [MF], euchromatin [CC], nervous system development [BP], regulation of transcription, DNA-dependent [BP], neuron differentiation [BP], pattern specification process [BP], RNA metabolic process [BP], transmembrane receptor protein tyrosine kinase signaling pathway [BP], cell differentiation [BP], neurogenesis [BP], axonogenesis [BP], BMP signaling pathway [BP], negative regulation of gene expression [BP], regulation of transcription from RNA polymerase II promoter [BP], Wnt receptor signaling pathway [BP], neuron projection development [BP], regulation of cell size [BP], negative regulation of transcription from RNA polymerase II promoter [BP], forebrain development [BP], transcription, DNA-dependent [BP], negative regulation of transcription, DNA-dependent [BP], transcription from RNA polymerase II promoter [BP]
CG_h9laurent_promoter_p_RM_12_254_18			3	0.5	3.42E-04	NARF, SCNN1B, SHROOM2, PLCB1	ligand-gated sodium channel activity [MF], lamin binding [MF]
CG_h9laurent_promoter_p_RM_12_142_18			4	0.75	3.27E-04	VWC2, IL27RA, YY1, CAV1, RPTOR	negative regulation of BMP signaling pathway [BP], interleukin-27 receptor activity [MF], TFIIIC-class transcription factor binding [MF], response to prostaglandin F stimulus [BP]
CG_h9laurent_promoter_p_RM_12_573_22			2	0.25	4.47E-04	CFLAR	enzyme activator activity [MF]
CG_h9laurent_promoter_p_RM_14_351_3			1	0.25	3.73E-04	SKI, PAX2, NT5E	optic chiasma development [BP], positive regulation of optic nerve formation [BP], adenosine biosynthetic process [BP], somatic stem cell maintenance [BP], vestibulocochlear nerve formation [BP]
CG_h9laurent_promoter_p_RM_12_420_12			2	0.25	3.08E-04	UST, SETMAR, UBE2V2	DNA double-strand break processing [BP], protein sulfation [BP]
CG_h9laurent_promoter_p_RM_14_78_9			2	0.25	3.10E-04	EGLN2, F2R, ADRA2C, OXT	regulation of sensory perception of pain [BP], regulation of neuron apoptotic process [BP]
CG_h9laurent_promoter_p_RM_12_326_19			3	0.25	2.11E-04	PRMT3	protein-arginine N-methyltransferase activity [MF]
CG_h9laurent_promoter_p_RM_16_21_5			4	0.5	6.19E-04	EFNA3, NTRK2, ADCY2, ADCYAP1R1	ephrin receptor binding [MF], adenylate cyclase binding [MF], activation of adenylate cyclase activity [BP], cAMP biosynthetic process [BP]
CG_h9laurent_promoter_p_RM_12_127_21			4	0.75	2.56E-04	DBH, DRD4, UBR3	olfactory behavior [BP], behavioral response to ethanol [BP]
CG_h9laurent_promoter_p_RM_12_410_4			4	0.75	3.27E-04	PPOX	oxygen-dependent protoporphyrinogen oxidase activity [MF]
CG_h9laurent_promoter_p_RM_12_433_24			4	0.5	3.06E-04	PAX2, FOXF1	ureter development [BP]
CG_h9laurent_promoter_p_RM_12_180_13			3	0.5	3.55E-04	SOX11, TSHZ1, TBC1D19, MAF1, TBC1D12, TELO2, ADCY2	intracellular [CC], soft palate development [BP]
CG_h9laurent_promoter_p_RM_12_111_13			4	0.5	3.16E-04	RIPK2, ITCH, UBA52	nucleotide-binding oligomerization domain containing signaling pathway [BP], nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [BP]
CG_h9laurent_promoter_p_RM_14_101_7			2	0.25	4.29E-04	GNAS	post-embryonic body morphogenesis [BP]
CG_h9laurent_promoter_p_RM_12_242_20			2	0.5	3.49E-04	LRRK2, AGRN, ARHGAP26, ARHGAP5, CANX, ERBB2	positive regulation of GTPase activity [BP], dendrite cytoplasm [CC], positive regulation of Rho GTPase activity [BP], Rho GTPase activator activity [MF], neuromuscular junction development [BP]
CG_h9laurent_promoter_p_RM_12_379_24			3	0.5	8.12E-05	TFAP2C, TCF7L1, MPG	DNA-7-methylguanine glycosylase activity [MF], dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis [BP], somatic stem cell maintenance [BP], DNA-7-methyladenine glycosylase activity [MF], DNA-3-methylguanine glycosylase activity [MF], DNA-3-methyladenine glycosylase activity [MF], positive regulation of transcription from RNA polymerase II promoter during mitosis [BP]
CG_h9laurent_promoter_p_RM_12_477_28			4	0.75	2.84E-04	ZFPM2, SOX11, RBPJ, MPST, ACVR2B, FSTL3, MOCS3, HIPK1, FGF18, FBXL15, PAX2, WNT5B, SMARCA2, TCF21, NPR2	respiratory system development [BP], embryonic camera-type eye morphogenesis [BP], metanephric mesenchymal cell differentiation [BP], lung development [BP], RNA polymerase II transcription coactivator activity [MF], ossification [BP], positive regulation of BMP signaling pathway [BP], thiosulfate sulfurtransferase activity [MF]
CG_h9laurent_promoter_p_RM_12_3_16			4	0.75	2.61E-04	RPP30, CCM2, POP1, NOD2, LYN, JAM3	endothelial tube morphogenesis [BP], negative regulation of toll-like receptor 2 signaling pathway [BP], ribonuclease P activity [MF], nucleolar ribonuclease P complex [CC], regulation of neutrophil chemotaxis [BP]
CG_h9laurent_promoter_p_RM_14_387_13			5	0.75	2.39E-04	LPIN1	regulation of fat cell differentiation [BP]
CG_h9laurent_promoter_p_RM_14_33_17			4	0.5	4.73E-04	HOOK3, AEBP2, EPC2, RING1, PAX2, HES1, POU3F3	metanephric epithelium development [BP], neuronal stem cell maintenance [BP], chromatin modification [BP], metanephric nephron tubule morphogenesis [BP], centriolar satellite [CC], metanephric distal convoluted tubule development [BP], metanephric DCT cell differentiation [BP]
CG_h9laurent_promoter_p_RM_14_314_6			2	0.5	2.18E-04	PIK3CA, PTPRM, PDXP	lamellipodium [CC]
CG_h9laurent_promoter_p_RM_12_591_11			2	0.25	2.99E-04	ACP1, PTPN18	non-membrane spanning protein tyrosine phosphatase activity [MF]
CG_h9laurent_promoter_p_RM_12_464_16			2	0.5	2.94E-04	SNRK, FMNL1, CDC34, EIF2AK4, CREB1, TPM1, MNAT1, B4GALT7, UGGT1, PRKAB1	protein phosphorylation [BP], bleb [CC], cellular protein modification process [BP], cellular protein metabolic process [BP]
CG_h9laurent_promoter_p_RM_12_51_22			2	0.25	2.89E-04	LRTOMT, ALDH5A1	neurotransmitter catabolic process [BP]
CG_h9laurent_promoter_p_RM_14_175_11			4	0.5	2.87E-04	TBC1D24, NRTN, CACNA1G, AGRN	axon guidance [BP], neuron projection development [BP]
CG_h9laurent_promoter_p_RM_16_2_3			2	0.25	3.49E-04	ESR1	estrogen-activated sequence-specific DNA binding RNA polymerase II transcription factor activity [MF]
CG_h9laurent_promoter_p_RM_18_10_4			4	0.25	4.68E-04	CACNA1D, MOCS3	voltage-gated calcium channel activity involved in regulation of SA node cell action potential [MF], voltage-gated calcium channel complex [CC], voltage-gated calcium channel activity involved in regulation of cardiac muscle cell action potential [MF], URM1 activating enzyme activity [MF]
CG_h9laurent_promoter_p_RM_14_310_12			2	0.25	4.00E-04	MAP3K3, TCF7, EPHB3, BLM	alpha-beta T cell differentiation [BP], MAP kinase kinase kinase activity [MF], ephrin receptor activity [MF]
CG_h9laurent_promoter_p_RM_14_264_6			2	0.25	4.52E-04	CHD7, TALDO1, PIK3CA, TACC3, HES1, ICT1	cranial nerve development [BP], N-box binding [MF], regulation of multicellular organism growth [BP], vasculature development [BP], negative regulation of stomach neuroendocrine cell differentiation [BP], 1-phosphatidylinositol-4-phosphate 3-kinase, class IA complex [CC], negative regulation of forebrain neuron differentiation [BP], negative regulation of pancreatic A cell differentiation [BP], lateral inhibition [BP], sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [MF], artery morphogenesis [BP], translation release factor activity, codon nonspecific [MF], hypomethylation of CpG island [BP], positive regulation of mitotic cell cycle, embryonic [BP], xylulose biosynthetic process [BP], mitochondrial translational termination [BP], hemopoiesis [BP], renal interstitial cell development [BP], negative regulation of auditory receptor cell differentiation [BP]
CG_h9laurent_promoter_p_RM_12_243_27			2	0.25	3.91E-04	GALNT12, GALNT13, ST3GAL3	O-glycan processing [BP]
CG_h9laurent_promoter_p_RM_12_260_9			4	0.5	4.08E-04	PLCB1, B3GNT7, CACNA1H, PCM1, PAX2, STXBP1, TACC1, CHST2, B3GNT4	interkinetic nuclear migration [BP], keratan sulfate metabolic process [BP], centriolar satellite [CC], keratan sulfate biosynthetic process [BP], positive regulation of acrosome reaction [BP], positive regulation of calcium ion-dependent exocytosis [BP]
CG_h9laurent_promoter_p_RM_12_53_18			2	0.25	1.26E-04	SALL3, NTMT1, BAHCC1, PQBP1, BARX2, PRDM2, OLIG1, RBM6	DNA binding [MF], protein methyltransferase activity [MF]
CG_h9laurent_promoter_p_RM_12_462_18			3	0.5	3.26E-04	PKD2, WNT1, SOX2	positive regulation of cell cycle arrest [BP], positive regulation of Notch signaling pathway [BP]
CG_h9laurent_promoter_p_RM_12_168_9			4	0.75	2.57E-04	FARP2, CNP, NDST1, NDST3, PRNP, DAND5, NR2F2, FOXO3, CHRD, BMPR2, SKI, ALDH1A3, EHMT1	heparin biosynthetic process [BP], negative regulation of BMP signaling pathway [BP], extrinsic to membrane [CC], negative regulation of activin receptor signaling pathway [BP], face development [BP], forebrain development [BP], embryo development [BP], [heparan sulfate]-glucosamine N-sulfotransferase activity [MF], lymphatic endothelial cell differentiation [BP]
CG_h9laurent_promoter_p_RM_12_601_8			2	0.25	2.58E-04	OGDH, ALDH1A3, DIO3, DUOX1	thyroid hormone generation [BP], retinoic acid metabolic process [BP], striatum development [BP]
CG_h9laurent_promoter_p_RM_12_502_11			3	0.5	3.08E-04	L3MBTL1	SAM domain binding [MF]
CG_h9laurent_promoter_p_RM_14_94_4			2	0.5	4.96E-04	YY1, POLI, GNAS, SIRT1	mu-type opioid receptor binding [MF], negative regulation of prostaglandin biosynthetic process [BP], post-embryonic body morphogenesis [BP], PcG protein complex [CC], negative regulation of cellular response to testosterone stimulus [BP], establishment of chromatin silencing [BP], DNA repair [BP], response to prostaglandin F stimulus [BP], negative regulation of cAMP-dependent protein kinase activity [BP], positive regulation of cAMP-dependent protein kinase activity [BP]
CG_h9laurent_promoter_p_RM_14_355_10			3	0.75	4.12E-04	PDXK, MPDU1, CHST12, ALG1	chitobiosyldiphosphodolichol beta-mannosyltransferase activity [MF], carbohydrate biosynthetic process [BP], pyridoxal 5'-phosphate salvage [BP], dolichol-linked oligosaccharide biosynthetic process [BP], lithium ion binding [MF], pyridoxal kinase activity [MF], pyridoxal phosphate biosynthetic process [BP]
CG_h9laurent_promoter_p_RM_14_109_8			3	0.5	4.46E-04	FOXA3, NAB1, HEY2	transcription factor binding [MF], Schwann cell differentiation [BP]
CG_h9laurent_promoter_p_RM_14_146_6			2	0.25	1.68E-04	LLGL1	cortical actin cytoskeleton [CC]
CG_h9laurent_promoter_p_RM_12_221_13			3	0.75	2.59E-04	ADRA2C, CKAP2, SLC6A11, RNF4, CRHR1, SLC6A1	gamma-aminobutyric acid:sodium symporter activity [MF], microtubule cytoskeleton [CC], negative regulation of epinephrine secretion [BP]
CG_h9laurent_promoter_p_RM_12_33_15			3	0.5	2.88E-04	VAX2, SOX11, UNCX, NR2F2, SHROOM2, CNOT8, FOSL2, SIX3, HOXD8	sequence-specific DNA binding transcription factor activity [MF], camera-type eye morphogenesis [BP], sequence-specific DNA binding [MF], lens morphogenesis in camera-type eye [BP], pattern specification process [BP], nucleic acid binding transcription factor activity [MF], camera-type eye development [BP]
CG_h9laurent_promoter_p_RM_12_294_18			2	0.5	3.09E-04	FOXG1, NAB1, FOXF2, CEBPB, NFATC1	transcription factor binding [MF], RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity [MF]
CG_h9laurent_promoter_p_RM_12_536_14			2	0.25	2.90E-04	GLE1, HHEX	poly(A)+ mRNA export from nucleus [BP]
CG_h9laurent_promoter_p_RM_12_144_10			2	0.5	3.26E-04	YY1, NAGS, HINFP, C1QTNF1, TRRAP, DNAJC3, SKIL, ACADSB, SP100, DNAJB9	protein heterotrimerization [BP], misfolded protein binding [MF], cellular nitrogen compound metabolic process [BP], transcription coactivator activity [MF]
CG_h9laurent_promoter_p_RM_12_328_6			3	0.25	2.36E-04	ONECUT2, CD40, FOXA3, SERPINF2, CKAP2, BMP6	endocrine pancreas development [BP], positive regulation of transcription from RNA polymerase II promoter [BP]
CG_h9laurent_promoter_p_RM_14_20_11			3	0.25	2.97E-04	ZFPM1	atrial septum morphogenesis [BP]
CG_h9laurent_promoter_p_RM_12_163_20			2	0.5	2.75E-04	TMOD2, TMOD3	tropomyosin binding [MF]
CG_h9laurent_promoter_p_RM_18_16_2			2	0.25	6.66E-04	BIRC7	regulation of natural killer cell apoptotic process [BP]
CG_h9laurent_promoter_p_RM_12_49_17			4	0.75	3.80E-04	RPS6KB2, TSC2, PRKCD, REPS2, AP2M1	epidermal growth factor receptor signaling pathway [BP]
CG_h9laurent_promoter_p_RM_18_6_4			2	0.25	4.06E-04	IGF1R, DPYSL5, PTK7, SPG7, ARID1B, PLXNA1, TACC3, FOXF2, HOOK3, TMEM57, POU3F3	neurogenesis [BP], interkinetic nuclear migration [BP], embryonic camera-type eye morphogenesis [BP], establishment of planar polarity [BP], brain development [BP], central nervous system development [BP], multicellular organismal development [BP], cytoplasmic microtubule organization [BP], establishment of planar polarity of embryonic epithelium [BP], nervous system development [BP]
CG_h9laurent_promoter_p_RM_12_129_14			4	0.75	3.52E-04	CNTNAP1, RBM4, BRSK2, FZD7, OXT, PSEN1, ITGA3, FSTL3, TNFAIP2, NR2C2, MAG, APCDD1, PTPRM, ARHGEF1, CST6, ROR1, ADCY1, COL15A1	negative regulation of axonogenesis [BP], axonogenesis [BP], anatomical structure morphogenesis [BP], neuron projection development [BP], paranode region of axon [CC], memory [BP], neuron projection morphogenesis [BP], Wnt-protein binding [MF], neuron projection terminus [CC], cell differentiation [BP], neuron development [BP]
CG_h9laurent_promoter_p_RM_14_227_12			3	0.25	4.01E-04	SGCA, PGM5	spot adherens junction [CC], dystrophin-associated glycoprotein complex [CC]
CG_h9laurent_promoter_p_RM_12_266_36			3	0.5	3.53E-04	SMAD5, STAT5A, SKI, CUL4A	RNA polymerase II core promoter sequence-specific DNA binding [MF], ubiquitin protein ligase binding [MF], positive regulation of mitotic cell cycle [BP]
CG_h9laurent_promoter_p_RM_12_250_27			3	0.5	3.16E-04	VWC2, CISD1, SAP30, ID4, TWIST2, SPEN, CHRD, SKIL, LFNG, SKI, SMYD1, PRDM16	negative regulation of BMP signaling pathway [BP], transcription corepressor activity [MF], compartment pattern specification [BP], negative regulation of osteoblast differentiation [BP], regulation of cellular respiration [BP]
CG_h9laurent_promoter_p_RM_18_14_2			1	0.25	4.00E-04	SLC22A18, DTX1	ubiquitin protein ligase binding [MF]
CG_h9laurent_promoter_p_RM_14_236_10			2	0.25	3.41E-04	ZNF236, ZFPM1, HOXC5, AACS, ZBED4, CBX2, NFE2L1, CDT1, PKNOX1, GZF1, FOXF2, RELB, NOS3, DPYSL2, WAC, FPGS, FOXL1, GATA4, SCAF8, FSCN2, GPATCH1, ACTN2, LZTR1, ADNP2, YBX1, ONECUT3	nucleobase-containing compound metabolic process [BP], anatomical structure morphogenesis [BP], sequence-specific DNA binding [MF], atrioventricular valve morphogenesis [BP], sequence-specific DNA binding transcription factor activity [MF], spliceosomal complex [CC], cellular response to glucose stimulus [BP], RNA polymerase core enzyme binding [MF], nucleic acid binding [MF], atrial septum morphogenesis [BP], DNA binding [MF], RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity [MF], negative regulation of potassium ion transport [BP]
CG_h9laurent_promoter_p_RM_12_324_8			3	0.25	3.68E-04	BLOC1S4, CHCHD6, MIA3, DOK1, THAP3, ID2, NUP85, PDS5B, DVL3, AP3S1, DCAF7, TAF15, VANGL1, RNF4, NPB, KREMEN1, ADAM9	anterograde axon cargo transport [BP], protein binding [MF], anterograde synaptic vesicle transport [BP]
CG_h9laurent_promoter_p_RM_12_398_10			4	0.5	2.90E-04	CNKSR2, NOG, WNK2, MAP3K3, STK11, KL, PTEN, GAB1, FGF2, HTRA2, TGFBR2	MAPK cascade [BP], negative regulation of cardiac muscle cell proliferation [BP], protein phosphorylation [BP], negative regulation of protein phosphorylation [BP], regulation of signal transduction [BP], fibroblast growth factor receptor signaling pathway [BP], cellular response to growth factor stimulus [BP]
CG_h9laurent_promoter_p_RM_12_309_9			3	0.5	2.68E-04	LMO4, TLX1, UBN1, ZNF236, NFKB1, PKNOX2, SOX11	enhancer sequence-specific DNA binding [MF], nucleic acid binding transcription factor activity [MF], sequence-specific DNA binding transcription factor activity [MF]
CG_h9laurent_promoter_p_RM_14_261_8			2	0.5	1.85E-04	PPIA, SLC5A2	uncoating of virus [BP], low-affinity glucose:sodium symporter activity [MF]
CG_h9laurent_promoter_p_RM_12_508_15			3	0.75	2.99E-04	LRP3, EPN1, SH3BP4	coated pit [CC]
CG_h9laurent_promoter_p_RM_12_106_12			4	0.5	2.50E-04	RYR1, GOLGA5, TRPM4, TRPV2, RHOBTB3, CCDC64	calcium channel activity [MF], Rab GTPase binding [MF]
CG_h9laurent_promoter_p_RM_12_565_23			3	0.5	5.07E-04	TUB, CAMK1D, FKBP10, PPIG	positive regulation of phagocytosis [BP], peptidyl-prolyl cis-trans isomerase activity [MF]
CG_h9laurent_promoter_p_RM_12_474_15			3	0.5	2.98E-04	NEURL, NCS1, SPTBN4, SKI, NCAM2, FZD7, NDST1, DYNLL2, NF1, GTF2I, DRAXIN, DAGLA, POU3F2, FARP2, CNP, NR2E1, SARM1, ZAK, ADCY1, ROBO3, TCF7L1, EMX1, ITM2C, PRDM6, GRM2, MORC3	neurogenesis [BP], cytoskeleton organization [BP], axonogenesis [BP], cell death [BP], somatic stem cell maintenance [BP], negative regulation of fibroblast proliferation [BP], cell projection [CC], generation of neurons [BP], brain development [BP], forebrain development [BP], Schwann cell development [BP], neuron differentiation [BP], myelination in peripheral nervous system [BP], axon [CC], microtubule-based process [BP], Rac protein signal transduction [BP], regulation of neuron projection development [BP], nervous system development [BP]
CG_h9laurent_promoter_p_RM_12_287_17			3	0.5	3.88E-04	ADCYAP1R1, CLTA, PTH1R	positive regulation of inositol phosphate biosynthetic process [BP], peptide binding [MF]
CG_h9laurent_promoter_p_RM_12_162_20			2	0.5	2.50E-04	IDUA, GNAS, NOG	adenylate cyclase activity [MF], skeletal system morphogenesis [BP], spinal cord development [BP]
CG_h9laurent_promoter_p_RM_12_585_30			2	0.25	4.17E-04	PRKCH, PRDM6, EHMT1	protein kinase C signaling cascade [BP], histone-lysine N-methyltransferase activity [MF]
CG_h9laurent_promoter_p_RM_14_120_11			2	0.25	4.14E-04	RRP1B, GNAO1, FOXG1, SPRED1, DHX30, MAP2K5, RBAK, SKI, BCR, JMY, LRRK2, EGR1, STOX2, DISP1, KCNIP3, APAF1, FARP1, TRIM24, SP4, BMI1, TRRAP, RXRA, CUX1, HEY2, ID4, CCND2, ID2, BASP1, CTCF, FOXC1, FOXK1	muscle organ development [BP], protein binding transcription factor activity [MF], negative regulation of transcription from RNA polymerase II promoter [BP], negative regulation of phosphatase activity [BP], chromatin DNA binding [MF], brain development [BP], cardiac muscle cell proliferation [BP], forebrain development [BP], transcription cofactor activity [MF], olfactory bulb development [BP], negative regulation of transcription, DNA-dependent [BP], chromatin [CC], diaphragm development [BP], metanephros development [BP], chromatin binding [MF], embryo development [BP], negative regulation of gene expression [BP], regulation of transcription from RNA polymerase II promoter [BP]
CG_h9laurent_promoter_p_RM_12_125_28			4	0.75	4.09E-04	PIWIL4, LONP2, ONECUT3, ZMIZ2, ATF7IP, TIGD3, KAT6B, GABRA5, TRIM54, SPTBN4, SKI, POFUT1, CERS4, SOX1, PDS5B, INPPL1, NFE2L3, IKZF1, RBPJ, NPAS1, PTPN6, ZAR1, RBM15, DRAP1, LCOR, ARID2, MTA1, BCL7A, KLHL10, PARP8, CDC25B, SCN8A, RXRA, SRGAP2, IRX5, PAX2, TRIM44, EP300, PKNOX1, URI1, NFIC, BRSK2, PLXNA3, ATL1, ZBTB42, MAFK, FZD9, HES1, FOXC1, AGFG1, FOXQ1	brain development [BP], multicellular organismal development [BP], nervous system development [BP], placenta blood vessel development [BP], sequence-specific DNA binding transcription factor activity [MF], neuron differentiation [BP], pattern specification process [BP], DNA binding [MF], cell differentiation [BP], axonogenesis [BP], transcription factor binding [MF], organ morphogenesis [BP], Notch signaling pathway [BP], neuron projection morphogenesis [BP], central nervous system development [BP], cell morphogenesis involved in neuron differentiation [BP], cell morphogenesis [BP], positive regulation of transcription from RNA polymerase II promoter [BP], negative regulation of gene expression [BP], regulation of transcription from RNA polymerase II promoter [BP], intracellular [CC], positive regulation of transcription of Notch receptor target [BP], negative regulation of transcription from RNA polymerase II promoter [BP], sequence-specific DNA binding [MF], negative regulation of transcription, DNA-dependent [BP], transcription from RNA polymerase II promoter [BP]
CG_h9laurent_promoter_p_RM_12_306_13			3	0.5	3.14E-04	FOXK1, HEY2, CUX2, EP300, NAB1, BMP2	muscle organ development [BP], cardiac epithelial to mesenchymal transition [BP], Notch signaling pathway [BP], RNA polymerase II activating transcription factor binding [MF], negative regulation of transcription, DNA-dependent [BP], tissue development [BP], atrioventricular valve development [BP], negative regulation of gene expression [BP]
CG_h9laurent_promoter_p_RM_12_138_7			6	0.75	3.24E-04	NPR1, ZDHHC2, LHX4, RAB31, SUV39H1, TUBB3, MAN2A2, AGAP1, GUCY1A3, ZNF584, ZNF628, TRAFD1, AGFG2, RNF121, RREB1, EHMT1	positive regulation of cGMP biosynthetic process [BP], GTP binding [MF], cGMP biosynthetic process [BP], histone methyltransferase activity (H3-K9 specific) [MF], guanylate cyclase activity [MF], zinc ion binding [MF]
CG_h9laurent_promoter_p_RM_12_113_10			3	0.5	2.37E-04	PARK7, DDX3X, ATN1	positive regulation of oxidative phosphorylation uncoupler activity [BP], toxin receptor binding [MF], RNA secondary structure unwinding [BP]
CG_h9laurent_promoter_p_RM_14_165_7			1	0.25	2.32E-04	SLAIN2, FES, EPO, PLXNA3	positive regulation of cytoskeleton organization [BP], response to electrical stimulus [BP], positive regulation of microtubule polymerization [BP]
CG_h9laurent_promoter_p_RM_12_179_17			3	0.5	4.26E-04	FERMT3, ZFX, ADD1, EPHA8, RPS6KB1, PDS5B, HABP4, SEPT7, HBP1, GNAI2, APLP2, POLI, TICRR, EHMT1, PXK, KLF11, ZBTB10, HIC1, IRF8, ITSN1, STUB1, SKI, SOX12, HSPB1, BHLHE22, FSTL3, SS18L1, RPS6KB2, ZNF783, EN2, MAPK4, CABLES1, EEFSEC, SLC6A11, URI1, CTDSPL, DGKZ, RAB7A, ZBED4, ZC3H7B, DIAPH2, PIM1, SAMD4B, SEPT2, ZNF48, RAB40C, SNAPC2, COX4I1, NUDT16, ARF6, ARID1A, HCFC2, EPB41, PAFAH1B1, COPS7A, PRDM16, RAB21, MLLT4, USP39, NANOS3, SRRM2, EMX2, ID4, EMX1, RNF169, RND2, UBQLN2, SECISBP2, COQ7, SNRK, FOXC1, GNAS, SRCAP	intracellular [CC], neuron projection [CC], cell projection [CC], cellular response to misfolded protein [BP], GTP binding [MF], cerebral cortex regionalization [BP], corpus callosum morphogenesis [BP], intracellular membrane-bounded organelle [CC], ribosomal protein S6 kinase activity [MF], nucleus [CC]
CG_h9laurent_promoter_p_RM_16_23_7			8	0.5	4.86E-04	EGR1, UBE2E1, SLIT2, SALL3, AEBP2, TSPYL2	cellular response to heparin [BP], histone H2B ubiquitination [BP], chromatin modification [BP], olfactory bulb interneuron development [BP]
CG_h9laurent_promoter_p_RM_18_19_7			1	0.25	2.59E-04	KCNIP3, TSPO	negative regulation of glial cell proliferation [BP], response to pain [BP]
CG_h9laurent_promoter_p_RM_14_26_14			3	0.25	3.56E-04	YTHDC2, ZFX, ZBED4, LHX9, SOX12, ARID1A, NFKB1, HOXD11, CUX1, SOX8, NEO1, DBF4, CHD2, MLL5, PDPK1, ZNF131, GTF2I, HIVEP1, PDE8B, YAP1, NFIC	DNA binding [MF], transcription coactivator activity [MF], regulation of transcription, DNA-dependent [BP], sequence-specific DNA binding transcription factor activity [MF], nucleic acid binding [MF], nucleic acid binding transcription factor activity [MF]
CG_h9laurent_promoter_p_RM_18_18_1			1	0.25	5.88E-04	OPRL1	nociceptin receptor activity [MF]
CG_h9laurent_promoter_p_RM_12_164_9			2	0.5	3.44E-04	FZD1, APCDD1	Wnt-protein binding [MF]
CG_h9laurent_promoter_p_RM_12_547_14			2	0.25	3.60E-04	SKI, CHD7, TLK2, GATA4	nose development [BP], negative regulation of autophagy [BP], SMAD protein signal transduction [BP]
CG_h9laurent_promoter_p_RM_14_58_12			3	0.5	3.34E-04	TCF7, HHEX, NANOS1, PGM5, MACF1, ILK, CASC3, RCOR1, WHSC1, SKI, CBX2, EPHB2	palate development [BP], establishment or maintenance of cell polarity [BP], response to stress [BP], costamere [CC], positive regulation of Wnt receptor signaling pathway [BP], chromatin binding [MF], epithelial cell migration [BP]
CG_h9laurent_promoter_p_RM_12_140_13			2	0.25	2.22E-04	SMARCA4, FYTTD1, SLC25A10, RREB1, PPCS, PRPF6, PKN1	androgen receptor binding [MF], transcription from RNA polymerase II promoter [BP], cellular nitrogen compound metabolic process [BP], nuclear speck [CC], phosphopantothenate--cysteine ligase activity [MF]
CG_h9laurent_promoter_p_RM_12_304_6			3	0.5	4.03E-04	ETV2	BMP signaling pathway involved in mesodermal cell fate specification [BP]
CG_h9laurent_promoter_p_RM_12_177_24			3	0.5	3.78E-04	POR, MCU	iron-cytochrome-c reductase activity [MF], nitrate catabolic process [BP], protein complex oligomerization [BP], nitric oxide catabolic process [BP], uniporter activity [MF]
CG_h9laurent_promoter_p_RM_14_150_33			6	0.75	4.45E-04	ADD1, BHLHE22, FCHO2, MOCS3, EPO, HIPK1, PKP4, CREBL2, SLC30A5, USP42, USP20, CERS6, BRPF3, SMG7, DAZAP1, FAM50A, ZNF703, NDST1, RBPJ, MAP3K1, MPP6, NTRK2, SIX3, NSG1, ZSWIM6, CBFB, CUL9, FOXF2, RNF111, WDR62, EEFSEC, MTMR3, CUL1, NABP1, DHX9, BAI1, ARHGEF16, TDRD3, SP2, ZNF362, PDS5B, USP39, AFTPH, TSPAN4, UBR3, PAFAH1B1, TRAF3IP1, URI1, LMTK2, ADCY2, POLE4, ARID1B, ARID1A, DDX42, RBBP6, RUNX2, PLEKHA5, MAFK, HUNK, ZNF276, WHSC1, ATMIN, RRP1, FOXK2, FOXP4, ACVR1B, SLC7A6, NRSN1, SNX9, RPS27A, KAT2B, FMN2, HABP4, SLAIN2, MAU2, EP400, ARHGAP5, SEPT7, SKI, HCCS, CDC16, TSPYL2, PPM1A, SOX11, SOX12, SSNA1, BICC1, EN2, ZIC2, TBC1D25, SNX33, SPSB4, UBE2E3, PLCB1, SIRT1, DPYSL5, GLRX5, XPOT, TTC3, MMP15, UNC5B, ARPC2, FAT4, PHRF1, MLLT10, IGFBP2, CUX1, CUX2, SQSTM1, GLTSCR2, POLR2C, PAX2, ZEB1, PKNOX2, PRDM16, CASC3, UHRF1BP1, PRKAA2, ZNF618, PSMD11, HOXD10, TNFAIP2, EML1, EBF4, IPO9, NSD1, FPGS, RPF2, AGFG1, INSM1, YY1, FGF9, EPHA8, SEC14L2, PAPD5, SEC14L5, SDCBP, CD4, RCOR1, DYRK2, ZNF839, EIF4H, REPS2, BCR, UBAP2L, FZD1, COASY, ZBTB10, HIC1, FZD7, IPO13, EPB41, NR2F2, MLST8, RAB22A, RNF115, ARNT2, MAPK4, ERC1, DUSP5, LFNG, MCU, FOXF1, MVP, TGFBR1, RAP2A, POMP, NLGN1, SIPA1, CARM1, PLEKHM2, COL5A1, PTPN12, ANKS1A, ZNF696, TRIOBP, LLGL1, PLXNA3, NAA35, ID4, TACC3, NECAB2, RAB21, TBC1D13, SUV420H2, HIVEP1, AKAP9, MAL2, PTK7, SPG7, BIRC7, DIP2A, PSMD1, BAHD1, SPNS1, BMPR1B, PRELID1, ATP11B, FMR1, CPSF6, NR1D2, SOX1, SMARCA4, SWSAP1, QKI, CPSF4, CEBPG, CAND1, CATSPER4, KLHDC2, TAL2, GDF7, SAE1, NPAS1, PXK, UBE2Z, SLIT2, CABLES1, NRG3, MTA3, POU3F2, GREM1, PIM3, ARIH1, HSPB1, NR4A1, REST, BUB3, COL6A1, AR, GTPBP1, SKIL, DYNC1H1, AGO4, ADRA2C, PBX3, TBKBP1, POGK, COL6A2, CHD7, ZBED4, TAB2, TLX1, ZNF292, RND2, AGAP3, PSKH1, WIPF3, WIPF2, COQ7, CRIM1, ILF3, BPTF	ubiquitin-dependent protein catabolic process [BP], nucleus [CC], protein binding [MF], transcription factor binding [MF], brain development [BP], sequence-specific DNA binding RNA polymerase II transcription factor activity [MF], GTP catabolic process [BP], enzyme linked receptor protein signaling pathway [BP], multicellular organismal development [BP], nucleic acid binding transcription factor activity [MF], cell fate commitment [BP], lens development in camera-type eye [BP], nervous system development [BP], SMAD binding [MF], substrate-dependent cell migration [BP], negative regulation of cellular response to growth factor stimulus [BP], regulation of signal transduction [BP], eye development [BP], sequence-specific DNA binding transcription factor activity [MF], transmembrane receptor protein serine/threonine kinase signaling pathway [BP], neuron differentiation [BP], regulation of neuron differentiation [BP], pattern specification process [BP], neuron development [BP], transmembrane receptor protein tyrosine kinase signaling pathway [BP], cell differentiation [BP], protein complex [CC], neurogenesis [BP], regulation of catalytic activity [BP], axonogenesis [BP], anatomical structure morphogenesis [BP], positive regulation of transcription, DNA-dependent [BP], positive regulation of cell differentiation [BP], organ morphogenesis [BP], intracellular [CC], neuron projection morphogenesis [BP], central nervous system development [BP], camera-type eye development [BP], cell morphogenesis [BP], lens morphogenesis in camera-type eye [BP], cerebral cortex development [BP], chromatin binding [MF], negative regulation of gene expression [BP], cellular response to growth factor stimulus [BP], protein complex assembly [BP], regulation of transcription from RNA polymerase II promoter [BP], negative regulation of transforming growth factor beta receptor signaling pathway [BP], camera-type eye morphogenesis [BP], regulation of transforming growth factor beta receptor signaling pathway [BP], DNA binding [MF], neuron projection development [BP], palate development [BP], neural tube formation [BP], telencephalon development [BP], regulation of cellular component organization [BP], forebrain development [BP], sequence-specific DNA binding [MF], negative regulation of transcription, DNA-dependent [BP], response to growth factor stimulus [BP], eye morphogenesis [BP], nucleoplasm [CC], embryo development [BP], transcription from RNA polymerase II promoter [BP], positive regulation of gene expression [BP], transcription initiation from RNA polymerase II promoter [BP]
CG_h9laurent_promoter_p_RM_14_336_7			2	0.25	2.57E-04	KCNK3	cochlea development [BP]
CG_h9laurent_promoter_p_RM_12_595_19			3	0.5	2.88E-04	SOX11	regulation of transforming growth factor beta receptor signaling pathway [BP]
CG_h9laurent_promoter_p_RM_12_575_6			1	0.25	2.79E-04	CDKN1A	PCNA-p21 complex [CC], cyclin-dependent protein kinase activating kinase activity [MF]
CG_h9laurent_promoter_p_RM_12_338_14			3	0.5	2.15E-04	MAN2A1, IDUA	mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [MF], L-iduronidase activity [MF], vacuole organization [BP]
CG_h9laurent_promoter_p_RM_12_278_16			2	0.25	2.74E-04	LMX1B	multicellular organismal development [BP]
CG_h9laurent_promoter_p_RM_12_173_19			2	0.5	2.63E-04	TGFBR2, CXADR, SMO	caveola [CC], negative regulation of cardiac muscle cell proliferation [BP]
CG_h9laurent_promoter_p_RM_14_104_5			2	0.25	3.09E-04	GNAS, LLGL1, KCNQ1, INHBB	genetic imprinting [BP], regulation of insulin secretion [BP], negative regulation of insulin secretion [BP], trans-Golgi network membrane [CC]
CG_h9laurent_promoter_p_RM_12_23_26			2	0.25	3.86E-04	SMAD6, NDFIP1, CUL4A	regulation of isotype switching to IgG isotypes [BP], positive regulation of S phase of mitotic cell cycle [BP]
CG_h9laurent_promoter_p_RM_14_296_8			2	0.25	2.86E-04	TGFBR1, ZIC2, SKI, ISL1, ZFYVE9	negative regulation of transforming growth factor beta receptor signaling pathway [BP], SMAD protein import into nucleus [BP], positive regulation of DNA binding [BP], pharyngeal system development [BP], retinal ganglion cell axon guidance [BP]
CG_h9laurent_promoter_p_RM_14_60_2			1	0.25	3.23E-04	GPD2	sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity [MF]
CG_h9laurent_promoter_p_RM_14_246_8			3	0.25	5.56E-04	ENOPH1, FZR1, PSMD11, PSMD2, GPR3	proteasome accessory complex [CC], S phase of mitotic cell cycle [BP], protein polyubiquitination [BP], acireductone synthase activity [MF], proteasome complex [CC], cell cycle checkpoint [BP], regulation of cellular amino acid metabolic process [BP], negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle [BP], regulation of meiosis [BP], positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle [BP], DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [BP], anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process [BP], regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle [BP]
CG_h9laurent_promoter_p_RM_12_281_14			4	0.5	3.79E-04	CARM1, FOXO3, SAMD4B, CBX3, UBN1, CAMK1D, CHD2, MUM1, TSFM, CMPK1, PXK, ZIC2, KLF2, MSX2, PRPF6, NABP1, FAN1, ZNF584, GNAI1, NANOS3, PPP2R5D, FUS	nucleus [CC]
CG_h9laurent_promoter_p_RM_12_228_13			3	0.75	3.22E-04	IGF1R, TIPARP, NSD1, ADM, TSC2, PTPRJ, DNAJA3	vasculogenesis [BP], histone methylation [BP], negative regulation of protein kinase activity [BP], negative regulation of protein kinase B signaling cascade [BP], negative regulation of vascular permeability [BP]
CG_h9laurent_promoter_p_RM_14_115_12			2	0.25	2.90E-04	RPIA	ribose-5-phosphate isomerase activity [MF]
CG_h9laurent_promoter_p_RM_12_100_16			2	0.5	2.50E-04	IGF2R, SOD1, TGFBR1, PIGT, MYB, TSC2, IGF1R	insulin-like growth factor-activated receptor activity [MF], insulin-like growth factor receptor signaling pathway [BP], negative regulation of protein kinase B signaling cascade [BP], trans-Golgi network transport vesicle [CC], neuron differentiation [BP], thymus development [BP], cell projection organization [BP]
CG_h9laurent_promoter_p_RM_14_207_6			2	0.25	2.82E-04	JPH3, NIPBL, IGF1R, CRHR1, HTR6	cognition [BP], G-protein alpha-subunit binding [MF], long-term synaptic potentiation [BP], exploration behavior [BP]
CG_h9laurent_promoter_p_RM_14_123_34			4	0.5	4.25E-04	FOXK1, FOXE1, RAP1B, ZNF839, KL, TSC2, CEBPB, KLF11, PIK3CA, EGR1, UNCX, RPS6KB2, TRIM24, KLF2, CDC25B, FOXB2, MAP1LC3B, VPS13A, ACVR2A, FOXJ2, NR4A1, HOXD4, HOXC5, TSHZ1, LMX1B, LNPEP, PKNOX1, GATA6, FGFR3, ROR1, PLXNC1, BMP6, GNAS, PLXNA3, MAF1, GRIK2, LRP5, CUX2, HOXD11, SHOC2, BMPR2, PLEKHA1, TBC1D12, NAB1, FOXC1, BPTF	sequence-specific DNA binding RNA polymerase II transcription factor activity [MF], intracellular [CC], skeletal system morphogenesis [BP], fibroblast growth factor receptor signaling pathway [BP], sequence-specific DNA binding [MF], positive regulation of bone mineralization [BP], endochondral ossification [BP], anterior/posterior pattern specification [BP], bone morphogenesis [BP], pattern specification process [BP], RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity [MF], transmembrane receptor protein tyrosine kinase signaling pathway [BP]
CG_h9laurent_promoter_p_RM_12_172_12			2	0.5	4.14E-04	UHRF1, ACSF3, RNF146, UBE2B	protein autoubiquitination [BP], malonate catabolic process [BP], protein K48-linked ubiquitination [BP], protein monoubiquitination [BP], histone ubiquitination [BP], replication fork [CC]
CG_h9laurent_promoter_p_RM_12_94_15			2	0.5	3.15E-04	CSGALNACT2, HIF1AN, EGLN2	dermatan sulfate proteoglycan biosynthetic process [BP], oxygen sensor activity [MF]
CG_h9laurent_promoter_p_RM_12_475_12			5	0.75	3.05E-04	ZBTB16, FZD6, GNAS, FZD9, LRP5, KIAA1279, CHD7, POU4F3, BMPER, SALL3, ZIC1, GNAL, SNX18, MAPK8IP2, GNAI1, KLC3	hindlimb morphogenesis [BP], extrinsic to internal side of plasma membrane [CC], limb development [BP], G-protein beta/gamma-subunit complex binding [MF], inner ear morphogenesis [BP], embryonic limb morphogenesis [BP], Wnt-activated receptor activity [MF], Wnt-protein binding [MF], heterotrimeric G-protein complex [CC], inner ear development [BP], kinesin binding [MF], embryonic hindlimb morphogenesis [BP]
CG_h9laurent_promoter_p_RM_12_529_15			5	0.75	3.75E-04	ZBTB18, BRSK2, BMP1, SPG7, CATSPER4, NEURL, ASPSCR1, MET, EN2, COL13A1, SLC18A2, AGFG1, TCF7	neurogenesis [BP], generation of neurons [BP], glucose homeostasis [BP], neuron differentiation [BP], nervous system development [BP], cell differentiation [BP], neuron development [BP]
CG_h9laurent_promoter_p_RM_12_24_8			2	0.5	3.37E-04	RAB11FIP4, TRIM32, DAND5, KIF23, NDFIP1, PIN1, ARL2BP, EGLN2	midbody [CC], ventricular septum development [BP], regulation of isotype switching to IgG isotypes [BP], positive regulation of protein catabolic process [BP]
CG_h9laurent_promoter_p_RM_14_25_5			2	0.25	2.74E-04	LMO4, ZIC2	neural tube closure [BP]
CG_h9laurent_promoter_p_RM_14_106_9			2	0.25	5.21E-04	TCF7, SOLH, SOX11, INSM2, CUX2, ATOH8, ZNF771, NCOA3	regulation of RNA biosynthetic process [BP], regulation of transcription, DNA-dependent [BP], embryonic digestive tract morphogenesis [BP]
CG_h9laurent_promoter_p_RM_12_219_12			1	0.25	3.47E-04	NR2E1, CDKN1A, MADD, SPHK1	positive regulation of fibroblast proliferation [BP], positive regulation of cell cycle [BP], protein kinase activator activity [MF], positive regulation of mitotic cell cycle [BP]
CG_h9laurent_promoter_p_RM_14_367_11			5	0.5	1.78E-04	GPC1, GALNT13, B4GALNT3, SHROOM2, SOX1, FGF2, GALNT16	polypeptide N-acetylgalactosaminyltransferase activity [MF], lens morphogenesis in camera-type eye [BP], fibroblast growth factor binding [MF], acetylgalactosaminyltransferase activity [MF]
CG_h9laurent_promoter_p_RM_14_23_6			3	0.5	3.11E-04	HLX, MLLT10, HOXD11, FOXO3, HNRNPAB, MYRF, NCOA3	developmental growth [BP], sequence-specific DNA binding transcription factor activity [MF]
CG_h9laurent_promoter_p_RM_16_71_4			2	0.25	5.52E-04	APLP1, IGF1R, SKI, CREBRF	alpha-2C adrenergic receptor binding [MF], inactivation of MAPKK activity [BP], cellular response to norepinephrine stimulus [BP], brain development [BP], negative regulation of endoplasmic reticulum unfolded protein response [BP], histone deacetylase inhibitor activity [MF], alpha-2B adrenergic receptor binding [MF]
CG_h9laurent_promoter_p_RM_12_270_10			2	0.25	3.64E-04	FOXK1, FOXO3	pattern specification process [BP]
CG_h9laurent_promoter_p_RM_12_381_14			5	0.5	3.18E-04	CRAMP1L, SMAD6, SMO, SOX9, GABRA5, SKI, POFUT1, GAPVD1, GPR27, NOD2, IRAK3, NRG3, CLIC6, IGF1R, RHOU, AGAP1, AGAP3, MIXL1, FGF2, PLD2, GABRQ, RAB42, ASAP2, FOXP4	prostate gland development [BP], positive regulation of cerebellar granule cell precursor proliferation [BP], signal transduction [BP], chloride channel complex [CC], response to peptidoglycan [BP], intracellular signal transduction [BP], negative regulation of interleukin-12 production [BP], prostate gland epithelium morphogenesis [BP], regulation of ARF GTPase activity [BP], pattern specification process [BP], heart development [BP], exocrine pancreas development [BP], chromatin binding [MF], ureteric bud development [BP], negative regulation of toll-like receptor signaling pathway [BP], positive regulation of epithelial cell proliferation [BP], ARF GTPase activator activity [MF], male sex determination [BP], small GTPase mediated signal transduction [BP], embryo development [BP], mammary gland development [BP], stem cell development [BP]
CG_h9laurent_promoter_p_RM_14_122_10			3	0.25	3.38E-04	RYR2, TMPO, EGR1, YY1, TBX4, LSM14A, DOCK1, ITGB3, ABCD3, WRNIP1, CTNNA1, CASP14, IFNGR2, EXOSC2, CPSF6, USP25, ATP7A, DOCK11, MLL5, ARNTL, NDUFAF3, JMY, BUB3, PLEKHF2, BHLHE40, SKI, PPM1L, GDF7, ZSWIM6, CAPZA2, BRPF3, SPAG6, INHBB, SCNN1D, CDK5R1, BCR, FOXB2, TGFBR1, CAB39, CYR61, RCN1, RAC1, FOXJ2, SOD1, SUV39H2, COL9A3, RAP1B, HTR6, PLEKHM2, EBF4, AMOTL1, AP2A2, VASP, LAMC1, PACS1, ROR1, KNSTRN, BMP6, NDE1, TMEM8B, PRMT8, GNAS, MMP2, LRRC3, LRP5, MAGEE1, STUB1, SPPL2B, MAG, CRIM1, NAB1, HIVEP1, WNT3A	RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity [MF], wound healing [BP], cell surface receptor signaling pathway [BP], positive regulation of pathway-restricted SMAD protein phosphorylation [BP], organ development [BP], sequence-specific DNA binding RNA polymerase II transcription factor activity [MF], multicellular organismal development [BP], cell projection organization [BP], nervous system development [BP], skeletal system morphogenesis [BP], extracellular structure organization [BP], neuron projection morphogenesis [BP], transmembrane receptor protein serine/threonine kinase signaling pathway [BP], neuron differentiation [BP], cell differentiation [BP], skeletal system development [BP], protein binding [MF], axonogenesis [BP], anatomical structure morphogenesis [BP], osteoblast differentiation [BP], BMP signaling pathway [BP], axon guidance [BP], endochondral ossification [BP], regulation of defense response to virus by virus [BP], morphogenesis of an epithelium [BP], neuron projection development [BP], blood coagulation [BP], Schwann cell differentiation [BP], tissue development [BP], bone morphogenesis [BP], embryo development [BP], extracellular matrix organization [BP]
CG_h9laurent_promoter_p_RM_14_77_26			2	0.25	3.69E-04	RNF10, RNF11, TBX21, FOXG1, EPO, USP9X, IKZF1, PRPF6, EHMT1, GTF2E1, CHD3, ASXL1, CDK13, ADRA2C, INHBB, KLF2, LCOR, POU3F3, ZBED4, ABCG1, RXRA, PTPN6, NFIC, DAZAP1, E2F4, BMP1, NOG, ID2, SPEN, ADRB1, GARS, RNF4, RNF2, NFATC3	recycling endosome [CC], epinephrine binding [MF], positive regulation of transcription, DNA-dependent [BP], negative regulation of transcription from RNA polymerase II promoter [BP], protein dimerization activity [MF], nuclear cyclin-dependent protein kinase holoenzyme complex [CC], positive regulation of transcription from RNA polymerase II promoter [BP], forebrain development [BP], negative regulation of transcription, DNA-dependent [BP], cell differentiation [BP], neural plate morphogenesis [BP], negative regulation of gene expression [BP], alpha-2A adrenergic receptor binding [MF], transcription from RNA polymerase II promoter [BP], positive regulation of gene expression [BP], regulation of transcription from RNA polymerase II promoter [BP]
CG_h9laurent_promoter_p_RM_12_4_22			3	0.75	2.62E-04	SOCS6, EGR1, UBE2D1, RNF217, RNF2, RNF213, TRAF2	ubiquitin-protein ligase activity [MF], protein ubiquitination [BP], response to norepinephrine stimulus [BP], protein catabolic process [BP]
CG_h9laurent_promoter_p_RM_14_186_12			3	0.75	4.18E-04	ZRANB1, FOXP4, RAD23A, ONECUT3, GLRX5, MSH3, TCF7, ZNF696, ITGB3, CRTC3, SETD1B, TEF, SEPT7, SOX1, PAN3, CEP164, CHD2, CEBPG, FZD7, CATSPER4, SOX11, PPP4C, SSNA1, SS18L1, THRA, CDCA2, FOXF2, SIPA1, ZNF559-ZNF177, MYB, MTA1, NABP1, FOXQ1, DHX9, FOXJ2, NLGN1, COG3, MIER1, EPN1, ZNF687, HOXC11, CUX1, POU4F2, EBF4, ZNF584, SALL3, UBR3, MUM1, PTPN6, POGK, GTF2I, WDTC1, ARID1B, SRRM2, LMO4, SYAP1, HOXD10, EMX1, RUNX2, MLLT4, CXXC5, ZNF618, ZNF131, ZNF114, ZNF292, RBPJ, PPIA, SKIL, HECTD2	neurogenesis [BP], double-stranded DNA binding [MF], nucleic acid binding transcription factor activity [MF], transcription factor binding [MF], generation of neurons [BP], embryonic digestive tract development [BP], sequence-specific DNA binding transcription factor activity [MF], sequence-specific DNA binding [MF], neuron differentiation [BP], nucleic acid binding [MF], chromatin binding [MF], multicellular organismal development [BP], nucleus [CC], embryo development [BP], DNA binding [MF], nervous system development [BP]
CG_h9laurent_promoter_p_RM_14_140_13			3	0.5	4.25E-04	TGFBR1, EPHA8, PLXNA1, STK11, BMPR1B, PSD2, INHBB, ABL1, FERMT3, WNT3A	regulation of cell adhesion mediated by integrin [BP], axonogenesis [BP], palate development [BP], axon guidance [BP], neuron differentiation [BP], transforming growth factor beta-activated receptor activity [MF], growth [BP], transforming growth factor beta receptor activity, type I [MF], transmembrane receptor protein serine/threonine kinase activity [MF], regulation of cell-cell adhesion mediated by integrin [BP]
CG_h9laurent_promoter_p_RM_14_129_15			3	0.5	4.53E-04	PIWIL4, ONECUT3, PDS5B, TIGD3, MAFK, SOX1, FZD9, NPAS1, PTPN6, ZAR1, DRAP1, LCOR, MTA1, FOXQ1, ARID2, RXRA, IRX5, PKNOX1, PLXNA3, KAT6B, FOXC1, AGFG1, LONP2	forebrain neuron development [BP], transcription factor binding [MF], gonad development [BP], sequence-specific DNA binding transcription factor activity [MF], sequence-specific DNA binding [MF], multicellular organismal development [BP], DNA binding [MF], cell differentiation [BP]
CG_h9laurent_promoter_p_RM_14_184_9			3	0.5	4.66E-04	CARM1	histone H3-R17 methylation [BP]
CG_h9laurent_promoter_p_RM_12_38_20			2	0.25	2.15E-04	ALDH1A3	nucleus accumbens development [BP]
CG_h9laurent_promoter_p_RM_14_249_9			2	0.25	4.32E-04	RDH10, FOXF1, RBCK1, ALDH1A3, GREM1	nose development [BP], retinal metabolic process [BP], retinoic acid biosynthetic process [BP], positive regulation of NF-kappaB import into nucleus [BP], morphogenesis of a branching structure [BP], retinol metabolic process [BP], retinoic acid metabolic process [BP]
CG_h9laurent_promoter_p_RM_12_308_20			3	0.5	4.43E-04	GNAS	post-embryonic body morphogenesis [BP]
CG_h9laurent_promoter_p_RM_14_147_40			5	0.75	2.43E-04	DYNLL1, FOXK2, CYFIP2, PPP4R4, SPTAN1, UBE2D4, ZFPM1, ILK, ITGA6, MX1, FOXO3, MAPK15, SQSTM1, BOK, STBD1, APLP1, GMNN, TCOF1, SKI, GNAI1, EHMT1, MPP6, CNTNAP1, MUM1, CHD1L, SUPT5H, MAST3, CD82, SAE1, ROPN1L, PACS1, AP2M1, VIL1, PVRL2, C19orf80, DIP2A, RELB, LIMD1, CTDSP1, GRIN1, ESRRA, ARHGAP10, NUF2, ALOX5, RAB22A, TDRD7, AIP, MAST2, USP11, PALM, KHDRBS3, SLC34A1, ADAP2, MAP2K3, EPB41, ACTR5, TCAP, RPS6KA1, IPO13, TBL1X, ARID5A, SPAST, RAB5B, STX4, CDC20, PIAS3, UPF3A, ARHGAP33, STK36, SWI5, BAIAP2, ELP5, MRPL48, MMP2, PSKH1, ELMO3, SMC2	protein binding [MF], SH3 domain binding [MF], protein domain specific binding [MF]
CG_h9laurent_promoter_p_RM_12_568_16			2	0.25	2.86E-04	SMO, FAM20C, TCF21, PRRX2, RUNX2	embryonic digestive tract morphogenesis [BP], osteoblast differentiation [BP], odontogenesis of dentin-containing tooth [BP], positive regulation of smoothened signaling pathway [BP], regulation of fibroblast growth factor receptor signaling pathway [BP], embryonic cranial skeleton morphogenesis [BP], smoothened signaling pathway [BP], bHLH transcription factor binding [MF]
CG_h9laurent_promoter_p_RM_12_117_27			2	0.25	4.15E-04	WDR5, UBXN2A, STAT5A, ACVR1B, GNAS, CUL4A, NTRK2, PROX1, RCOR3, IRF4, NEO1, CDK5R1, SALL3, FOXL1, YEATS2, ADCYAP1R1, ZNF555, PLCB1	positive regulation of developmental growth [BP], regulation of transcription, DNA-dependent [BP], histone H3 acetylation [BP], G-protein coupled acetylcholine receptor signaling pathway [BP], regulation of gene expression [BP], positive regulation of mitotic cell cycle [BP], activation of adenylate cyclase activity [BP], positive regulation of S phase of mitotic cell cycle [BP]
CG_h9laurent_promoter_p_RM_12_29_16			3	0.25	3.24E-04	ESPN, NLGN1, ENPP1, MOCS3, PALM, CTU2	tRNA thio-modification [BP], positive regulation of filopodium assembly [BP], nucleoside-triphosphate diphosphatase activity [MF], tRNA wobble uridine modification [BP]
CG_h9laurent_promoter_p_RM_12_302_10			3	0.5	2.91E-04	VRK1, LRRK2, LHX9, SH3GLB1, NR2F2, ACAT1, INHBB, STK4, SPPL2B, SYNDIG1, IGF1R	ovarian follicle development [BP], protein homodimerization activity [MF], protein autophosphorylation [BP], female gonad development [BP]
CG_h9laurent_promoter_p_RM_12_149_17			2	0.5	1.72E-04	LRRK2	negative regulation of GTPase activity [BP]
CG_h9laurent_promoter_p_RM_12_195_15			3	0.5	2.82E-04	HHEX, IL4R, FZD7, SMAD6, SOX17, PLAU, ID1, RDH10, FOXF2, PAX2, ALDH1A3, SKI, CAV1, PTPRU	gall bladder development [BP], Wnt receptor signaling pathway [BP], primary lung bud formation [BP], regulation of cell proliferation [BP], stem cell differentiation [BP], skeletal muscle tissue development [BP], embryonic camera-type eye morphogenesis [BP], BMP signaling pathway [BP], nose development [BP], optic cup morphogenesis involved in camera-type eye development [BP], embryonic camera-type eye development [BP], positive regulation of Wnt receptor signaling pathway [BP], negative regulation of transcription by transcription factor localization [BP], common bile duct development [BP], canonical Wnt receptor signaling pathway [BP], embryonic eye morphogenesis [BP]
CG_h9laurent_promoter_p_RM_12_121_27			6	0.75	3.50E-04	TRAF3, UBE2QL1, MIB1, NAB1, UBE2E1, SCCPDH, UHRF1, GPC1, HSD3B7, BLVRA, SKI, PTBP1, UHRF2, HECTD2	ubiquitin-protein ligase activity [MF], Schwann cell differentiation [BP], nucleotide binding [MF]
CG_h9laurent_promoter_p_RM_16_56_11			3	0.5	3.12E-04	MAN1C1, CSGALNACT2, ST8SIA2, DGKZ	lipid phosphorylation [BP], integral to Golgi membrane [CC]
CG_h9laurent_promoter_p_RM_12_345_11			2	0.25	3.02E-04	CRHBP, FMN2, GPC1, SKI, LDHC, GREM1	negative regulation of BMP signaling pathway [BP], meiotic chromosome movement towards spindle pole [BP], negative regulation of bone trabecula formation [BP], negative regulation of bone mineralization involved in bone maturation [BP], negative regulation of corticotropin-releasing hormone receptor activity [BP], negative regulation of corticotropin secretion [BP], Schwann cell differentiation [BP], lactate oxidation [BP]
CG_h9laurent_promoter_p_RM_14_341_14			2	0.5	2.96E-04	SMCHD1, KIF26A, DYRK2, ATP11A, ABL1, ADRBK2, PHLPP1, SBK1, TADA2A, ZFP1, CBFB, NF2, IRX5, CDH6, TRIM28, PKN3, ACSF3, RXRA, HOXD1, RIMKLB, SPATA5L1, TP53INP2, ZNF84, URI1, DAZAP1, NFIA, ADCY1, ACTN4, TACC1, NUBP2, CXXC5, YBX1, MAP4K4	ATP binding [MF], protein phosphorylation [BP], nucleoside binding [MF], cortical cytoskeleton [CC], nucleus [CC]
CG_h9laurent_promoter_p_RM_12_128_26			3	0.75	3.71E-04	SYNM, ILK, FOXC1, PIKFYVE, LAMC3	astrocyte development [BP], costamere [CC], camera-type eye development [BP], myelin assembly [BP], eye development [BP]
CG_h9laurent_promoter_p_RM_14_138_12			3	0.5	2.97E-04	KL, FGFR3	positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [BP]
CG_h9laurent_promoter_p_RM_14_361_21			2	0.25	3.66E-04	ITGB3, SSH3, FERMT3	regulation of lamellipodium assembly [BP], platelet aggregation [BP]
CG_h9laurent_promoter_p_RM_14_374_11			4	0.5	3.83E-04	PLEKHA1	phosphatidylinositol 3-kinase cascade [BP]
CG_h9laurent_promoter_p_RM_12_131_13			6	0.75	3.56E-04	STIM2, HCN2, P2RX6, MFN2, PLCG2	cation channel activity [MF], activation of store-operated calcium channel activity [BP], intrinsic to mitochondrial outer membrane [CC], channel activity [MF]
CG_h9laurent_promoter_p_RM_14_208_6			1	0.25	3.35E-04	PKN3, PKN1	protein kinase C activity [MF], epithelial cell migration [BP]
CG_h9laurent_promoter_p_RM_14_47_9			1	0.25	1.28E-04	ACTN4	positive regulation of pinocytosis [BP]
CG_h9laurent_promoter_p_RM_12_58_12			2	0.25	1.84E-04	RPA1, STAG3	synaptonemal complex [CC], male germ cell nucleus [CC]
CG_h9laurent_promoter_p_RM_12_495_11			1	0.25	1.53E-04	SLC22A18, NUP85, G6PC3, SLC5A3	transmembrane transport [BP], myo-inositol:sodium symporter activity [MF], small molecule metabolic process [BP]
CG_h9laurent_promoter_p_RM_12_283_15			2	0.25	2.72E-04	RHOQ, PPP2R5A, TPM1, SHROOM2, DNAJA3	filamentous actin [CC], actin filament [CC], negative regulation of establishment of protein localization to plasma membrane [BP]
CG_h9laurent_promoter_p_RM_14_29_6			2	0.25	2.59E-04	LRP5, RAMP1	coreceptor activity [MF]
CG_h9laurent_promoter_p_RM_14_180_13			3	0.5	3.14E-04	FGF2	C21-steroid hormone biosynthetic process [BP]
CG_h9laurent_promoter_p_RM_14_381_7			5	0.75	3.68E-04	BRSK2, WNK2, PLK5, PKN1, CHAF1A, ANKK1, IRAK3, SMARCA4, ACVR2B	intracellular protein kinase cascade [BP], protein serine/threonine kinase activity [MF], protein kinase activity [MF], WINAC complex [CC]
CG_h9laurent_promoter_p_RM_12_489_33			4	0.75	3.75E-04	VLDLR, RALBP1, CYFIP2, DOCK3, DYNC1H1, RAP1B, EPO, SETD1B, RHOT1, NOC4L, SOX1, ACVR1B, TRAF3, MACF1, MAPKAPK3, PPP4C, EML1, SNX18, PRKG1, CAPN2, BIRC6, WEE1, CUL9, ASCL1, LONRF3, IFI35, IL13RA1, ENPP1, IGFBP2, SEC24B, STT3A, ZEB1, PTPN4, YTHDC2, IPO13, TPCN1, CAMSAP2, ID4, RUNX2, BASP1, ARHGAP33, PSEN1, KDM1A	protein binding [MF], cerebral cortex neuron differentiation [BP], bHLH transcription factor binding [MF]
CG_h9laurent_promoter_p_RM_12_377_13			3	0.5	3.00E-04	ID1, FST, TWIST2, ACVR1B, SKI	activin receptor signaling pathway [BP], negative regulation of activin receptor signaling pathway [BP], negative regulation of osteoblast differentiation [BP]
CG_h9laurent_promoter_p_RM_14_166_14			3	0.5	2.75E-04	CD83, MMP2, ADAMTS14, PPAPDC3	collagen catabolic process [BP], positive regulation of CD4-positive, alpha-beta T cell differentiation [BP], hydrolase activity [MF]
CG_h9laurent_promoter_p_RM_12_261_15			2	0.25	2.90E-04	PLXNC1, MADD, LMNB1, ZFYVE27, KIF1B, IGF1R, TNFSF9, TPGS1, EPHB2	dendrite [CC], neuron projection [CC], cell death [BP], apoptotic process [BP], receptor binding [MF]
CG_h9laurent_promoter_p_RM_12_526_8			4	0.5	2.47E-04	GATA4, DIS3L, GTPBP1	epithelial cell fate commitment [BP], cytoplasmic exosome (RNase complex) [CC]
CG_h9laurent_promoter_p_RM_12_191_15			5	0.75	2.06E-04	MAN1A2, MAN1B1	mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [MF]
CG_h9laurent_promoter_p_RM_12_473_15			5	1.0	3.73E-04	CNTNAP1, SETD1B, APCDD1, SOX2, NKX2-3, SMARCA4, FZD1, FZD2, CHD2, SOX11, UNCX, RAI1, CYB5D2, HNRNPAB, FOXB2, ERBB2, PRKCB, PAX2, SQSTM1, CIRH1A, MXI1, TLX2, MET, ADRB2, NTN1, CDK5RAP3, HES3, HOXC5	neuron projection morphogenesis [BP], Wnt-protein binding [MF], nervous system development [BP], ventricular septum morphogenesis [BP], hard palate development [BP], regulation of transcription, DNA-dependent [BP], neuron differentiation [BP], positive regulation of transcription, DNA-dependent [BP], Wnt receptor signaling pathway, calcium modulating pathway [BP], brain development [BP], optic cup morphogenesis involved in camera-type eye development [BP], positive regulation of transcription from RNA polymerase II promoter [BP], membranous septum morphogenesis [BP], regulation of transcription from RNA polymerase II promoter [BP], neural tube formation [BP], inner ear morphogenesis [BP], transcription, DNA-dependent [BP], tissue development [BP], muscular septum morphogenesis [BP], transcription from RNA polymerase II promoter [BP], G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger [BP], positive regulation of gene expression [BP]
CG_h9laurent_promoter_p_RM_12_70_15			5	0.75	4.18E-04	TFAP2C, SOX12, SP1	enhancer binding [MF], trophectodermal cell differentiation [BP], RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription [MF]
CG_h9laurent_promoter_p_RM_14_49_4			3	0.5	3.39E-04	SOX1, TWSG1, SOX2	forebrain neuron differentiation [BP], negative regulation of osteoblast differentiation [BP], lens morphogenesis in camera-type eye [BP]
CG_h9laurent_promoter_p_RM_12_578_13			6	0.75	3.54E-04	CREB1, TLE4, FOXO3, FOXF1, PROX1, FOXK2	RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity [MF]
CG_h9laurent_promoter_p_RM_12_137_13			3	0.5	2.97E-04	SHROOM2	cell-cell junction maintenance [BP]
CG_h9laurent_promoter_p_RM_12_166_16			4	0.75	2.51E-04	COL5A1, RNF128, SALL3, LRP5, MRAP2	endoplasmic reticulum [CC], proteoglycan binding [MF], negative regulation of smoothened signaling pathway [BP]
CG_h9laurent_promoter_p_RM_12_323_15			3	0.25	3.90E-04	FGF9, LRP5, FOXF1	positive regulation of mesenchymal cell proliferation [BP]
CG_h9laurent_promoter_p_RM_12_41_8			2	0.25	3.05E-04	POGLUT1, SOX2, NOTCH2NL, PCM1, DTX4	neuronal stem cell maintenance [BP], Notch signaling pathway [BP]
CG_h9laurent_promoter_p_RM_12_584_17			5	0.75	2.84E-04	CLN8	somatic motor neuron differentiation [BP]
CG_h9laurent_promoter_p_RM_14_388_20			2	0.25	4.24E-04	SMO	forebrain morphogenesis [BP]
CG_h9laurent_promoter_p_RM_12_85_9			2	0.5	3.15E-04	ST3GAL3	N-acetyllactosaminide alpha-2,3-sialyltransferase activity [MF]
CG_h9laurent_promoter_p_RM_12_524_4			5	0.75	1.58E-04	FABP5, LPIN3, B3GNT7	galactosyltransferase activity [MF], phosphatidylcholine biosynthetic process [BP]
CG_h9laurent_promoter_p_RM_12_159_31			2	0.25	3.09E-04	ARHGEF12, BAI3, ZFPM1, TPM1, ADRA2C, MAFK, MAG, BAIAP3, KLC1, APLP2, TAS1R3, MAFF, ADORA2A	blood coagulation [BP], regulation of norepinephrine secretion [BP], G-protein coupled receptor signaling pathway [BP], wound healing [BP]
CG_h9laurent_promoter_p_RM_16_24_9			4	0.5	4.38E-04	IGFBP2, ZSWIM6, EPHA8, PXK	neuron projection morphogenesis [BP], cell communication [BP], neuron projection development [BP], response to mechanical stimulus [BP]
CG_h9laurent_promoter_p_RM_12_561_11			3	0.5	2.95E-04	RPS6KA4, ARID5A, TCF7	neurogenesis [BP], generation of neurons [BP], positive regulation of histone acetylation [BP]
CG_h9laurent_promoter_p_RM_14_269_5			1	0.25	3.48E-04	MYOD1, ZEB1	E-box binding [MF]
CG_h9laurent_promoter_p_RM_12_513_15			4	0.75	3.27E-04	RQCD1, CNOT8	nuclear-transcribed mRNA poly(A) tail shortening [BP]
CG_h9laurent_promoter_p_RM_12_521_11			2	0.25	3.40E-04	BMP6, STRIP2, ETS2, NFATC1, RHOQ, SIX3, NR2C2, DCAF6, HES1, WTIP, MAPRE1, PRPF6, KNSTRN	cytoskeleton organization [BP], positive regulation of transcription from RNA polymerase II promoter [BP], microtubule plus end [CC]
CG_h9laurent_promoter_p_RM_12_27_11			2	0.25	3.23E-04	PLEKHG6, ZFPM1, TBX1, HES1, TBCD, CACNG4, CNIH2	pharyngeal system development [BP], regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity [BP], alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid selective glutamate receptor complex [CC], outflow tract morphogenesis [BP], GTPase activator activity [MF], regulation of secondary heart field cardioblast proliferation [BP]
CG_h9laurent_promoter_p_RM_12_292_13			2	0.5	3.35E-04	TSC2, PRKCE	14-3-3 protein binding [MF]
CG_h9laurent_promoter_p_RM_14_250_10			3	0.5	4.88E-04	ACVR1B, BMPR1B	receptor signaling protein serine/threonine kinase activity [MF], transmembrane receptor protein serine/threonine kinase activity [MF], transforming growth factor beta-activated receptor activity [MF]
CG_h9laurent_promoter_p_RM_12_504_24			2	0.25	3.82E-04	PLEKHA1	multicellular organism growth [BP]
CG_h9laurent_promoter_p_RM_14_265_9			1	0.25	2.98E-04	MAVS, CYP46A1, DECR2	positive regulation of IP-10 production [BP], peroxisomal membrane [CC], cholesterol 24-hydroxylase activity [MF]
CG_h9laurent_promoter_p_RM_12_57_11			3	0.75	1.87E-04	CTTN, FNTA, CNN2, PKD2, PPP4C, PRKCE, ADRA2C, F2R, PLCG1, FGFR1OP, RPA1, SQSTM1	cytoskeleton organization [BP], microtubule cytoskeleton organization [BP], receptor tyrosine kinase binding [MF], positive regulation of cell migration [BP], regulation of sensory perception of pain [BP], positive regulation of epithelial cell migration [BP], aorta development [BP], cytoskeleton [CC], positive regulation of vasoconstriction [BP], release of sequestered calcium ion into cytosol [BP], homeostasis of number of cells within a tissue [BP]
CG_h9laurent_promoter_p_RM_14_64_5			2	0.25	2.70E-04	CABP1, VAPA, NCS1, PDLIM5	protein localization to endoplasmic reticulum [BP], postsynaptic density [CC], neuron projection development [BP]
CG_h9laurent_promoter_p_RM_12_91_16			1	0.25	3.17E-04	IGF1R, PPM1A, KL, ATP6V0B	insulin receptor signaling pathway [BP]
CG_h9laurent_promoter_p_RM_14_74_2			2	0.25	1.37E-04	IL13RA1, IL17RB, SUFU, NPR1	interleukin-13 receptor complex [CC], signal transducer activity [MF], cell surface receptor signaling pathway [BP], cytokine receptor activity [MF]
CG_h9laurent_promoter_p_RM_14_221_7			2	0.25	3.17E-04	TRAF7, ASF1A, PSEN1, C1QTNF1, MEIS1, ATP6AP2, HTR6, TGIF1, SMC3, MAPKAPK2, ING2, CRHR1, NR4A1	response to DNA damage stimulus [BP], MAPK cascade [BP], long-term synaptic potentiation [BP], regulation of synaptic plasticity [BP], regulation of MAPK cascade [BP], positive regulation of MAPK cascade [BP], cellular response to vascular endothelial growth factor stimulus [BP], chromatin binding [MF]
CG_h9laurent_promoter_p_RM_12_206_17			2	0.5	3.69E-04	MTMR14, MRFAP1, MYO9B, NDOR1	perinuclear region of cytoplasm [CC]
CG_h9laurent_promoter_p_RM_14_91_16			2	0.25	4.27E-04	CEBPB, FOXG1, SLC6A8, UNCX, SLC44A1, BMPR2, FOXL1, PKNOX1, FOXC1, MAPK8IP3, FZD1	choline transmembrane transporter activity [MF], pattern specification process [BP], RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity [MF], lung alveolus development [BP]
CG_h9laurent_promoter_p_RM_12_542_22			2	0.5	3.53E-04	SOX11, PAX2, SMO, PPARA, GATA3, NME2	nucleoside triphosphate biosynthetic process [BP], regulation of stem cell maintenance [BP], negative regulation of DNA binding [BP], regulation of nephron tubule epithelial cell differentiation [BP], nephric duct morphogenesis [BP], optic cup morphogenesis involved in camera-type eye development [BP], ureter maturation [BP], embryonic camera-type eye development [BP], nephric duct formation [BP], mesenchymal to epithelial transition [BP], negative regulation of transcription regulatory region DNA binding [BP]
CG_h9laurent_promoter_p_RM_12_577_20			4	0.75	3.86E-04	NKD2, TRIM28, RCN1, ZBTB18, TRAF3, PCBP2, PRKAR2B, FLVCR1	ubiquitin protein ligase binding [MF], in utero embryonic development [BP]
CG_h9laurent_promoter_p_RM_14_192_25			8	0.5	3.07E-04	SENP5, USP30	cysteine-type peptidase activity [MF]
CG_h9laurent_promoter_p_RM_14_62_6			1	0.25	4.05E-04	DUT, NFIX, NT5M, NFIC	DNA replication [BP]
CG_h9laurent_promoter_p_RM_14_41_6			2	0.25	3.44E-04	TCOF1, ZBTB16, PKDCC	positive regulation of chondrocyte differentiation [BP], forelimb morphogenesis [BP], positive regulation of ossification [BP], skeletal system development [BP]
CG_h9laurent_promoter_p_RM_14_57_11			2	0.25	4.53E-04	CDC25B, CDK5R1, MGMT, GATA4, GRIN1, CDC42, TLK2	positive regulation of cell cycle cytokinesis [BP], protein phosphorylation [BP], peptidyl-serine phosphorylation [BP], cellular response to ionizing radiation [BP], ionotropic glutamate receptor signaling pathway [BP], negative regulation of autophagy [BP]
CG_h9laurent_promoter_p_RM_12_483_4			2	0.25	2.08E-04	LTB4R, EGR1, SLC12A5	positive regulation of glomerular metanephric mesangial cell proliferation [BP], thermosensory behavior [BP], leukotriene B4 receptor activity [MF]
CG_h9laurent_promoter_p_RM_14_263_2			3	0.25	3.39E-04	XPOT, FOXF1, ABCG1	embryonic ectodermal digestive tract morphogenesis [BP], sterol-transporting ATPase activity [MF], tRNA export from nucleus [BP], detection of hormone stimulus [BP], detection of wounding [BP], mesenchyme migration [BP], branching involved in open tracheal system development [BP], right lung morphogenesis [BP]
CG_h9laurent_promoter_p_RM_14_168_13			3	0.25	4.92E-04	CDK5R1, EFNA2, DOK7, TMOD2, PSEN2	growth cone [CC], ephrin receptor binding [MF], neuromuscular junction [CC], ephrin receptor signaling pathway [BP]
CG_h9laurent_promoter_p_RM_12_263_10			3	0.5	3.73E-04	SPEN, MIER1, PRKAA2, TOP1, YEATS2, CUX1, PIAS4, SOX2, NACC1, HSF1	chromatin binding [MF], negative regulation of transcription, DNA-dependent [BP]
CG_h9laurent_promoter_p_RM_12_357_27			3	0.5	3.35E-04	DRAXIN, OLIG1, TSC2	dorsal spinal cord development [BP], protein dimerization activity [MF], insulin-like growth factor receptor signaling pathway [BP]
CG_h9laurent_promoter_p_RM_12_384_16			3	0.5	2.49E-04	HINFP, CIRH1A, BMPR1A, CHRD, VEGFA, PCNT, TRIM71, ZNF660, WEE1, UHRF1, FOXK2, GRHL1	protein autoubiquitination [BP], regulation of gene expression [BP], positive regulation of mesenchymal cell proliferation [BP], regulation of transcription, DNA-dependent [BP], neural precursor cell proliferation [BP], in utero embryonic development [BP], mitotic cell cycle [BP], mesoderm development [BP], embryo development [BP], regulation of transcription from RNA polymerase II promoter [BP]
CG_h9laurent_promoter_p_RM_12_104_7			4	0.75	3.35E-04	OXT, RIPK1, ITPKC, RNF139, TSPO, PTPRJ, ITPKA	contact inhibition [BP], regulation of protein processing [BP], positive regulation of necrotic cell death [BP], positive regulation of ossification [BP], inositol-1,4,5-trisphosphate 3-kinase activity [MF]
CG_h9laurent_promoter_p_RM_12_415_9			3	0.5	3.05E-04	HS3ST2, PKD2, AGRN, GRIN3B, HES1, CHST3, CSGALNACT2, ZMIZ1, B3GNT4	calcium ion transport [BP], S-shaped body morphogenesis [BP], regulation of calcium ion transport [BP], artery morphogenesis [BP], glycosaminoglycan metabolic process [BP], glycosaminoglycan biosynthetic process [BP]
CG_h9laurent_promoter_p_RM_12_572_16			2	0.25	2.85E-04	IGF1R, SIRT1, ALDH1A3, NPR1	regulation of JNK cascade [BP], NAD+ binding [MF], hormone binding [MF]
CG_h9laurent_promoter_p_RM_12_267_23			1	0.25	3.16E-04	ADAP2, GPR98, AGFG1, ARFGAP1, SLC12A2	regulation of ARF GTPase activity [BP], ARF GTPase activator activity [MF], detection of mechanical stimulus involved in sensory perception of sound [BP]
CG_h9laurent_promoter_p_RM_12_586_18			4	0.5	3.02E-04	GRK4, GRK6	G-protein coupled receptor kinase activity [MF]
CG_h9laurent_promoter_p_RM_16_28_6			8	0.5	3.97E-04	YY1, ADD1, SEC14L2, ILK, AFTPH, FMN2, CD4, CREBL2, AEBP2, MAPKAPK5, CPSF4, NR1D2, ZNF703, SSNA1, BHLHE22, RNF114, SS18L1, LANCL2, ZSWIM6, CBFB, ZIC2, FOXF1, GLI4, MTA3, MVP, ARIH1, POGK, TRIM24, ZNF362, UBE2E1, REST, HTATSF1, ATF7IP, DAZAP1, ZNRF1, ADCY1, ADCY2, PLXNA3, NAA35, TACC3, INSM1, CCNF, NSD1, PHF20L1, CRIM1, HIVEP1, BPTF	neurogenesis [BP], calcium- and calmodulin-responsive adenylate cyclase activity [MF], neuron projection morphogenesis [BP], multicellular organismal development [BP], zinc ion binding [MF], nervous system development [BP], nucleus [CC]
CG_h9laurent_promoter_p_RM_12_139_10			6	0.75	4.03E-04	FST, INHBB	negative regulation of follicle-stimulating hormone secretion [BP]
CG_h9laurent_promoter_p_RM_12_213_10			3	0.25	2.86E-04	SPEN, TREX1, MSH3, FOXK2, FOXO3	single-stranded DNA binding [MF], double-stranded DNA binding [MF]
CG_h9laurent_promoter_p_RM_12_232_31			3	0.5	4.09E-04	EGLN2	regulation of neuron apoptotic process [BP]
CG_h9laurent_promoter_p_RM_14_338_16			4	0.5	2.33E-04	DNM1, EPHX1, FZD6, RAC1, LRP3	cis-stilbene-oxide hydrolase activity [MF], Wnt receptor signaling pathway, planar cell polarity pathway [BP], establishment of planar polarity [BP], non-canonical Wnt receptor signaling pathway [BP], receptor-mediated endocytosis [BP]
CG_h9laurent_promoter_p_RM_14_80_6			2	0.25	2.62E-04	ULK1	radial glia guided migration of cerebellar granule cell [BP]
CG_h9laurent_promoter_p_RM_12_235_12			3	0.5	2.38E-04	SMAD1, SMAD6	co-SMAD binding [MF], I-SMAD binding [MF], SMAD protein complex assembly [BP]
CG_h9laurent_promoter_p_RM_12_343_30			2	0.5	3.13E-04	PKD2, ING5, HCN3, PDS5B, WNK2	centrosome duplication [BP], negative regulation of cell proliferation [BP], sodium channel activity [MF]
CG_h9laurent_promoter_p_RM_12_79_9			4	0.75	2.70E-04	TANC1, NEO1	myoblast fusion [BP]
CG_h9laurent_promoter_p_RM_14_241_6			1	0.25	2.44E-04	PAOX	positive regulation of spermidine biosynthetic process [BP]
CG_h9laurent_promoter_p_RM_16_22_9			4	0.5	4.45E-04	FOXP4, SPG7, BAHD1, EPB41, CPSF4, E4F1, COASY, CHD7, SOX11, RBPJ, TMOD2, ZIC2, FOXF2, ZNF660, TMEM57, CUL1, BCL7A, FBXO45, IGF1R, MAPK4, HOOK3, REST, CARM1, HOXC11, CUX1, EP300, PKNOX2, FSD1, POGK, USP39, ARID1B, PLXNA1, TACC3, ZNF710, HUNK, GNA11, ZMIZ1, CRIM1, RNF169, POU3F3	interkinetic nuclear migration [BP], DNA binding [MF], organ morphogenesis [BP], heart morphogenesis [BP], insulin-like growth factor-activated receptor activity [MF], artery morphogenesis [BP], negative regulation of transcription, DNA-dependent [BP], chromatin binding [MF], cardiac muscle cell myoblast differentiation [BP], multicellular organismal development [BP], nucleus [CC], heart development [BP], nervous system development [BP]
CG_h9laurent_promoter_p_RM_12_237_11			2	0.5	3.04E-04	AQP6	nitrate transmembrane transporter activity [MF]
CG_h9laurent_promoter_p_RM_12_135_14			3	0.5	2.71E-04	TCF7L1, IDUA, PLOD1	hydroxylysine biosynthetic process [BP], L-iduronidase activity [MF], positive regulation of transcription from RNA polymerase II promoter during mitosis [BP], epidermis development [BP]
CG_h9laurent_promoter_p_RM_12_491_14			2	0.5	3.68E-04	REST, AGRN, INHBB, PFKL, P2RX3, ACTR3, FOXC2, ADIPOQ, BASP1	sialic acid binding [MF], chromatin DNA binding [MF], negative regulation of insulin secretion [BP], negative regulation of hormone secretion [BP], response to carbohydrate stimulus [BP], glomerular visceral epithelial cell differentiation [BP]
CG_h9laurent_promoter_p_RM_14_82_7			2	0.25	2.79E-04	SQSTM1, NFIC, SOX11, HOXC4, HOXD11, KDM2A, CREB3L4, HDAC11, IKZF1, HSF1	positive regulation of multicellular organism growth [BP], regulation of transcription, DNA-dependent [BP], sequence-specific DNA binding transcription factor activity [MF], sequence-specific DNA binding [MF], positive regulation of transcription from RNA polymerase II promoter [BP], nucleic acid binding transcription factor activity [MF]
CG_h9laurent_promoter_p_RM_12_360_18			4	0.75	2.87E-04	PIAS1, TRIM28, DRAP1, SPEN	transcription corepressor activity [MF]
CG_h9laurent_promoter_p_RM_12_603_18			4	0.75	2.63E-04	S1PR1, RYR2, GCKR, ENPP1, GNAL, ITPR3, TAS1R3, ITPR1, GNAI2, OPRL1, CHST12	inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [MF], sensory perception of umami taste [BP], enzyme binding [MF], sensory perception of sweet taste [BP], calcium-release channel activity [MF], intracellular ligand-gated calcium channel activity [MF], 3'-phosphoadenosine 5'-phosphosulfate binding [MF], adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway [BP]
CG_h9laurent_promoter_p_RM_12_447_13			5	0.75	3.15E-04	MIF, CD4, CHAF1A, CBX3, RBM15B, MUM1, ETS2, MAPRE1, EPHB2, TRAF3, MAST2, DAG1, HES1, RAB25, TBL1X, AKAP1, NANOS1, TACC3, USP10, PPIF, MRPL48, YBX1, LCK, SPTAN1	peptidyl-tyrosine phosphorylation [BP], protein binding [MF], positive regulation of peptidyl-tyrosine phosphorylation [BP], regulation of defense response to virus [BP], protein domain specific binding [MF]
CG_h9laurent_promoter_p_RM_12_376_9			3	0.5	2.90E-04	PHF17, BIRC7, LIMK1, CDADC1, TAF15, PNMA3, KLF13, ADAMTSL3, ZNF354C, DDHD2, ZIC2, ZIC1, LFNG, ZNF517, MORF4L1, ZNF185, ACVR2B, CISD1, ING1, TRIM41, GDPD1, ZNF501, ADAMTS15, MMP15	histone H4 acetylation [BP], metal ion binding [MF], zinc ion binding [MF]
CG_h9laurent_promoter_p_RM_12_201_13			2	0.25	2.02E-04	GNAS	mu-type opioid receptor binding [MF], post-embryonic body morphogenesis [BP]
CG_h9laurent_promoter_p_RM_20_7_3			1	0.25	4.76E-04	PDXK	lithium ion binding [MF], pyridoxal phosphate biosynthetic process [BP], pyridoxal 5'-phosphate salvage [BP], pyridoxal kinase activity [MF]
CG_h9laurent_promoter_p_RM_12_217_28			2	0.25	3.97E-04	DOK1, FPGS, PTPN1	response to chemical stimulus [BP], insulin receptor binding [MF]
CG_h9laurent_promoter_p_RM_12_272_20			2	0.5	4.13E-04	NOG, EGFR, CHD7, FGF9, APCDD1	embryonic limb morphogenesis [BP], negative regulation of Wnt receptor signaling pathway [BP], positive regulation of epithelial cell proliferation [BP], limb development [BP], morphogenesis of an epithelial fold [BP]
CG_h9laurent_promoter_p_RM_12_105_21			3	0.5	3.04E-04	NELFCD, NELFB	NELF complex [CC]
CG_h9laurent_promoter_p_RM_12_48_23			2	0.25	2.02E-04	ACVR1B, SLC7A6, UNCX, UNC5D, BMPR1B, CDK5R1, SLC1A4, PRPS2, SEPT2, PTPN6, SH3GL2, DPYSL2	amino acid transport [BP], neuron projection development [BP], axon guidance [BP], neuron differentiation [BP], transforming growth factor beta-activated receptor activity [MF], cartilage condensation [BP], kinase activity [MF], transmembrane receptor protein serine/threonine kinase activity [MF], cell differentiation [BP], nervous system development [BP]
CG_h9laurent_promoter_p_RM_14_321_15			1	0.25	2.80E-04	CSK, BAIAP2	proline-rich region binding [MF]
CG_h9laurent_promoter_p_RM_12_330_7			2	0.25	3.47E-04	BMPR1A	paraxial mesoderm structural organization [BP], neural plate mediolateral regionalization [BP]
CG_h9laurent_promoter_p_RM_14_308_3			2	0.25	3.50E-04	TSSK3, ATP11A, ENO3	magnesium ion binding [MF]
CG_h9laurent_promoter_p_RM_12_42_12			2	0.25	2.38E-04	NCAPD2, TGM4	condensin core heterodimer [CC], protein polyamination [BP]
CG_h9laurent_promoter_p_RM_12_240_12			3	0.5	2.20E-04	CEBPB, STRIP2, PPFIA1, CYP46A1, VIL1, RIMKLB, ROPN1B	cytoplasmic actin-based contraction involved in cell motility [BP], lysophosphatidic acid binding [MF], cytoplasm [CC], cholesterol 24-hydroxylase activity [MF], citrate-L-glutamate ligase activity [MF]
CG_h9laurent_promoter_p_RM_12_362_17			3	0.5	3.35E-04	IGF1R, CACNA1C, RHPN1, ERBB2IP, ADORA2A, DACT1, FRAT1, CACNA1D, MOCOS, GNAZ, RAC1, ARHGAP23, APPL1, FGF18, PIAS4, LZTS2, MARC1, MAPK8IP2, BAI1	Wnt receptor signaling pathway [BP], molybdenum ion binding [MF], alpha-actinin binding [MF], adenylate cyclase-modulating G-protein coupled receptor signaling pathway [BP], dendrite morphogenesis [BP], signal transduction [BP], high voltage-gated calcium channel activity [MF]
CG_h9laurent_promoter_p_RM_14_88_6			1	0.25	3.24E-04	ESRRA, RXRA, ZC3H6, SLC2A4RG, ZFAND6, COL27A1, ZIC2, PIAS4, PAPD5, ING1, RREB1, INPP1	metal ion binding [MF], chromatin DNA binding [MF], zinc ion binding [MF]
CG_h9laurent_promoter_p_RM_12_63_9			2	0.5	2.39E-04	NELFCD, PPARD, SMAD5, ISL2, PAX2, EVX1, TCF25, REST, SLC2A4RG, EN2, GZF1, PPARA, ARID4A, HEY2, MMP14	sequence-specific DNA binding [MF], transcription from RNA polymerase II promoter [BP], negative regulation of transcription regulatory region DNA binding [BP], sequence-specific DNA binding transcription factor activity [MF]
CG_h9laurent_promoter_p_RM_12_68_15			2	0.5	3.94E-04	BMPR1A, ID4, GNAS, PRKCD, PRKAA2, PDK1, KIAA1804, MAPK4, IL6R, TRIM28	protein phosphorylation [BP], protein kinase activity [MF], positive regulation of osteoblast differentiation [BP]
CG_h9laurent_promoter_p_RM_12_567_20			2	0.5	3.64E-04	DHX38, DYRK2, MTDH, CHD7, HINFP, SUFU, RRP1B, SOX11, HIST1H2BO, PPRC1, WAC, NCS1, MVP, HABP4, MRPL40, SETMAR, MAPK4, ZNF576, ALKBH5, AKIP1, KLF13	intracellular membrane-bounded organelle [CC], nucleus [CC]
CG_h9laurent_promoter_p_RM_12_61_16			4	0.75	2.03E-04	METTL20	protein methyltransferase activity [MF]
CG_h9laurent_promoter_p_RM_14_189_4			4	0.5	2.61E-04	PLCG2, PLCB3, SKI, LRP5, APC2	Wnt receptor signaling pathway [BP], negative regulation of osteoblast differentiation [BP], phospholipase C activity [MF], phosphatidylinositol phospholipase C activity [MF], positive regulation of mitosis [BP], regulation of insulin secretion involved in cellular response to glucose stimulus [BP]
CG_h9laurent_promoter_p_RM_12_130_16			2	0.5	3.00E-04	AGFG1, ADAP2	regulation of ARF GTPase activity [BP], ARF GTPase activator activity [MF]
CG_h9laurent_promoter_p_RM_12_509_10			2	0.5	3.06E-04	PRKCI, TRAF3, RIPK1, TSPO, ADIPOQ, HSF1	tumor necrosis factor-mediated signaling pathway [BP], positive regulation of necrotic cell death [BP], negative regulation of tumor necrosis factor production [BP], positive regulation of glial cell proliferation [BP]
CG_h9laurent_promoter_p_RM_12_108_14			4	0.5	2.90E-04	LHX2, ZRANB1, SOX11, GLRX3, DACT1, SQSTM1	protein kinase C binding [MF], neural tube formation [BP], negative regulation of transcription regulatory region DNA binding [BP], K63-linked polyubiquitin binding [MF]
CG_h9laurent_promoter_p_RM_14_326_6			2	0.25	3.74E-04	SNCAIP, RAB31, PI4K2A, PPP1CB	myosin phosphatase activity [MF], myosin-light-chain-phosphatase activity [MF], AP-3 adaptor complex binding [MF], presynaptic membrane [CC], host cell presynaptic membrane [CC], regulated secretory pathway [BP], basophil degranulation [BP]
CG_h9laurent_promoter_p_RM_12_388_13			4	0.5	2.80E-04	BCKDHA, MCCC2	branched-chain amino acid catabolic process [BP]
CG_h9laurent_promoter_p_RM_14_151_26			6	0.75	4.68E-04	ZFPM2, CDKN2AIP, MAN1B1, SETD1B, ZXDB, LEMD3, PDE9A, EIF3L, RBPJ, CACNA1C, FSTL3, FOXF1, KDM2A, SOBP, IGF1R, TRIM28, ZNF362, KCNF1, ATP2B3, MAN1A2, URI1, MOCS3, ZNF672, SAP30L, RUNX2, YBX1, CTCF, ACVR1B, CARM1, POLR1C, ZFP92, SKI, PPM1E, PPM1A, USP47, MKL2, CDK5R1, CAMTA1, B4GALT7, SIRT1, XPOT, CDC25B, RHOQ, KCNQ5, MLLT10, PAX1, ZEB1, PKNOX2, TAF5, GNAS, ZNF618, RING1, PPP4C, YY1, ZNF333, CLYBL, SMAD6, SMAD1, UPF1, KCNA6, FNIP2, HIC1, FZD7, NR2F2, FAHD1, ATOH8, WAC, RXRA, SALL3, MNAT1, MAPK8IP3, BMPR1B, BASP1, ATP1A1, PPP5C, ZMIZ2, ZMIZ1, SNRNP48, ASAP2, KCNC1, USP3, SOX8, SOX2, DGKZ, QKI, HCFC2, PDE1B, YWHAH, KCNS2, SMARCB1, NDUFS7, ACAP1, FOXD3, MAN1C1, RTF1, USP15, NFIX, CHD7, RNF169, ZNF710, ZNF711, GNA11, CYB561D1, CRIM1, TADA2B, HSF1	BMP signaling pathway [BP], negative regulation of SMAD protein complex assembly [BP], negative regulation of activin receptor signaling pathway [BP], delayed rectifier potassium channel activity [MF], regulation of transcription, DNA-dependent [BP], transmembrane receptor protein serine/threonine kinase signaling pathway [BP], nucleoplasm [CC], in utero embryonic development [BP], metal ion binding [MF], mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [MF], positive regulation of transcription, DNA-dependent [BP], transcription regulatory region DNA binding [MF], bone morphogenesis [BP], positive regulation of transcription from RNA polymerase II promoter [BP], chromatin binding [MF], nuclear chromatin [CC], embryo development [BP], regulation of transcription from RNA polymerase II promoter [BP], negative regulation of transforming growth factor beta receptor signaling pathway [BP], protein domain specific binding [MF], insulin-like growth factor-activated receptor activity [MF], SMAD binding [MF], SMAD protein complex assembly [BP], transcription corepressor activity [MF], negative regulation of transcription from RNA polymerase II promoter [BP], negative regulation of transcription, DNA-dependent [BP], regulation of gene expression [BP], negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway [BP], transcription from RNA polymerase II promoter [BP], positive regulation of gene expression [BP]
CG_h9laurent_promoter_p_RM_14_354_17			4	0.5	2.74E-04	CDK5R1, KAZN, LLGL1, PDIA2, PKP4, PKP3, MMP23B, KDELR3, TSC2, IGF1R	protein retention in ER lumen [BP], desmosome [CC], intracellular [CC], insulin-like growth factor receptor signaling pathway [BP], axon [CC]
CG_h9laurent_promoter_p_RM_12_427_11			4	0.5	4.17E-04	COASY, NLGN1, CACNA1C, CACNA1D, KCNK13, ADORA2A, SPTBN4, PPCS, KCNJ12	coenzyme A biosynthetic process [BP], positive regulation of synaptic transmission, GABAergic [BP], blood circulation [BP], alpha-actinin binding [MF], voltage-gated ion channel activity [MF], pantothenate metabolic process [BP], high voltage-gated calcium channel activity [MF], cardiac conduction [BP], regulation of heart contraction [BP]
CG_h9laurent_promoter_p_RM_12_279_20			4	0.75	3.94E-04	PDXK, FPGS, SMCHD1, TGFBR1, HOXC6, KIF11, EDNRA, CEBPG, ZNF740, ITPKC, MAGI3, ACVR2B, SMARCB1, MIER1, CCRN4L, SALL3, SBK1, FGFR3, ADCY1, SQSTM1, ZNF526, CIRH1A, HLX, ID2, FN3KRP, PDPK1, ACTR5, TFDP1, KCNH3	transcription, DNA-dependent [BP], regulation of transcription, DNA-dependent [BP], enucleate erythrocyte differentiation [BP], glomerular filtration [BP], kinase activity [MF], digestive tract morphogenesis [BP], ATP binding [MF], positive regulation of protein phosphorylation [BP]
CG_h9laurent_promoter_p_RM_14_22_5			2	0.25	5.61E-04	USP10, ADCY1, OPRL1, EHMT1	p53 binding [MF], nociceptin receptor activity [MF], adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway [BP]
CG_h9laurent_promoter_p_RM_12_425_18			3	0.5	3.51E-04	ONECUT3, FOXE1, HOXC4, EPB41, FOXO3, BMPR1A, BMPR1B, SOX1, UBN1, SLC2A4RG, RIPK1, MYBL2, BHLHE40, LHX9, TFAP2C, TPM4, PBX3, TBX21, EN2, ZIC2, FOXF1, RNF207, SIPA1L3, LMX1B, HNRNPM, ACVR2A, FOXJ2, TRIM28, CDC25B, ACAP1, RHOU, IL6R, CUX1, EP300, ZNF804A, PKNOX1, NFIC, STXBP1, LRP5, PLXNA3, PTPN12, IRF4, RUNX2, TADA2A, ATF1, TFDP1, PTH1R	protein domain specific binding [MF], protein complex [CC], intracellular [CC], positive regulation of osteoblast differentiation [BP], lateral mesodermal cell differentiation [BP], podosome [CC], lateral mesoderm development [BP], sequence-specific DNA binding transcription factor activity [MF], receptor complex [CC], pattern specification process [BP], transcription factor complex [CC]
CG_h9laurent_promoter_p_RM_14_103_11			2	0.25	4.32E-04	SIRT1, UBR2	negative regulation of TOR signaling cascade [BP]
CG_h9laurent_promoter_p_RM_14_92_12			2	0.5	4.82E-04	BMP6, GMEB1, BMP2, FOXK1, GNAS, ASXL1, ITGA6, PPARD, PKP4, ZNF275, EP300, HEY2, CTCF, NFIC	SMAD protein signal transduction [BP], positive regulation of pathway-restricted SMAD protein phosphorylation [BP], positive regulation of fat cell differentiation [BP], genetic imprinting [BP], BMP receptor binding [MF], positive regulation of bone mineralization [BP], growth [BP], positive regulation of transcription, DNA-dependent [BP], cardiac epithelial to mesenchymal transition [BP], endochondral ossification [BP], mesenchymal cell development [BP], negative regulation of gene expression [BP], regulation of transcription from RNA polymerase II promoter [BP], positive regulation of osteoblast differentiation [BP], negative regulation of transcription from RNA polymerase II promoter [BP], transcription, DNA-dependent [BP], negative regulation of transcription, DNA-dependent [BP], tissue development [BP], atrioventricular valve development [BP], gene expression [BP], transcription from RNA polymerase II promoter [BP], positive regulation of gene expression [BP], positive regulation of transcription from RNA polymerase II promoter [BP]
CG_h9laurent_promoter_p_RM_12_102_28			2	0.5	3.25E-04	KALRN, PSEN1, NR4A1, MAG, MAPKAPK2, TRIO	nerve growth factor receptor signaling pathway [BP]
CG_h9laurent_promoter_p_RM_14_324_4			1	0.25	2.29E-04	SOCS6, FGF2, FGFRL1	fibroblast growth factor binding [MF], regulation of growth [BP]
CG_h9laurent_promoter_p_RM_12_380_12			5	0.5	3.16E-04	FZD3, FZD6, SQSTM1	regulation of Ras protein signal transduction [BP], cell proliferation in midbrain [BP], G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger [BP]
CG_h9laurent_promoter_p_RM_14_384_7			3	0.5	4.69E-04	CACNA1C, CACNA1D, KCNJ12	alpha-actinin binding [MF], high voltage-gated calcium channel activity [MF], regulation of heart contraction [BP]
CG_h9laurent_promoter_p_RM_14_248_7			2	0.25	2.58E-04	ARHGAP5	Rho GTPase activator activity [MF]
CG_h9laurent_promoter_p_RM_12_476_21			5	0.75	3.41E-04	EPHB1, CHD7, SMAD1, USP6, POU4F2, ZIC2, ATP11A, UPF1, ADM, SKI, CBX2, MYB	neural tube closure [BP], SMAD protein complex assembly [BP], recycling endosome [CC], retinal ganglion cell axon guidance [BP], chromatin binding [MF], camera-type eye development [BP]
CG_h9laurent_promoter_p_RM_12_150_7			1	0.25	2.85E-04	PKN3, DEF8, PRKAR2B, ABL1, RAB40C, FGFR3, ARL4A, CEBPB	brown fat cell differentiation [BP], intracellular signal transduction [BP], perinuclear region of cytoplasm [CC]
CG_h9laurent_promoter_p_RM_12_290_17			2	0.5	2.69E-04	SMARCB1, PLXNA1, INHBB, GADD45B, HUNK, RBM38, ANGPTL4	multicellular organismal development [BP], cell differentiation [BP]
CG_h9laurent_promoter_p_RM_12_359_16			3	0.5	3.12E-04	SPIN1, SAC3D1	spindle [CC]
CG_h9laurent_promoter_p_RM_12_441_19			3	0.5	3.03E-04	SLC2A4	glucose import [BP], amylopectin biosynthetic process [BP]
CG_h9laurent_promoter_p_RM_12_8_13			3	0.5	3.91E-04	CEBPB, DSCR6, SOX17, MOSPD3, SMYD1, NFATC1	RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity [MF], heart development [BP]
CG_h9laurent_promoter_p_RM_12_72_11			5	0.75	3.46E-04	TRIB1, ZBED4, RMI1, DCPS, QKI, JMY, ZNF628, GRHL1, FAS, MKL2, KDM4B, ZNF574, FOXB1, MSX2, PARVA, TRAF4, TSHZ1, SNAPC2, SALL3, NFIC, MXI1, ZNF713, BABAM1, SOX11, AATF, ZNF397, HOXC5	soft palate development [BP], sequence-specific DNA binding transcription factor activity [MF], negative regulation of transcription regulatory region DNA binding [BP], outflow tract morphogenesis [BP], nucleic acid binding transcription factor activity [MF], outflow tract septum morphogenesis [BP], nucleus [CC]
CG_h9laurent_promoter_p_RM_14_320_5			2	0.25	2.49E-04	PCYOX1	chloride-transporting ATPase activity [MF], prenylcysteine oxidase activity [MF]
CG_h9laurent_promoter_p_RM_12_505_11			3	0.5	3.42E-04	GNAZ, NPB, GNAS	G-protein coupled receptor binding [MF], G-protein beta/gamma-subunit complex binding [MF]
CG_h9laurent_promoter_p_RM_12_276_18			3	0.5	3.46E-04	CD2AP, MYO6	filamentous actin [CC]
CG_h9laurent_promoter_p_RM_14_229_8			1	0.25	3.01E-04	PLCB1, BLOC1S3, VAX2, KIF1B, LLGL1, NDST1, MGMT, COL5A1, CACNA1H, PAX2, OCLN, BMP8A, WNT3A	anterograde axon cargo transport [BP], structural molecule activity [MF], axonogenesis [BP], neuron projection development [BP], eye development [BP], forebrain development [BP], neuron differentiation [BP], positive regulation of embryonic development [BP], mesodermal cell fate specification [BP], eye morphogenesis [BP], regulation of cysteine-type endopeptidase activity involved in apoptotic process [BP], positive regulation of acrosome reaction [BP], cell differentiation [BP]
CG_h9laurent_promoter_p_RM_12_147_25			3	0.5	3.48E-04	SLIT2, ADIPOQ, FOXD2	axon extension involved in axon guidance [BP], negative regulation of smooth muscle cell migration [BP]
CG_h9laurent_promoter_p_RM_14_83_5			3	0.25	2.88E-04	STARD8, PSMC6, ARL4A, UBE4B	small GTPase mediated signal transduction [BP], ubiquitin-dependent protein catabolic process [BP], protein polyubiquitination [BP]
CG_h9laurent_promoter_p_RM_12_419_13			3	0.75	3.32E-04	PCGF5, LRWD1, TLK2, JAM3, SUZ12, NCMAP, CBX2, CHD3	chromatin organization [BP], methylated histone residue binding [MF], Schmidt-Lanterman incisure [CC], chromatin modification [BP], PcG protein complex [CC]
CG_h9laurent_promoter_p_RM_14_289_6			2	0.25	2.42E-04	HS3ST3B1, LLGL1, MET	maintenance of apical/basal cell polarity [BP], [heparan sulfate]-glucosamine 3-sulfotransferase 3 activity [MF], hepatocyte growth factor-activated receptor activity [MF], negative regulation of hydrogen peroxide-mediated programmed cell death [BP]
CG_h9laurent_promoter_p_RM_12_337_6			3	0.25	2.80E-04	NT5E	purine nucleotide catabolic process [BP]
CG_h9laurent_promoter_p_RM_12_436_19			2	0.25	3.48E-04	POU3F3	metanephric macula densa development [BP]
CG_h9laurent_promoter_p_RM_14_143_12			4	0.75	2.14E-04	KLF11, RBBP8, IL4R, SOX11, CDS2, PIK3R1, MYB, KCNIP3, AGPAT9, EHMT1	negative regulation of transcription from RNA polymerase II promoter [BP], insulin receptor substrate binding [MF], CDP-diacylglycerol biosynthetic process [BP], positive regulation of T-helper cell differentiation [BP]
CG_h9laurent_promoter_p_RM_14_145_16			3	0.5	3.37E-04	NPR3, PREX2, INPPL1, GNAS, RHOQ, FOXL1, IGF1R, GNAZ, FRS2, STK11, CDK5R1, MAPK8IP2, SNX30, GABRA5, APLP1, FOXC1, PTGFR	cellular response to catecholamine stimulus [BP], G-protein coupled receptor signaling pathway [BP], adenylate cyclase-modulating G-protein coupled receptor signaling pathway [BP], brain development [BP], insulin receptor signaling pathway [BP], protein kinase activator activity [MF], cell communication [BP], adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway [BP]
CG_h9laurent_promoter_p_RM_20_3_1			1	0.25	4.27E-04	MPG	DNA-7-methylguanine glycosylase activity [MF], DNA-7-methyladenine glycosylase activity [MF], DNA-3-methylguanine glycosylase activity [MF], DNA-3-methyladenine glycosylase activity [MF]
CG_h9laurent_promoter_p_RM_14_290_6			2	0.25	2.97E-04	KRT18, P2RY1	A1 adenosine receptor binding [MF], scaffold protein binding [MF]
CG_h9laurent_promoter_p_RM_12_438_14			3	0.25	3.00E-04	TCF7, CRAMP1L, ONECUT3, SIN3B, BAHCC1, ZBTB18, MAEL, RASSF7, ZNF592, ZBTB42, LUC7L3, FOXF2, ARID1B, ZEB1, PKNOX2, POU3F3	XY body [CC], sequence-specific DNA binding [MF], negative regulation of transcription, DNA-dependent [BP], DNA binding [MF], autosome [CC], regulation of transcription from RNA polymerase II promoter [BP]
CG_h9laurent_promoter_p_RM_12_6_19			4	0.75	2.37E-04	GATA3, RET, TGFBR1	ureter maturation [BP], parathyroid gland development [BP], pharyngeal system development [BP]
CG_h9laurent_promoter_p_RM_14_380_8			3	0.5	3.53E-04	HES1, FBXW8	labyrinthine layer blood vessel development [BP]
CG_h9laurent_promoter_p_RM_14_209_7			2	0.25	3.02E-04	FGF18, ATP9B, GNAS, TNFRSF14	endochondral ossification [BP], cell surface receptor signaling pathway [BP], trans-Golgi network [CC]
CG_h9laurent_promoter_p_RM_12_143_18			3	0.75	3.60E-04	FOXP4, SPG7, ONECUT3, ZNF710, BAHD1, ZNF696, VENTX, UPF1, GNAI2, KLF13, ZNF143, DMBX1, CATSPER4, ZBTB18, EN2, GAL, KLF3, FOXF2, LBH, FBXO45, TCF7, RBL2, EBF4, ZNF22, YAP1, CRAMP1L, ARID1B, PLXNA1, TACC3, ZNF57, GNAZ, RUNX2, ABI2, PRDM6, GNA11, ATF4, NFIX, PHF3, ZNF771, FBXO18	neurogenesis [BP], G-protein beta/gamma-subunit complex binding [MF], multicellular organismal development [BP], DNA binding [MF], transcription factor complex [CC], nervous system development [BP]
CG_h9laurent_promoter_p_RM_14_285_6			2	0.5	3.08E-04	SLC12A9	cation:chloride symporter activity [MF]
CG_h9laurent_promoter_p_RM_14_225_15			2	0.5	3.92E-04	SRSF6, SMARCB1, ACVR1B, ERBB2	transcription from RNA polymerase II promoter [BP], growth factor binding [MF], nervous system development [BP]
CG_h9laurent_promoter_p_RM_12_218_14			4	0.5	4.07E-04	MMP17, ECE2, MMP15	metalloendopeptidase activity [MF]
CG_h9laurent_promoter_p_RM_12_15_15			4	0.75	1.88E-04	ARNTL2, ZBED4, HIC1, HOXC8, TCEB3, CRAMP1L, TCEA2, NPAS2, CRHBP, LMX1B, MARK4, BANF2, ADNP2, ZNF860, SALL3, ZNF263, ZIC2, ZNF84, OLIG2, GPSM1, INTU	neuron differentiation [BP], axon terminus [CC], DNA binding [MF], nervous system development [BP]
CG_h9laurent_promoter_p_RM_12_445_15			3	0.5	3.37E-04	PRKCB, HTRA3, STK4, KPNA2, SMOC1, IGF2R, LEMD3, HTRA1, DAG1, SNX11	negative regulation of transforming growth factor beta receptor signaling pathway [BP], negative regulation of BMP signaling pathway [BP], NLS-bearing substrate import into nucleus [BP], signal transduction [BP], insulin-like growth factor binding [MF], cell communication [BP]
CG_h9laurent_promoter_p_RM_12_192_14			2	0.5	1.97E-04	ING2	regulation of response to DNA damage stimulus [BP]
CG_h9laurent_promoter_p_RM_12_277_8			3	0.5	3.86E-04	CHD7, TADA2A, NR4A3	semicircular canal morphogenesis [BP], regulation of tubulin deacetylation [BP]
CG_h9laurent_promoter_p_RM_12_510_15			4	0.75	1.70E-04	TRAF3, SKI, FSTL3, EIF4E2, CUL4A	ubiquitin protein ligase binding [MF], negative regulation of activin receptor signaling pathway [BP]
CG_h9laurent_promoter_p_RM_12_295_20			1	0.25	3.91E-04	ZNF236, ZFPM1, HOXC5, NFKBIZ, SOX1, CBX2, ARHGEF16, ASXL3, GSX1, NPAS2, DOCK11, VCL, GZF1, FOXF2, RELB, KCNIP3, ZBTB1, CYR61, SOLH, WAC, SP4, RXRA, FOXL1, HEXIM2, ING5, GATA4, GMEB1, PKNOX1, PTMA, LZTR1, L3MBTL3, ADNP2, RNF4, YBX1, NFE2L1, ONECUT3	Rho GTPase binding [MF], atrioventricular valve morphogenesis [BP], sequence-specific DNA binding transcription factor activity [MF], transcription, DNA-dependent [BP], atrial septum morphogenesis [BP], transcription from RNA polymerase II promoter [BP], regulation of transcription from RNA polymerase II promoter [BP]
CG_h9laurent_promoter_p_RM_14_205_8			2	0.25	2.60E-04	ATF4, PSEN1, EPHB2, GABRA5	negative regulation of axonogenesis [BP], gamma-aminobutyric acid signaling pathway [BP]
CG_h9laurent_promoter_p_RM_14_36_10			2	0.25	4.26E-04	MAVS, TUFT1, TPM1, OSR2	positive regulation of transcription factor import into nucleus [BP], positive regulation of IP-10 production [BP], positive regulation of heart rate by epinephrine [BP], odontogenesis [BP]
CG_h9laurent_promoter_p_RM_12_576_22			4	0.75	3.17E-04	PRKAR2B	response to antipsychotic drug [BP]
CG_h9laurent_promoter_p_RM_14_48_7			1	0.25	3.53E-04	RLF, ACVR1B, SQSTM1, RPS6KA1	positive regulation of trophoblast cell migration [BP], DNA mediated transformation [BP], positive regulation of transcription from RNA polymerase II promoter [BP], positive regulation of hepatic stellate cell activation [BP], positive regulation of transcription, DNA-dependent [BP]
CG_h9laurent_promoter_p_RM_14_201_12			5	0.75	1.69E-04	POR, EVC	endochondral bone growth [BP], positive regulation of smoothened signaling pathway [BP]
CG_h9laurent_promoter_p_RM_16_26_28			8	0.5	4.47E-04	RAB21, BHLHE22, ZFPM1, FCHO2, RBBP6, HIPK1, MAFK, ZXDB, CREBL2, SLC30A5, USP20, CERS6, SGPL1, MLST8, NTNG2, ZNF703, NDST1, RBPJ, MAP3K1, MPP6, NTRK2, SIX3, MCU, ZSWIM6, CBFB, CUL9, FOXF2, RNF111, CDK5R1, FMN2, CUL1, MTMR1, DHX9, BAI1, RAB5A, TDRD3, UBAP2L, SP2, ZNF362, PDS5B, USP39, USP30, SEC23IP, PAFAH1B1, PDE8A, URI1, BRSK2, ADCY2, POLE4, PTPN12, ARID1A, DDX42, AKAP9, RUNX2, PLEKHA5, PKP4, HUNK, UBC, ATMIN, MVK, YBX1, XPO7, PCMTD2, ARPC5L, TNRC6A, FOXP4, SLC7A6, NRSN1, SNX9, UBE2D2, KAT2B, ZNF696, HABP4, SLAIN2, UHRF1BP1, ZNF853, ARHGAP5, SEPT7, SKI, ADRBK2, LMTK2, HCCS, CDC16, TTC3, PPM1A, SOX11, SOX12, SSNA1, USP42, EN2, ZIC2, CAMTA1, TRAF3IP1, PLCB1, SIRT1, DPYSL5, IL4R, TSPYL2, UNC5B, ARPC2, GLT1D1, MAL2, UBE2E3, IGFBP2, NR2F2, HOXC12, GLTSCR2, POLR2C, PAX2, PKNOX2, PRDM16, FAM50A, CUX1, PTF1A, UBE2B, PSMD11, HOXD10, INSM1, AR, IPO9, HES1, CPSF4, WWC1, AGFG1, YY1, EPHA8, ONECUT3, SEC14L2, PAPD5, AFTPH, SDCBP, DYRK2, ZNF839, SAMD4B, BCR, SPSB4, FZD1, ZBTB10, HIC1, FZD7, ARF1, FAT4, EPB41, RAB22A, SGCA, REPS2, NDFIP1, RNF115, MAPK6, ARNT2, MAPK4, DUSP5, LFNG, BCL7A, LURAP1, MVP, TGFBR1, RAP2A, POMP, TAL2, PSMD1, EFNA3, CARM1, MPZL1, PLEKHM2, SALL3, EEFSEC, FAIM, ANKS1A, UCHL3, SPNS1, TRIOBP, LLGL1, PLXNA3, MTMR3, TACC3, NECAB2, RPF2, SLK, TBC1D13, KIAA0513, HIVEP1, TNFAIP2, DTX4, PHF17, CAMK1D, PTK7, SPG7, BIRC7, ERC1, GTPBP1, BAHD1, CPEB2, FOXO3, SOX8, PRELID1, ATP11B, FMR1, CPSF6, NR1D2, SOX1, SMARCA4, QKI, ADCYAP1R1, CAND1, CATSPER4, KLHDC2, NLGN1, GDF7, CPNE6, BRPF3, UBE2Z, SLIT2, CABLES1, NANS, CNOT6, MTA3, POU3F3, POU3F2, GREM1, PIM3, ARIH1, HSPB1, NR4A3, NR4A1, ENDOG, CNIH3, REST, CASC3, COL6A1, POGK, FPGS, SKIL, AGO4, ADRA2C, PBX3, TBKBP1, PPM1B, SQSTM1, COL6A2, CHD7, ZBED4, TAB2, TLX1, ZNF292, RND2, PSKH1, WIPF3, WIPF2, MID2, CRIM1, ILF3, GLCCI1, HTATSF1	midbrain development [BP], metanephric epithelium development [BP], ubiquitin-dependent protein catabolic process [BP], nucleus [CC], camera-type eye morphogenesis [BP], protein heterotrimerization [BP], cell surface receptor signaling pathway [BP], regulation of signal transduction [BP], ephrin receptor binding [MF], protein complex [CC], transcription initiation from RNA polymerase II promoter [BP], signal transduction [BP], multicellular organismal development [BP], nucleic acid binding transcription factor activity [MF], cell fate commitment [BP], lens development in camera-type eye [BP], nervous system development [BP], nucleobase-containing compound metabolic process [BP], central nervous system neuron development [BP], RNA polymerase II transcription coactivator activity [MF], substrate-dependent cell migration [BP], metanephric nephron tubule morphogenesis [BP], regulation of transcription, DNA-dependent [BP], eye development [BP], sequence-specific DNA binding transcription factor activity [MF], neuron projection morphogenesis [BP], sequence-specific DNA binding RNA polymerase II transcription factor activity [MF], neuron differentiation [BP], nucleic acid binding [MF], regulation of neuron differentiation [BP], cellular response to growth factor stimulus [BP], neuron development [BP], RNA metabolic process [BP], transmembrane receptor protein tyrosine kinase signaling pathway [BP], cell differentiation [BP], neuron projection development [BP], neurogenesis [BP], protein binding [MF], axonogenesis [BP], positive regulation of transcription, DNA-dependent [BP], organ morphogenesis [BP], intracellular [CC], positive regulation of transcription from RNA polymerase II promoter [BP], brain development [BP], central nervous system development [BP], cell morphogenesis involved in neuron differentiation [BP], cell morphogenesis [BP], lens morphogenesis in camera-type eye [BP], cerebral cortex development [BP], negative regulation of gene expression [BP], protein complex assembly [BP], regulation of transcription from RNA polymerase II promoter [BP], negative regulation of transforming growth factor beta receptor signaling pathway [BP], cell migration [BP], regulation of transforming growth factor beta receptor signaling pathway [BP], cell motility [BP], RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription [MF], protein catabolic process [BP], palate development [BP], camera-type eye development [BP], telencephalon development [BP], cytoplasm [CC], response to growth factor stimulus [BP], ephrin receptor signaling pathway [BP], forebrain development [BP], transcription, DNA-dependent [BP], sequence-specific DNA binding [MF], negative regulation of transcription, DNA-dependent [BP], negative regulation of cellular response to growth factor stimulus [BP], DNA binding [MF], nucleoplasm [CC], cerebral cortex radially oriented cell migration [BP], negative regulation of glial cell proliferation [BP], embryo development [BP], gene expression [BP], transcription from RNA polymerase II promoter [BP], intracellular signal transduction [BP], positive regulation of gene expression [BP], transforming growth factor beta receptor signaling pathway [BP]
CG_h9laurent_promoter_p_RM_12_382_24			3	0.75	3.11E-04	SQSTM1, ARHGEF12, SPTBN4, FARP2, GLDN, FARP1, MAEL, PKDCC, FGF18, ASAP2, LGALS3, PHLDB2, ADCYAP1R1, UHRF2, FGD5	phospholipid binding [MF], cell differentiation [BP], nervous system development [BP]
CG_h9laurent_promoter_p_RM_14_157_20			3	0.5	3.73E-04	WASF3, CDK5R1, NLGN1, NCMAP	neuron cell-cell adhesion [BP], positive regulation of myelination [BP]
CG_h9laurent_promoter_p_RM_14_65_8			2	0.25	4.00E-04	DMRT3, HMGN2, TBX21, ZNF236, BAHD1, PKP4, CEBPB, OPTN, MAP3K4, KLF2, ZIC1, TRIM28, TSPYL2, HOXD4, CREB1, SMYD1, PACS1, E2F5, ARID1A, NOG, ID2, ID1, HTT, BPTF	organ development [BP], negative regulation of osteoblast differentiation [BP], placenta development [BP], regulation of transcription, DNA-dependent [BP], protein targeting to Golgi [BP], transcription, DNA-dependent [BP], negative regulation of transcription, DNA-dependent [BP], regulation of gene expression [BP], chromatin [CC], chromatin remodeling [BP], neural plate morphogenesis [BP], negative regulation of gene expression [BP], positive regulation of gene expression [BP], nuclear euchromatin [CC]
CG_h9laurent_promoter_p_RM_12_249_12			3	0.75	2.75E-04	LTBP4, OXSR1, BMPR1B, TLK2, CDK12, PRDX5, CACNA1C, RBPMS, WNK4, PDK2, PKDCC, SETD1B, MAPK6, MAP2K5, PDIK1L, ADCK5, FAM20B, ADRBK2, NAB2, RBM6	negative regulation of transcription from RNA polymerase III promoter [BP], protein serine/threonine kinase activity [MF], protein kinase activity [MF], phosphotransferase activity, alcohol group as acceptor [MF], growth hormone secretion [BP], nucleotide binding [MF], kinase activity [MF]
CG_h9laurent_promoter_p_RM_12_210_6			5	0.75	3.67E-04	MCM4, SPEN	single-stranded DNA binding [MF]
CG_h9laurent_promoter_p_RM_12_588_9			2	0.25	3.52E-04	ZNF804A, ZNF839	intracellular [CC]
CG_h9laurent_promoter_p_RM_14_222_2			2	0.5	1.50E-04	PAX2	positive regulation of optic nerve formation [BP], pancreas development [BP], optic chiasma development [BP], vestibulocochlear nerve formation [BP]
CG_h9laurent_promoter_p_RM_12_110_18			5	0.75	3.39E-04	TFAP2C, FCHO2, FOXD3, GAB1, CTR9, ARF6, RAB10, LMTK2	protein localization to plasma membrane [BP], recycling endosome [CC], interleukin-6-mediated signaling pathway [BP], trophectodermal cell differentiation [BP], vesicle-mediated transport [BP]
CG_h9laurent_promoter_p_RM_12_366_10			2	0.25	3.89E-04	SUV39H1, EHMT1, PKN1	histone methyltransferase activity (H3-K9 specific) [MF], hyperosmotic response [BP]
CG_h9laurent_promoter_p_RM_12_35_25			3	0.5	3.24E-04	KIAA1804, ACVR1B, CSNK1G2, MELK, CHAF1A, SMARCA4, SMARCB1	WINAC complex [CC], Tat protein binding [MF], positive regulation by host of viral transcription [BP], npBAF complex [CC], nBAF complex [CC], protein autophosphorylation [BP]
CG_h9laurent_promoter_p_RM_14_183_27			4	0.5	4.64E-04	PLK5, DOCK5, SEC23IP, SAMD4B, SKI, DGKZ, HIC1, MLLT4, RPS6KB1, MAPK6, HNRNPAB, SLC6A11, MAP1LC3B, SEPT11, EPB41L5, DIAPH2, PIM1, YKT6, PLEKHM2, URI1, MIF, PAFAH1B1, FSCN2, MOB4, COPS7A, DAZAP1, TRIOBP, GNAS, WHSC1, NANOS3, DNAJC3, WIPF3, RNF5, FOXC1, RNF146, ITCH	intracellular [CC], protein K48-linked ubiquitination [BP], cytoplasm [CC], intracellular membrane-bounded organelle [CC]
CG_h9laurent_promoter_p_RM_12_525_7			4	0.5	3.20E-04	ADORA2B, GATA4, FGFR3, HES1	positive regulation vascular endothelial growth factor production [BP], epithelial cell fate commitment [BP], positive regulation of BMP signaling pathway [BP], ureteric bud morphogenesis [BP], morphogenesis of an epithelium [BP], positive regulation of tyrosine phosphorylation of Stat3 protein [BP]
CG_h9laurent_promoter_p_RM_12_422_31			3	0.5	3.39E-04	FOXP4, FOXF1	embryonic foregut morphogenesis [BP]
CG_h9laurent_promoter_p_RM_12_507_16			5	0.75	2.43E-04	RBBP8, BMP2, FOXP4, SMAD4, SOX11, FOXD2, MTA1, FOXK2, KLF11	RNA polymerase II repressing transcription factor binding [MF], SMAD protein signal transduction [BP], neural crest cell differentiation [BP], BMP signaling pathway [BP], sequence-specific DNA binding RNA polymerase II transcription factor activity [MF], positive regulation of BMP signaling pathway [BP], mesenchyme development [BP], branching involved in ureteric bud morphogenesis [BP], mesenchymal cell differentiation [BP], DNA binding, bending [MF]
CG_h9laurent_promoter_p_RM_14_346_4			2	0.25	2.57E-04	AK4	tetracycline metabolic process [BP], carbon tetrachloride metabolic process [BP]
CG_h9laurent_promoter_p_RM_14_220_6			1	0.25	3.31E-04	ARHGAP33, BCR, NR4A3	Rac GTPase activator activity [MF], neuromuscular process controlling balance [BP]
CG_h9laurent_promoter_p_RM_14_266_12			2	0.25	3.67E-04	NIT2, SMAD4, TTC19, PRKAR2B, KIF2A, CCDC64	centrosome [CC]
CG_h9laurent_promoter_p_RM_18_1_2			2	0.25	3.26E-04	GNAZ, OPRL1	adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway [BP]
CG_h9laurent_promoter_p_RM_12_109_8			4	0.5	2.87E-04	EPO, ANLN, PDE8A, PDE4A, MAEA	negative regulation of myeloid cell apoptotic process [BP], actomyosin contractile ring [CC], 3',5'-cyclic-AMP phosphodiesterase activity [MF]
CG_h9laurent_promoter_p_RM_16_62_3			3	0.25	2.65E-04	CORO1A	negative regulation of actin nucleation [BP]
CG_h9laurent_promoter_p_RM_14_251_5			2	0.25	2.24E-04	VIL1, LRRK1, TARBP2	cytoplasmic actin-based contraction involved in cell motility [BP], small GTPase mediated signal transduction [BP], lysophosphatidic acid binding [MF], miRNA loading onto RISC involved in gene silencing by miRNA [BP]
CG_h9laurent_promoter_p_RM_12_590_20			2	0.25	2.82E-04	FAM20C, EEF2K	elongation factor-2 kinase activity [MF], odontoblast differentiation [BP], dentinogenesis [BP], osteoclast maturation [BP]
CG_h9laurent_promoter_p_RM_14_187_10			5	0.5	3.80E-04	NTN1, CHD7, EPHB2	inner ear morphogenesis [BP]
CG_h9laurent_promoter_p_RM_12_116_16			2	0.25	3.55E-04	WDR5, PHF17, IRF4, YEATS2, SPTBN4, AGRN	histone H3 acetylation [BP], clustering of voltage-gated sodium channels [BP]
CG_h9laurent_promoter_p_RM_14_344_8			3	0.5	3.73E-04	AHCYL1, GPD1L	positive regulation of sodium ion transport [BP]
CG_h9laurent_promoter_p_RM_12_285_20			5	0.75	2.97E-04	MEST, COL27A1	fibrillar collagen [CC], regulation of lipid storage [BP]
CG_h9laurent_promoter_p_RM_14_139_7			3	0.5	1.85E-04	NOD2, TAB1	nucleotide-binding oligomerization domain containing signaling pathway [BP]
CG_h9laurent_promoter_p_RM_12_311_3			2	0.25	3.39E-04	NNT, OXT	NAD(P)+ transhydrogenase (AB-specific) activity [MF], NAD(P)+ transhydrogenase (B-specific) activity [MF], oxytocin receptor binding [MF]
CG_h9laurent_promoter_p_RM_12_220_14			3	0.5	3.40E-04	ADAMTSL4, EMILIN1, ISL1, COL5A1, FOXF1, FBLN1, HPN, SPINT1	pancreas development [BP], extracellular matrix organization [BP], serine-type exopeptidase activity [MF], endocardial cushion development [BP]
CG_h9laurent_promoter_p_RM_14_63_5			2	0.25	3.35E-04	ACR, IRAK3	acrosome matrix dispersal [BP], positive regulation of macrophage tolerance induction [BP], amidase activity [MF], negative regulation of cytokine-mediated signaling pathway [BP]
CG_h9laurent_promoter_p_RM_12_156_16			5	0.5	3.57E-04	SMCHD1, MYO1B, MAPK15, UBE2L3, FUK, BCR, BCL2L11, ZBTB16, PRPS1, MAP3K3, TPM1, PKN1, MAGI3, CAPN2, CDK5R1, POU3F3, TRIO, EPHB6, CSK, WNK2, SNTG2, NDEL1, CXADR, BMP1, SYNGR3, AK4, NAB2, MMP17	brain development [BP], protein kinase activity [MF], central nervous system development [BP], cytoskeletal protein binding [MF], positive regulation of catalytic activity [BP], neuromuscular junction [CC], cerebral cortex radially oriented cell migration [BP], kinase activity [MF], nervous system development [BP], ATP binding [MF], positive regulation of cartilage development [BP], protein autophosphorylation [BP]
CG_h9laurent_promoter_p_RM_14_136_7			3	0.5	1.50E-04	NTRK1, B4GALT7, EMD	developmental programmed cell death [BP], negative regulation of fibroblast proliferation [BP]
CG_h9laurent_promoter_p_RM_12_480_8			3	0.5	3.31E-04	ACVR1B, PPARA, MDK, HMGA1, EPO, ING2, PAX2, ING1, SOX4, BMPER, ACVR2A	negative regulation of chromatin silencing [BP], positive regulation of transcription, DNA-dependent [BP], activin-activated receptor activity [MF], regulation of pathway-restricted SMAD protein phosphorylation [BP], inhibin binding [MF], positive regulation of activin receptor signaling pathway [BP]
CG_h9laurent_promoter_p_RM_14_243_11			3	0.25	4.81E-04	WNT1, SKIL, STUB1	negative regulation of transforming growth factor beta receptor signaling pathway [BP], ubiquitin-dependent SMAD protein catabolic process [BP]
CG_h9laurent_promoter_p_RM_12_244_26			5	0.5	4.14E-04	YY1, BUB3, SUV39H2, CDT1, WRNIP1, SKI, EGR1	regulation of DNA-dependent DNA replication initiation [BP], regulation of chromosome segregation [BP], chromatin assembly or disassembly [BP], BMP signaling pathway [BP], chromosome organization [BP]
CG_h9laurent_promoter_p_RM_12_289_13			2	0.25	2.83E-04	BASP1, UHRF2, IRX5	positive regulation of cell cycle arrest [BP], gonad development [BP]
CG_h9laurent_promoter_p_RM_14_42_6			1	0.25	3.18E-04	STX3, SLC17A9, FES, PDPK1	exocytosis [BP], regulation of mast cell degranulation [BP]
CG_h9laurent_promoter_p_RM_12_2_15			3	0.75	2.15E-04	PALM, SYNGAP1	positive regulation of dendritic spine development [BP], dendrite development [BP]
CG_h9laurent_promoter_p_RM_14_46_7			2	0.25	3.65E-04	HTT, BMPR2, LRP5, NELL1	cell differentiation [BP], anterior/posterior pattern specification [BP], retina vasculature development in camera-type eye [BP]
CG_h9laurent_promoter_p_RM_12_450_10			2	0.25	3.05E-04	YY1, EPHB2, DACT1, NSD1	camera-type eye morphogenesis [BP], gastrulation with mouth forming second [BP]
CG_h9laurent_promoter_p_RM_12_484_9			2	0.25	3.64E-04	ETV2, RPS6KA4, CHD7, ONECUT3, SPEN, UNCX, PSMD3, ZKSCAN1, SETD8, NEO1, ZNF584, ZBTB33, MYBL2, ZEB1, TFDP1, NFATC1	histone phosphorylation [BP], mitogen-activated protein kinase p38 binding [MF], regulation of transcription, DNA-dependent [BP], sequence-specific DNA binding transcription factor activity [MF], transcription, DNA-dependent [BP], gene expression [BP], RNA metabolic process [BP], regulation of transcription from RNA polymerase II promoter [BP]
CG_h9laurent_promoter_p_RM_14_135_9			8	0.5	2.86E-04	COQ7, SKI, FSTL3, APPL1	negative regulation of BMP signaling pathway [BP], negative regulation of activin receptor signaling pathway [BP], regulation of establishment of protein localization to plasma membrane [BP], neural tube formation [BP]
CG_h9laurent_promoter_p_RM_12_99_14			3	0.5	3.07E-04	SPAG6, PTPN11, UBE2E1, PDE3B, GAS8, HTRA2, ING2, UBE2C, SLC25A4, PSMB3, CUL1, PDE8B, SEC11C	sperm motility [BP], regulation of insulin secretion [BP], negative regulation of insulin secretion [BP], positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle [BP], cellular response to growth factor stimulus [BP], regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle [BP]
CG_h9laurent_promoter_p_RM_12_371_6			2	0.25	2.58E-04	BCL2L11	BIM-BCL-2 complex [CC], BIM-BCL-xl complex [CC]
CG_h9laurent_promoter_p_RM_12_518_13			4	0.75	3.76E-04	TADA2A, SMAD6, MYO6, SS18L1, TLE4, MAN1B1, PTEN, VIL1, MAN1C1, MYBL2, SKI, SMC3, SCIN, TWSG1	negative regulation of BMP signaling pathway [BP], mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [MF], actin nucleation [BP], dendrite development [BP], actin filament severing [BP], regulation of dendrite development [BP], chromatin binding [MF], regulation of neuron projection development [BP]
CG_h9laurent_promoter_p_RM_14_364_9			5	0.5	3.17E-04	DAO, ABCD3	peroxisomal matrix [CC]
CG_h9laurent_promoter_p_RM_14_40_8			2	0.25	4.15E-04	CYLD, FOXF1, MAPKAPK5, PTPRJ, USP25	protein K63-linked deubiquitination [BP], mitogen-activated protein kinase binding [MF], positive regulation of cell-substrate adhesion [BP]
CG_h9laurent_promoter_p_RM_12_320_11			4	0.5	3.23E-04	ITGB4, MET	basal plasma membrane [CC]
CG_h9laurent_promoter_p_RM_14_287_12			3	0.5	3.31E-04	KRT18, CACNA1H	scaffold protein binding [MF]
CG_h9laurent_promoter_p_RM_12_416_11			5	0.75	2.80E-04	NQO2, AGRN, ZMYND15, POLR3B, DNM2, DUSP22, TSC2, CBX2, LHX2, SAMD11, RAN, FAS, UNCX, EN2, ADRA2C, ZNF341, CDK5R1, FOXF1, ZNF551, HNRNPAB, UTP18, MORF4L1, FOXQ1, BSPRY, ZBED4, TRMT61A, BAHCC1, ARL6IP4, VCL, BMI1, TRRAP, FOXD3, C15orf48, NAA38, UCHL1, PKNOX1, SNRPD3, ZNF441, KCNH3, MXI1, ZNF844, BARHL1, SLC2A4RG, SRRT, ZNF567, ANP32B, RNF4, NFIX, ZNF136, WBSCR22	DNA binding [MF], alpha-2A adrenergic receptor binding [MF], RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity [MF], dystroglycan binding [MF], regulation of transcription, DNA-dependent [BP], transcription, DNA-dependent [BP], regulation of gene expression [BP], gene expression [BP], RNA metabolic process [BP], nucleus [CC]
CG_h9laurent_promoter_p_RM_12_55_11			2	0.5	3.28E-04	ADD1, FZD7, FZD10	cellular response to retinoic acid [BP], non-canonical Wnt receptor signaling pathway via JNK cascade [BP]
CG_h9laurent_promoter_p_RM_12_556_30			3	0.5	2.70E-04	NOG, ZRANB1, FGFR3, CHD7, RNF169	negative regulation of astrocyte differentiation [BP], face development [BP], K63-linked polyubiquitin binding [MF]
CG_h9laurent_promoter_p_RM_18_21_2			1	0.25	4.62E-04	SLC22A3	dopamine transmembrane transporter activity [MF], histamine uptake [BP]
CG_h9laurent_promoter_p_RM_12_145_14			3	0.5	3.67E-04	SQSTM1, PHF17, ZNF628, NFX1, NR4A3, RNF187, MAN2A2, CD4, ZNF696, LMCD1, TIPARP, ZNF587B, GLI4, ZNF586, KDM2A, KAT6B, INSM1, HAGHL, ZACN	zinc ion binding [MF]
CG_h9laurent_promoter_p_RM_14_238_19			3	0.25	4.11E-04	KCNQ4, HCN2, KCNS3, CNTNAP1	voltage-gated potassium channel complex [CC]
CG_h9laurent_promoter_p_RM_12_582_23			1	0.25	2.80E-04	PTDSS2	CDP-diacylglycerol-serine O-phosphatidyltransferase activity [MF]
CG_h9laurent_promoter_p_RM_14_44_5			2	0.25	3.21E-04	PRDM16, YY1, MTM1, RCOR1, PGM5, RAB12, WNT3A	endosome to lysosome transport [BP], phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [MF], palate development [BP], transcriptional repressor complex [CC], RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription [MF], positive regulation of canonical Wnt receptor signaling pathway involved in controlling type B pancreatic cell proliferation [BP], anterior/posterior pattern specification [BP], response to prostaglandin F stimulus [BP], spot adherens junction [CC], positive regulation of mesodermal cell fate specification [BP]
CG_h9laurent_promoter_p_RM_12_194_9			3	0.5	2.04E-04	INHBB, IL4R, DRAXIN, PDPK1	3-phosphoinositide-dependent protein kinase activity [MF], negative regulation of hepatocyte growth factor biosynthetic process [BP], commissural neuron differentiation in spinal cord [BP], host cell surface receptor binding [MF], ovulation [BP]
CG_h9laurent_promoter_p_RM_14_349_10			2	0.25	3.70E-04	HES3, RPA1, MAN2A1, RDH10	in utero embryonic development [BP]
CG_h9laurent_promoter_p_RM_14_378_12			3	0.5	3.88E-04	FBXO45, FBXO18, WBSCR22, SPG7, ONECUT3, BAHD1, EVI5L, UPF1, RABL6, KLF13, CEP164, ZNF143, PPP1R1B, DMBX1, CATSPER4, SOX11, ZBTB18, RPS6KB1, EN2, TMEM57, FOXF2, FOSL2, LBH, WEE1, MORF4L1, POU3F3, TCF7, CDC25B, ZNF22, SUV420H2, YAP1, PTMA, ABI2, ARID1B, PLXNA1, KSR1, ATF4, ZMIZ1, NFIX, ZNF771, PABPN1	intracellular [CC], DNA binding [MF], nucleus [CC], regulation of transcription, DNA-dependent [BP], embryonic digestive tract development [BP], transcription, DNA-dependent [BP], sequence-specific DNA binding [MF], multicellular organismal development [BP], regulation of transcription from RNA polymerase II promoter [BP], transcription from RNA polymerase II promoter [BP], cell differentiation [BP], nervous system development [BP]
CG_h9laurent_promoter_p_RM_12_496_13			4	0.75	3.29E-04	TRIB2, ID4	negative regulation of fat cell differentiation [BP]
CG_h9laurent_promoter_p_RM_12_564_25			1	0.25	6.41E-05	WEE2, RPS6KA1, KSR1, RPS21, WNT3A	female pronucleus assembly [BP], endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [BP], positive regulation of cell growth [BP], protein serine/threonine kinase activity [MF], positive regulation of canonical Wnt receptor signaling pathway involved in controlling type B pancreatic cell proliferation [BP], negative regulation of oocyte development [BP], positive regulation of mesodermal cell fate specification [BP], meiotic metaphase II [BP]
CG_h9laurent_promoter_p_RM_14_300_17			4	0.5	2.87E-04	PTH1R, OPRD1, PBX3, RIPK1	receptor complex [CC], adult locomotory behavior [BP]
CG_h9laurent_promoter_p_RM_12_154_14			2	0.5	3.13E-04	CISD1, PRDM16	regulation of cellular respiration [BP]
CG_h9laurent_promoter_p_RM_16_66_4			2	0.25	2.39E-04	PTPRM, CDK5R1, ACSL3	cadherin binding [MF], perinuclear region of cytoplasm [CC]
CG_h9laurent_promoter_p_RM_12_448_15			2	0.5	3.59E-04	TGFBR1, CARM1, SUZ12, AEBP2, TGFBR2	transforming growth factor beta receptor homodimeric complex [CC], transforming growth factor beta binding [MF], histone methyltransferase activity [MF], ESC/E(Z) complex [CC], growth factor binding [MF]
CG_h9laurent_promoter_p_RM_14_1_3			2	0.25	2.96E-04	SMOX, DRD4, CHRNB2, P2RY11, SLC1A4, BAI1	norspermine:oxygen oxidoreductase activity [MF], L-hydroxyproline transmembrane transporter activity [MF], response to cocaine [BP], N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity [MF], regulation of synaptic transmission, dopaminergic [BP], neurotransmitter receptor activity [MF], threonine transport [BP], olfactory learning [BP], social behavior [BP], associative learning [BP], cognition [BP], regulation of dopamine metabolic process [BP], L-threonine transmembrane transporter activity [MF], hydroxyproline transport [BP], lateral geniculate nucleus development [BP], dopamine metabolic process [BP], integral to plasma membrane [CC], synaptic transmission, dopaminergic [BP]
CG_h9laurent_promoter_p_RM_12_50_12			2	0.5	3.62E-04	FMNL2, GADD45B, PRCC, RDH10, PAK4, PDPK1, WEE1, NEK11, BCR, NEK7	cytoskeleton organization [BP], cell cycle [BP], regulation of cell cycle [BP], protein serine/threonine kinase activity [MF], protein kinase activity [MF], nucleotide binding [MF], kinase activity [MF]
CG_h9laurent_promoter_p_RM_16_53_6			2	0.5	1.89E-04	RAB31, PDPK1	3-phosphoinositide-dependent protein kinase activity [MF], regulated secretory pathway [BP]
CG_h9laurent_promoter_p_RM_12_355_20			3	0.5	1.89E-04	NR4A3	adult behavior [BP]
CG_h9laurent_promoter_p_RM_14_347_12			1	0.25	3.99E-04	BCL2L11, CORO1A	T cell homeostasis [BP]
CG_h9laurent_promoter_p_RM_12_264_15			3	0.5	3.51E-04	TGFB2, JMY, DMBX1, SMAD6, DAO, SP4, MKL2, HOXD3, NAV2, CBFB, FOSL2, SOX2, GTF2I, GLI1, MAFF, SRCAP	transcription regulatory region DNA binding [MF], dopamine biosynthetic process [BP], sequence-specific DNA binding transcription factor activity [MF], glossopharyngeal nerve development [BP], transcription from RNA polymerase II promoter [BP], regulation of transcription from RNA polymerase II promoter [BP]
CG_h9laurent_promoter_p_RM_14_154_10			4	0.75	5.10E-04	CACNG4, SYNDIG1, NLGN1, CACNG8	synaptic vesicle clustering [BP], regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity [BP]
CG_h9laurent_promoter_p_RM_14_132_12			2	0.5	3.72E-04	RAB31, ARF6	establishment of epithelial cell polarity [BP], Golgi to plasma membrane protein transport [BP]
CG_h9laurent_promoter_p_RM_12_368_15			2	0.5	3.46E-04	HMGN2, PKN1, ID2, NEFH, KIT, EPO, AP2A2, PDPK1, RNF4, SMARCA4, LDLRAP1, INHA	hemoglobin biosynthetic process [BP], negative regulation of B cell differentiation [BP], neurofilament [CC], chromatin [CC], androgen receptor binding [MF], AP-2 adaptor complex [CC], erythrocyte differentiation [BP], hyperosmotic response [BP]
CG_h9laurent_promoter_p_RM_14_89_6			2	0.25	2.64E-04	KCNJ12, CTNNB1	ion channel inhibitor activity [MF], lens morphogenesis in camera-type eye [BP]
CG_h9laurent_promoter_p_RM_12_559_12			3	0.25	2.58E-04	NPR1, ADORA2B, CHD7, BACE2, ITM2B, PLEKHA1, FOXF2, EPHB2	negative regulation of amyloid precursor protein biosynthetic process [BP], positive regulation of cGMP biosynthetic process [BP], palate development [BP]
CG_h9laurent_promoter_p_RM_12_223_20			3	0.5	2.96E-04	DMBX1, ARID1B, TCF7L1, COQ7, GDF11, PRDM16	central nervous system development [BP], neurogenesis [BP], nervous system development [BP]
CG_h9laurent_promoter_p_RM_14_279_11			3	0.25	3.26E-04	FGFR3, BTRC	negative regulation of smoothened signaling pathway [BP]
CG_h9laurent_promoter_p_RM_12_305_10			2	0.5	3.60E-04	ACVR2A, PPM1L, BTG2, NOG, ID2, PKP4, EPO, USP9X, HTT, MAN1B1, WNT16, USP25, BPTF	cellular protein metabolic process [BP], cell aging [BP], BMP signaling pathway [BP], cellular protein modification process [BP], aging [BP], transmembrane receptor protein serine/threonine kinase signaling pathway [BP], anterior/posterior pattern specification [BP], neural plate morphogenesis [BP], receptor signaling protein serine/threonine kinase activity [MF], positive regulation of gene expression [BP]
CG_h9laurent_promoter_p_RM_16_64_6			3	0.25	2.91E-04	SQSTM1, ARID3A, TCF7L1, YAP1, SMAD4	somatic stem cell maintenance [BP], mesoderm development [BP], positive regulation of transcription from RNA polymerase II promoter [BP], chromatin binding [MF]
CG_h9laurent_promoter_p_RM_14_111_6			3	0.5	3.50E-04	CDT1, BACH1	regulation of transcription involved in G1/S phase of mitotic cell cycle [BP]
CG_h9laurent_promoter_p_RM_14_309_4			2	0.25	1.91E-04	PDPK1	3-phosphoinositide-dependent protein kinase activity [MF]
CG_h9laurent_promoter_p_RM_14_319_5			4	0.5	2.88E-04	MACF1, TUBGCP5, HOOK3	microtubule binding [MF]
CG_h9laurent_promoter_p_RM_12_307_10			3	0.5	4.25E-04	ZAR1, FOXG1, RPS27A, HOXC5, MAP2K5, CEBPB, KLF11, HIC1, CATSPER4, PIK3CA, PARK7, UNCX, PTP4A1, LBH, CCBP2, PRDX5, SLC44A1, SLC6A8, SP4, FOXL1, PKNOX1, MAPK8IP3, ADCY1, PLXNA3, KL, PTPRG, MAG, PDPK1, NFIX, FOXC1, ACVR2A	nerve growth factor receptor signaling pathway [BP], fibroblast growth factor receptor signaling pathway [BP], transmembrane receptor protein tyrosine kinase signaling pathway [BP], activin-activated receptor activity [MF], sequence-specific DNA binding RNA polymerase II transcription factor activity [MF], regulation of gene expression [BP], choline transmembrane transporter activity [MF], multicellular organismal development [BP], peroxiredoxin activity [MF], RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity [MF], pattern specification process [BP], regulation of transcription from RNA polymerase II promoter [BP]
CG_h9laurent_promoter_p_RM_12_370_22			2	0.25	3.50E-04	SPAST, RAPGEFL1	nervous system development [BP]
CG_h9laurent_promoter_p_RM_12_62_18			2	0.25	4.26E-04	GPX4	phospholipid-hydroperoxide glutathione peroxidase activity [MF]
CG_h9laurent_promoter_p_RM_12_87_16			2	0.5	2.70E-04	VASH1, PTPRJ, BMPER	regulation of endothelial cell migration [BP], negative regulation of blood vessel endothelial cell migration [BP], negative regulation of cell migration [BP], negative regulation of endothelial cell migration [BP]
CG_h9laurent_promoter_p_RM_14_281_16			4	0.5	4.16E-04	BRSK2, BMP1, RAC1, CATSPER4, ZBTB18, BMPR1A, EN2, COL13A1, YAP1, AGFG1, TCF7	neurogenesis [BP], generation of neurons [BP], lateral mesoderm development [BP], neuron differentiation [BP], anatomical structure arrangement [BP], cell differentiation [BP], neuron development [BP]
CG_h9laurent_promoter_p_RM_14_206_4			2	0.25	2.68E-04	EBF4, USPL1, CD4	multicellular organismal development [BP], protein palmitoleylation [BP], Cajal body organization [BP], induction by virus of host cell-cell fusion [BP]
CG_h9laurent_promoter_p_RM_16_48_3			3	0.5	1.08E-04	DSE, SLC35A1, TUBB6	CMP-N-acetylneuraminate transport [BP], 'de novo' posttranslational protein folding [BP], chondroitin-glucuronate 5-epimerase activity [MF], CMP-N-acetylneuraminate transmembrane transporter activity [MF]
CG_h9laurent_promoter_p_RM_18_2_3			2	0.25	4.39E-04	COPS7B, GPS1	cullin deneddylation [BP], signalosome [CC]
CG_h9laurent_promoter_p_RM_20_1_34			2	0.25	4.12E-04	PHF17, HSPB1, ACVR1B, ONECUT3, NRSN1, PAPD5, SOX1, CARM1, ZNF711, CBFB, HIPK1, ZXDB, TNRC6A, FMR1, SIX3, SAMD4B, BCR, HCCS, CNIH3, ZBTB10, HIC1, CHD7, FZD7, NDST1, RBPJ, SPG7, GDF7, NPAS2, KCNK3, FGF18, ZIC2, SLIT2, SLC12A2, KDM2A, PSMD1, FOXF1, POU3F3, TGFBR1, RAB5A, TSPYL2, TAL2, NR4A3, ZNF362, WAC, MLLT10, NR2F2, CUX1, AR, AGO4, ADRA2C, FMN2, PDE8A, USP42, PRDM16, BRSK2, TLK2, ZNF618, UBE2B, ZNF710, TCF7L1, INSM1, ADRB1, NLGN1, ARID1B, ATMIN, PRELID1, NFIX, HIVEP1, SOX8, TNFAIP2, KDM1B	mammary duct terminal end bud growth [BP], brain development [BP], generation of neurons [BP], micro-ribonucleoprotein complex [CC], multicellular organismal development [BP], cell fate commitment [BP], nervous system development [BP], intracellular signal transduction [BP], regulation of transcription, DNA-dependent [BP], neuron differentiation [BP], in utero embryonic development [BP], growth [BP], DNA binding [MF], RNA metabolic process [BP], cell differentiation [BP], neurogenesis [BP], anatomical structure morphogenesis [BP], positive regulation of transcription, DNA-dependent [BP], organ morphogenesis [BP], central nervous system development [BP], histone lysine demethylation [BP], negative regulation of gene expression [BP], alpha-2A adrenergic receptor binding [MF], forebrain development [BP], transcription, DNA-dependent [BP], sequence-specific DNA binding [MF], epinephrine binding [MF], embryo development [BP], gene expression [BP], positive regulation of gene expression [BP]
CG_h9laurent_promoter_p_RM_12_361_8			2	0.25	3.72E-04	DNM1, GNAS, PLCG1	adenylate cyclase activity [MF], protein complex binding [MF], glutamate receptor binding [MF]
CG_h9laurent_promoter_p_RM_16_55_10			2	0.25	3.60E-04	SMC3, MLL, EPB41, FOXO3, BSN, SETD1B, PDPK1, DYNLL2	protein complex [CC], microtubule cytoskeleton [CC], motor activity [MF], histone methyltransferase activity (H3-K4 specific) [MF], nucleoplasm [CC], histone H3-K4 methylation [BP]
CG_h9laurent_promoter_p_RM_12_373_12			3	0.5	2.96E-04	CTNNB1, NR4A1, DEPTOR, ADCY1, PKN3, LIMK1, CAP1, CNTNAP1, ELK3, SOX8, FGF18, FGF9, PAX2, GPSM1, DGKZ	renal vesicle formation [BP], intracellular signal transduction [BP], fibroblast growth factor receptor signaling pathway [BP], nephron tubule formation [BP], cellular response to fibroblast growth factor stimulus [BP], signal transduction [BP], metanephric nephron tubule formation [BP], ureter morphogenesis [BP]
CG_h9laurent_promoter_p_RM_12_284_9			2	0.25	2.47E-04	ORAI1, STIM2, TNFRSF19, TNFRSF14	tumor necrosis factor-activated receptor activity [MF], store-operated calcium channel activity [MF]
CG_h9laurent_promoter_p_RM_12_10_11			2	0.25	2.45E-04	BCL2L13, SLC25A4, COX4I1, SLC25A14, RSAD2, PMPCA	mitochondrial membrane [CC], mitochondrial inner membrane [CC]
CG_h9laurent_promoter_p_RM_12_176_12			3	0.5	4.10E-04	RAB31, SGPL1, PPAPDC1A, PTEN, FES, PDPK1, PDGFRA	internal side of plasma membrane [CC], regulation of actin cytoskeleton reorganization [BP], estrogen metabolic process [BP], phospholipid dephosphorylation [BP], regulated secretory pathway [BP], luteinization [BP], regulation of mast cell degranulation [BP], Leydig cell differentiation [BP]
CG_h9laurent_promoter_p_RM_12_101_19			2	0.25	2.02E-04	B4GALNT3	acetylgalactosaminyltransferase activity [MF]
CG_h9laurent_promoter_p_RM_12_458_27			2	0.25	3.23E-04	EPHB2, TBL1X, GRHL1, RCC1, OXT, PTF1A, BMI1, PRDM8, SETD8, BANF2, ATF5, YBX1, SALL3, ZNF646, SPTBN4, ZNF101, HTRA2, POU3F3	transcription corepressor activity [MF], brain development [BP], forebrain development [BP], central nervous system development [BP], central nervous system projection neuron axonogenesis [BP], corpus callosum development [BP], positive regulation of synapse assembly [BP], DNA binding [MF], cell division [BP]
CG_h9laurent_promoter_p_RM_14_282_8			3	0.25	4.43E-04	B3GNT7	galactosyltransferase activity [MF]
CG_h9laurent_promoter_p_RM_12_81_20			4	0.75	2.65E-04	TALDO1	sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [MF]
CG_h9laurent_promoter_p_RM_12_403_14			3	0.5	2.27E-04	CCDC64, THAP3, HSPA14, CDKN3, NOP56, CALU, BASP1, RPL11, PPARA, DNM1L, TRIM41, CXADR, NUDT16L1	protein binding [MF], regulation of glycolysis by positive regulation of transcription from RNA polymerase II promoter [BP], Golgi to secretory granule transport [BP], membrane fission involved in mitochondrial fission [BP], snoRNA binding [MF], regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter [BP], dynamin polymerization involved in mitochondrial fission [BP]
CG_h9laurent_promoter_p_RM_12_273_12			1	0.25	2.01E-04	B3GNT5	beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity [MF], lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity [MF], lipopolysaccharide N-acetylglucosaminyltransferase activity [MF]
CG_h9laurent_promoter_p_RM_12_414_18			5	1.0	2.13E-04	SHROOM2, GDF11, SCNN1G	camera-type eye morphogenesis [BP], ligand-gated sodium channel activity [MF]
CG_h9laurent_promoter_p_RM_14_247_10			4	0.5	4.19E-04	FOXK2, FOXD2, CPE, MIF, PTEN, FOXF1, TLE4, BCL2L11	B cell apoptotic process [BP], cardiac left ventricle morphogenesis [BP], RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity [MF], cell surface receptor signaling pathway [BP], negative regulation of cell aging [BP]
CG_h9laurent_promoter_p_RM_14_121_16			4	0.5	4.74E-04	SLC44A1, NFATC3, ZRANB1, LRP5, SLC6A8, CELSR2, CUX1, STAT5A, MARK1, SLC12A2, NFKB1, FZD1, ROR1, KLF2, GNAS	multicellular organism growth [BP], Wnt receptor signaling pathway [BP], cellular response to interleukin-1 [BP], adenylate cyclase activity [MF], Wnt-protein binding [MF], choline transmembrane transporter activity [MF], regulation of transcription from RNA polymerase II promoter [BP], transmembrane receptor protein tyrosine kinase signaling pathway [BP], creatine metabolic process [BP]
CG_h9laurent_promoter_p_RM_12_187_11			5	0.75	1.46E-04	L3MBTL1	SAM domain binding [MF]
CG_h9laurent_promoter_p_RM_12_74_21			6	0.75	3.35E-04	RYR2, ZFPM1, VAPA, AGRN, SFXN1, ABL1, SPTBN4, SMARCA4, ACER3, SGPL1, DAZAP1, PPM1L, SREK1, HSP90AB1, RBM33, LYN, SNRNP70, ITGB3, PPRC1, SSNA1, PRKCB, QKI, CUX1, VEGFA, HTATSF1, URI1, SMO, PKD2, ID2, NUBP2, BST1, SRCAP	platelet-derived growth factor receptor binding [MF], primitive erythrocyte differentiation [BP], muscle cell differentiation [BP], positive regulation of vascular endothelial growth factor receptor signaling pathway [BP], clustering of voltage-gated sodium channels [BP], vascular endothelial growth factor receptor 2 binding [MF], ion channel binding [MF], nucleotide binding [MF], sphingolipid biosynthetic process [BP], calcium-induced calcium release activity [MF], ciliary receptor clustering involved in smoothened signaling pathway [BP], erythrocyte differentiation [BP], regulation of transcription from RNA polymerase II promoter [BP]
CG_h9laurent_promoter_p_RM_14_12_10			2	0.25	1.86E-04	SLC2A4, DOK1, PRKCB, ADAM9, BAIAP2	insulin receptor signaling pathway [BP], protein kinase C binding [MF], cellular response to insulin stimulus [BP]
CG_h9laurent_promoter_p_RM_14_117_9			2	0.25	3.56E-04	ZRANB1, USP25	protein K63-linked deubiquitination [BP]
CG_h9laurent_promoter_p_RM_12_523_26			2	0.5	3.56E-04	GRK5, EIF2B2, EIF2AK4, CORO1A, EIF5B, ADRBK2, MLPH, CAPZA2	cortical actin cytoskeleton [CC], cortical cytoskeleton [CC], regulation of translational initiation [BP], G-protein coupled receptor kinase activity [MF]
CG_h9laurent_promoter_p_RM_12_182_22			3	0.25	2.19E-04	NFIC, NPR2, GDI1, CREB3L4, IRF5, GPSM2, HOXC4, TSHZ1, HOXD3, CSF1, ATRN, SNAPC2, CUX2, KLF3, FOXF2, GUCY1A3, SPTBN4, IKZF1, HOXD11, HSF1	positive regulation of multicellular organism growth [BP], guanylate cyclase activity [MF], regulation of multicellular organism growth [BP], GDP-dissociation inhibitor activity [MF], sequence-specific DNA binding transcription factor activity [MF]
CG_h9laurent_promoter_p_RM_12_34_20			3	0.5	3.32E-04	RBM4, GNAS, STK11, PDE3B, RAB33B, RAP2A, GTPBP1, DLGAP4, GNAL, AGO4, GNAI1, DBH	G-protein beta/gamma-subunit complex binding [MF], extrinsic to internal side of plasma membrane [CC], GTP binding [MF], GTPase activity [MF], regulation of autophagic vacuole assembly [BP], glucose homeostasis [BP], negative regulation of translation involved in gene silencing by miRNA [BP], heterotrimeric G-protein complex [CC], cell-cell signaling [BP], adenylate cyclase-activating dopamine receptor signaling pathway [BP]
CG_h9laurent_promoter_p_RM_12_13_9			1	0.25	2.94E-04	CYP27A1	cholestanetriol 26-monooxygenase activity [MF], cholesterol 26-hydroxylase activity [MF]
CG_h9laurent_promoter_p_RM_14_156_6			3	0.5	3.46E-04	CCNE1	cyclin-dependent protein kinase regulator activity [MF]
CG_h9laurent_promoter_p_RM_14_360_6			2	0.25	3.72E-04	IKZF1, ANLN	positive regulation of neutrophil differentiation [BP], septin ring assembly [BP]
CG_h9laurent_promoter_p_RM_14_239_10			2	0.25	4.78E-04	CISD1, PRDM16	regulation of cellular respiration [BP]
CG_h9laurent_promoter_p_RM_18_9_17			4	0.25	5.10E-04	AFTPH, FMR1, CHD7, RBPJ, GDF7, MKL2, GPR124, FGF18, MAPK6, SLIT2, RNF111, SOBP, LFNG, MTMR3, MTMR1, SIRT1, GREM1, PIM3, TSPYL2, NLGN1, MAN1C1, PAX2, BRSK2, TLK2, TNFAIP2, PTEN, BASP1, LDLRAP1, SOX12, IGF1R	blood vessel morphogenesis [BP], AP-1 adaptor complex [CC], mesenchymal to epithelial transition [BP], positive regulation of heart growth [BP], cell fate commitment [BP], reproductive structure development [BP], chromatin modification [BP], cellular protein metabolic process [BP], negative regulation of protein phosphorylation [BP], synaptic vesicle clustering [BP], regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [BP], brain morphogenesis [BP], angiogenesis [BP], anatomical structure morphogenesis [BP], organ morphogenesis [BP], central nervous system development [BP], negative regulation of monocyte chemotaxis [BP], negative regulation of leukocyte chemotaxis [BP], SUMO polymer binding [MF], ureteric bud development [BP], negative regulation of protein kinase B signaling cascade [BP], protein phosphorylation [BP], phosphatidylinositol-3-phosphatase activity [MF], negative regulation of phosphorylation [BP], metanephros development [BP]
CG_h9laurent_promoter_p_RM_12_428_20			4	0.5	3.72E-04	DPYSL4, NDOR1, NELFCD, CHD7, SPG7, TCEB3, PDLIM5, MDFIC, CACNA1C, CACNA1D, CPNE6, NOS3, FGF18, FOXF2, ADORA2A, EP300, SMARCA4, ATOH8, KCNJ12	genitalia development [BP], NADPH-hemoprotein reductase activity [MF], alpha-actinin binding [MF], actinin binding [MF], positive regulation of viral transcription [BP], nervous system development [BP], regulation of heart contraction [BP]
CG_h9laurent_promoter_p_RM_16_35_2			1	0.25	5.23E-04	OPRL1	nociceptin receptor activity [MF]
CG_h9laurent_promoter_p_RM_14_306_7			2	0.25	3.61E-04	HES1, GABRA5	cochlea development [BP]
CG_h9laurent_promoter_p_RM_12_351_13			2	0.25	2.91E-04	ADCYAP1R1, FGFR3, SALL3, EDNRA	glomerular filtration [BP], positive regulation of phospholipase activity [BP], negative regulation of smoothened signaling pathway [BP], positive regulation of calcium ion transport into cytosol [BP]
CG_h9laurent_promoter_p_RM_12_440_11			3	0.5	2.65E-04	POU4F3, EPHB2	retinal ganglion cell axon guidance [BP]
CG_h9laurent_promoter_p_RM_14_323_8			2	0.25	3.08E-04	MAEL, SIN3B	autosome [CC], XY body [CC]
CG_h9laurent_promoter_p_RM_14_161_17			3	0.5	3.80E-04	HHEX, EIF4EBP2, SOX11	eukaryotic initiation factor 4E binding [MF], negative regulation of glial cell proliferation [BP]
CG_h9laurent_promoter_p_RM_16_33_3			2	0.5	3.81E-04	SLC5A3, RBM15B, CREB1, RXRA, SLC22A3	myo-inositol:sodium symporter activity [MF], histamine uptake [BP], virus-host interaction [BP]
CG_h9laurent_promoter_p_RM_14_288_3			3	0.5	3.44E-04	MAP3K3, PSEN1, MLYCD	activation of MAPKK activity [BP], malonyl-CoA catabolic process [BP], Cajal-Retzius cell differentiation [BP]
CG_h9laurent_promoter_p_RM_12_385_4			1	0.25	2.47E-04	MVB12A, SMARCB1, OGG1, VPS37A, ARID1A	8-oxo-7,8-dihydroguanine DNA N-glycosylase activity [MF], late endosome membrane [CC], npBAF complex [CC], nBAF complex [CC], nucleosome disassembly [BP], nucleosome mobilization [BP], oxidized purine nucleobase lesion DNA N-glycosylase activity [MF], SWI/SNF complex [CC]
CG_h9laurent_promoter_p_RM_12_557_16			3	0.5	2.78E-04	SELV, DOCK1, TNFAIP3, USP20, SELT	guanyl-nucleotide exchange factor activity [MF], protein K63-linked deubiquitination [BP], selenium binding [MF]
CG_h9laurent_promoter_p_RM_16_57_2			2	0.25	5.01E-04	PHF2, ZMIZ1	vitellogenesis [BP], negative regulation of chromatin silencing at rDNA [BP]
CG_h9laurent_promoter_p_RM_12_443_23			4	0.75	3.72E-04	FGFRL1, CHD7, TALDO1, PIK3CA, GNG10, SLC25A4, ARFGEF2, HES1, ICT1	energy reserve metabolic process [BP], cranial nerve development [BP], N-box binding [MF], ventricular septum morphogenesis [BP], negative regulation of pancreatic A cell differentiation [BP], telencephalon development [BP], protein kinase activator activity [MF], heart morphogenesis [BP], lateral inhibition [BP], sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [MF], artery morphogenesis [BP], translation release factor activity, codon nonspecific [MF], hypomethylation of CpG island [BP], mitochondrial translational termination [BP], ventricular septum development [BP], symmetric synapse [CC], positive regulation of mitotic cell cycle, embryonic [BP], negative regulation of stomach neuroendocrine cell differentiation [BP]
CG_h9laurent_promoter_p_RM_14_302_4			2	0.5	3.53E-04	OGG1, GCDH, POU3F3	glutaryl-CoA dehydrogenase activity [MF], metanephric macula densa development [BP], 8-oxo-7,8-dihydroguanine DNA N-glycosylase activity [MF], oxidized purine nucleobase lesion DNA N-glycosylase activity [MF]
CG_h9laurent_promoter_p_RM_12_429_20			4	0.5	3.73E-04	UHRF1	euchromatin [CC]
CG_h9laurent_promoter_p_RM_12_412_15			2	0.25	2.62E-04	PRRX2, CHD7, LRP5, TBX1	semicircular canal morphogenesis [BP], negative regulation of mesenchymal cell apoptotic process [BP], positive regulation of mesenchymal cell proliferation [BP], mesenchymal cell apoptotic process [BP]
CG_h9laurent_promoter_p_RM_12_581_14			3	0.25	3.40E-04	PLCG2	follicular B cell differentiation [BP]
CG_h9laurent_promoter_p_RM_12_170_15			4	0.5	3.36E-04	PSEN2, NTRK2, SMO, PSD2, JAK2, SPTBN4, PHAX	negative regulation of heart contraction [BP], neuronal cell body [CC], dorsal/ventral neural tube patterning [BP]
CG_h9laurent_promoter_p_RM_12_103_11			3	0.5	3.10E-04	TRAF3, ARF6, FAM21C, FAM21B, RAB10, EPHB2	thioesterase binding [MF], corpus callosum development [BP], WASH complex [CC], vesicle-mediated transport [BP]
CG_h9laurent_promoter_p_RM_12_599_12			2	0.25	3.22E-04	CDC34	cellular protein modification process [BP]
CG_h9laurent_promoter_p_RM_14_97_16			4	0.5	3.48E-04	GNAS, CCNE1, CCNY, ADRB1, GPR65, PDX1, ADORA2A	response to fatty acid [BP], positive regulation of cAMP biosynthetic process [BP], activation of adenylate cyclase activity [BP], cyclin-dependent protein kinase regulator activity [MF]
CG_h9laurent_promoter_p_RM_14_376_9			2	0.25	3.08E-04	HSF1, STAT5A, PTPN6, OXT	JAK-STAT cascade involved in growth hormone signaling pathway [BP], positive regulation of multicellular organism growth [BP], female pregnancy [BP]
CG_h9laurent_promoter_p_RM_12_430_18			3	0.75	2.48E-04	CACNA1C, RUNX2, MSX2, P2RX4, GALNT2, WBSCR17	polypeptide N-acetylgalactosaminyltransferase activity [MF], positive regulation of calcium ion transport into cytosol [BP], osteoblast development [BP], calcium ion transport into cytosol [BP], chondrocyte development [BP], regulation of blood pressure [BP]
CG_h9laurent_promoter_p_RM_12_545_13			2	0.25	2.51E-04	UVSSA, WAC	RNA polymerase II core binding [MF]
CG_h9laurent_promoter_p_RM_12_282_18			4	0.5	3.68E-04	SPHK1, ZRANB1, TMOD2, FOXG1, CNOT6, IGF1R, GLRX3, FOXO3, ZFAND6, PDE9A, TBX1, CHAF1A, CHAF1B, STXBP2, YY1, ADRA2C, RNF32, SWSAP1, POFUT1, RARA, BIK, NTNG2, PELI2, CHD9, S1PR1, EML1, NEFH, MIB2, FGF2, CDK5R1, ZIC3, ARPC2, ZNF646, NDOR1, CUL1, CDK10, EXOSC7, DPYSL4, EIF3B, DPYSL2, MAT2B, WIPI2, ARID2, SPATA18, SCN8A, RXRA, LRRC3, USP10, THAP3, MERTK, PPIF, RHOB, MIF, FGFR3, CHD1L, PRDM16, E2F4, BRSK2, IRF4, PTF1A, TRAK1, GLYCTK, ST8SIA2, ATL1, INA, SREBF2, EME1, SOX9, VIM, ASAP2, STIM2, NCAPH, KAT6B, YBX1, TFAP2C, FOXC1, CSRP2BP, MMP15	neurogenesis [BP], substantia nigra development [BP], axonogenesis [BP], somatic stem cell maintenance [BP], DNA replication-dependent nucleosome assembly [BP], retinoic acid receptor signaling pathway [BP], epithelial cell differentiation [BP], CAF-1 complex [CC], neuron differentiation [BP], protein binding [MF], positive regulation of steroid hormone biosynthetic process [BP], retinoic acid-responsive element binding [MF], chondroblast differentiation [BP], nervous system development [BP]
CG_h9laurent_promoter_p_RM_14_179_8			4	0.75	2.86E-04	HIC1, RAN, CREB1, HSP90AB1, PPARD, ZC3H12A, LFNG, ST6GALNAC3, CIDEA, CHST12	positive regulation of fat cell differentiation [BP], intrinsic apoptotic signaling pathway in response to DNA damage [BP], positive regulation of protein binding [BP], integral to Golgi membrane [CC]
CG_h9laurent_promoter_p_RM_12_602_14			3	0.5	3.32E-04	ACAD10, PTPN11, IL4R, ACAD9	insulin receptor substrate binding [MF], acyl-CoA dehydrogenase activity [MF]
CG_h9laurent_promoter_p_RM_12_123_22			2	0.5	3.34E-04	TSKU, EFNA3, EFNA2, PTPN1, PAFAH1B1, CCDC64	osteoclast development [BP], ephrin receptor binding [MF], osteoclast differentiation [BP], dynactin binding [MF], corpus callosum morphogenesis [BP]
CG_h9laurent_promoter_p_RM_12_107_14			5	0.75	1.79E-04	SUV39H2, BMI1, HOXD10, EP400, MOG, RAN	central nervous system development [BP], chromatin binding [MF]
CG_h9laurent_promoter_p_RM_12_444_30			4	0.75	3.27E-04	RGCC, PTPRM	negative regulation of endothelial cell proliferation [BP], negative regulation of endothelial cell migration [BP]
CG_h9laurent_promoter_p_RM_18_20_2			2	0.25	4.40E-04	SLC22A3	dopamine transmembrane transporter activity [MF], histamine uptake [BP]
CG_h9laurent_promoter_p_RM_12_318_8			3	0.25	2.42E-04	DGAT2, SIRT1	cellular triglyceride homeostasis [BP], fatty acid homeostasis [BP]
CG_h9laurent_promoter_p_RM_12_408_26			3	0.5	4.12E-04	LHX9, ERCC4, IFNAR2	gonad morphogenesis [BP], nucleotide-excision repair factor 1 complex [CC], type I interferon binding [MF]
CG_h9laurent_promoter_p_RM_12_67_24			3	0.75	2.73E-04	ADAM9	response to hydrogen peroxide [BP]
CG_h9laurent_promoter_p_RM_14_343_8			3	0.5	3.53E-04	MAP1B, NFE2L3, SMAD1, TRRAP, RXRA, NR1D2, FGF2, PRPF6, RARA	retinoic acid-responsive element binding [MF], transcription coactivator activity [MF], ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity [MF], cardiac muscle cell proliferation [BP], chondroblast differentiation [BP], steroid hormone receptor activity [MF], establishment of monopolar cell polarity [BP], retinoic acid receptor activity [MF]
CG_h9laurent_promoter_p_RM_12_255_4			3	0.5	3.98E-04	AGPAT5, GABARAPL2, PIK3CD, PGS1, CPLX2	CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity [MF], SNARE binding [MF], glycerophospholipid biosynthetic process [BP], mast cell degranulation [BP], phospholipid biosynthetic process [BP]
CG_h9laurent_promoter_p_RM_16_17_7			1	0.25	4.65E-04	IGF1R, NR4A1, DGAT2, GDF7, OPRL1, STIM1	roof plate formation [BP], nociceptin receptor activity [MF], inactivation of MAPKK activity [BP], ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity [MF], positive regulation of tendon cell differentiation [BP], cellular response to oleic acid [BP], identical protein binding [MF]
CG_h9laurent_promoter_p_RM_14_294_14			5	0.5	4.04E-04	CACNA1D, FOXP4, CACNA1C	alpha-actinin binding [MF], pattern specification process [BP], high voltage-gated calcium channel activity [MF]
CG_h9laurent_promoter_p_RM_12_30_13			3	0.25	2.47E-04	ADRA1B, SSTR4, FRMD6	positive regulation of MAPK cascade [BP], apical junction complex [CC]
CG_h9laurent_promoter_p_RM_14_286_8			2	0.25	2.68E-04	TRAF3, FGFR3, FGFRL1	regulation of interferon-beta production [BP], fibroblast growth factor binding [MF], heart valve morphogenesis [BP], fibroblast growth factor receptor signaling pathway [BP], fibroblast growth factor-activated receptor activity [MF]
CG_h9laurent_promoter_p_RM_12_583_11			4	0.5	3.17E-04	EPB41L1, FHDC1, MYRIP, AGAP1, TMOD2, WASF3, EPN1, FMN2, SETD8, YWHAH, AGAP3, ASAP2, MLPH, EHMT1	actin binding [MF], regulation of ARF GTPase activity [BP], embryonic organ development [BP], peptidyl-lysine monomethylation [BP], ARF GTPase activator activity [MF]
CG_h9laurent_promoter_p_RM_14_328_2			1	0.25	2.21E-04	PTPN11, FAM20C, TCF7L1, DLST	negative regulation of growth hormone secretion [BP], dihydrolipoyllysine-residue succinyltransferase activity [MF], negative regulation of cortisol secretion [BP], dentinogenesis [BP], positive regulation of transcription from RNA polymerase II promoter during mitosis [BP], osteoclast maturation [BP]
CG_h9laurent_promoter_p_RM_12_167_10			2	0.25	2.91E-04	RPS6KA4, PTPRJ, NFATC1	mitogen-activated protein kinase binding [MF], mitogen-activated protein kinase p38 binding [MF]
CG_h9laurent_promoter_p_RM_12_327_9			3	0.25	2.06E-04	VDAC3	voltage-gated anion channel activity [MF]
CG_h9laurent_promoter_p_RM_14_108_15			2	0.5	3.08E-04	BLOC1S4, CYFIP2, SOCS6, FGD2, MAPK4, MACF1, EML1, MGAT2, RIMKLB, MPDU1, DNM2, PKNOX1, GPS1	post-Golgi vesicle-mediated transport [BP], cytoplasm [CC], oligosaccharide biosynthetic process [BP]
CG_h9laurent_promoter_p_RM_12_158_24			2	0.25	4.59E-04	PGS1, ST3GAL3	N-acetyllactosaminide alpha-2,3-sialyltransferase activity [MF], CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity [MF]
CG_h9laurent_promoter_p_RM_12_421_12			2	0.25	3.32E-04	PPARD, MMP2, ALDH1A3, EPO	face development [BP], embryo implantation [BP]
CG_h9laurent_promoter_p_RM_16_39_7			4	0.5	4.29E-04	ZNF181, FOXF2, FOXP4, DHX9, CATSPER4, ARID1B, NPAS3, ZNF696, ABL1, ZSWIM6, FOXF1, SALL3, AEBP2, WIPF3, ZNF628, CEBPG, ZNF292, POGK	multicellular organismal development [BP], intracellular membrane-bounded organelle [CC], neuron projection morphogenesis [BP], DNA binding [MF], embryonic foregut morphogenesis [BP]
CG_h9laurent_promoter_p_RM_12_409_23			3	0.5	3.12E-04	INPPL1, GPT2, ACSL3, GNAZ, NR2F2, SOX9, MERTK, FOXL1, GPT, SKI, FOXC1, IGF1R	adenylate cyclase-modulating G-protein coupled receptor signaling pathway [BP], limb development [BP], L-alanine metabolic process [BP], L-alanine catabolic process [BP], brain development [BP], cell surface receptor signaling pathway [BP], retina development in camera-type eye [BP], camera-type eye development [BP], L-alanine:2-oxoglutarate aminotransferase activity [MF]
CG_h9laurent_promoter_p_RM_14_159_5			3	0.5	3.22E-04	HLA-G, PLEKHA1, HLA-E, NOG	MHC class I receptor activity [MF], integral to lumenal side of endoplasmic reticulum membrane [CC], MHC class I protein complex [CC], antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent [BP], ER to Golgi transport vesicle membrane [CC], face morphogenesis [BP]
CG_h9laurent_promoter_p_RM_12_136_15			3	0.5	3.35E-04	NFATC1, PMAIP1, BMP2, FOXP4, DSCR6, ECE2, INPPL1, PTPRJ, HTRA2, ST3GAL3	mitogen-activated protein kinase binding [MF], cellular protein metabolic process [BP], negative regulation of insulin-like growth factor receptor signaling pathway [BP], positive regulation of intrinsic apoptotic signaling pathway [BP], heart development [BP], negative regulation of platelet-derived growth factor receptor signaling pathway [BP]
CG_h9laurent_promoter_p_RM_12_291_13			3	0.75	3.57E-04	SACM1L	phosphatidylinositol bisphosphate phosphatase activity [MF]
CG_h9laurent_promoter_p_RM_14_203_12			3	0.25	3.47E-04	POLA1, RNF17, ZNF696, PDE9A, TBX1, HPCA, ZBTB10, ZNF703, PPP4C, MIB1, MIB2, SARM1, TES, ZBTB1, DPYSL5, TRHDE, TRIM24, RXRA, AGAP1, HHEX, EP300, PROX1, AK5, MYO9B, WTIP, ASAP2, LGR5	nucleoside kinase activity [MF], metal ion binding [MF], hepatocyte differentiation [BP], muscle tissue morphogenesis [BP], inner ear development [BP], signal transduction [BP], zinc ion binding [MF]
CG_h9laurent_promoter_p_RM_12_358_19			4	0.75	2.79E-04	HHEX, COMMD1, GDF7, NTRK2, UPF1, ASRGL1, SLC6A1	brain-derived neurotrophic factor binding [MF], mRNA export from nucleus [BP], forebrain morphogenesis [BP], protein homodimerization activity [MF], roof plate formation [BP], hepatic duct development [BP], brain-derived neurotrophic factor-activated receptor activity [MF], morphogenesis of an epithelial fold [BP], gamma-aminobutyric acid import [BP], positive regulation of tendon cell differentiation [BP], asparagine catabolic process via L-aspartate [BP], brain-derived neurotrophic factor receptor signaling pathway [BP]
CG_h9laurent_promoter_p_RM_14_11_5			1	0.25	1.92E-04	TCOF1, RBL2, RPP21	transcription of nuclear large rRNA transcript from RNA polymerase I promoter [BP], nucleolus [CC]
CG_h9laurent_promoter_p_RM_14_90_10			2	0.25	3.84E-04	MLLT10, L3MBTL1, CUX2, KLF3, ARNTL2, FOXK2	sequence-specific DNA binding transcription factor activity [MF]
CG_h9laurent_promoter_p_RM_12_392_31			2	0.25	4.37E-04	TGFBR1, SPCS3, ZNF703, CLN5, PLEKHA1, FOXF2, MYB, TSPO, YAP1, EPHB2	contact inhibition [BP], regulation of transforming growth factor beta receptor signaling pathway [BP], signal peptide processing [BP], embryonic digestive tract development [BP], palate development [BP]
CG_h9laurent_promoter_p_RM_14_87_18			2	0.25	4.86E-04	FBXO18, ZFX, ERBB2IP, SETD1B, RBM15B, DLG3, FAM50A, SAMD11, WWC1, MIB1, ZNF783, FOXF1, TRIM28, DIAPH2, TRIM24, ZNF362, DR1, ARID1A, TCF7L1, RUNX2, PTEN, PLEKHA1, MAG, ID4, XPO7, ZNF211, FOXK2, KAT2B, POLR1C, EED, CHD7, SOX12, EN2, RAB7A, MAU2, XPOT, FZD1, DAP3, PEX3, NAA15, PRDM12, RWDD3, HOXD10, EBF4, ALKBH5, AGFG1, RAP1B, EVI5L, DYRK2, MXD1, NCOA3, ATXN1L, AFMID, BSN, MVP, POMP, USP6, HTATSF1, SNRK, ADRB1, BASP1, TBC1D13, HMGB3, PSMD3, NFYA, PIN1, SOX1, RMI2, DGKZ, KLF11, CAND1, BHLHE22, ZNF555, PRKCI, NR4A3, PDIK1L, CASC3, USP11, PPP6R2, USP15, TRIP13, UBAP2L, UBE2Z, ZNF711, KAT6B, NFIX, ILF3, HECTD2	protein complex [CC], intracellular [CC], Ada2/Gcn5/Ada3 transcription activator complex [CC], positive regulation of transcription, DNA-dependent [BP], establishment or maintenance of epithelial cell apical/basal polarity [BP], regulation of transcription, DNA-dependent [BP], transcription, DNA-dependent [BP], transcription cofactor activity [MF], nucleoplasm [CC], nucleic acid binding [MF], Schmidt-Lanterman incisure [CC], regulation of RNA biosynthetic process [BP], positive regulation of heart growth [BP], intracellular membrane-bounded organelle [CC], positive regulation of gene expression [BP], nucleus [CC]
CG_h9laurent_promoter_p_RM_12_563_8			1	0.25	3.09E-04	CTDP1, UBE2C	exit from mitosis [BP]
CG_h9laurent_promoter_p_RM_12_118_20			4	0.5	3.78E-04	SYNM, GPC6, GNAS, AGRN, FREM2, COL5A1, FGF9, APLP1, SKI, CHST11	neurofilament cytoskeleton [CC], basement membrane [CC], cellular response to catecholamine stimulus [BP], embryonic limb morphogenesis [BP], proteoglycan binding [MF], heparan sulfate proteoglycan binding [MF], chondroitin sulfate metabolic process [BP]
CG_h9laurent_promoter_p_RM_14_155_6			2	0.25	3.64E-04	SLC27A4, DRD4, CAMP, MOCS3	negative regulation of growth of symbiont on or near host surface [BP], URM1 activating enzyme activity [MF], olfactory learning [BP], long-chain fatty acid transport [BP], enzyme active site formation via L-cysteine persulfide [BP], fatty acid transport [BP], cell wall [CC]
CG_h9laurent_promoter_p_RM_12_451_6			1	0.25	3.22E-04	PKN1, STX4, KAT5, NUP188, CDK7, CUL5, AGTRAP, FTL, KDM4C	androgen receptor binding [MF], post-Golgi vesicle-mediated transport [BP], intracellular membrane-bounded organelle [CC], viral reproduction [BP]
CG_h9laurent_promoter_p_RM_14_345_5			2	0.25	4.31E-04	IGF1R, HOOK3	protein localization to centrosome [BP], inactivation of MAPKK activity [BP]
CG_h9laurent_promoter_p_RM_14_359_11			2	0.25	3.78E-04	CYLD, ARF6, EPB41, USP25	cortical actin cytoskeleton organization [BP], protein K63-linked deubiquitination [BP]
CG_h9laurent_promoter_p_RM_12_596_15			4	0.5	1.93E-04	DRD4, DRD5, TRAF2, TIRAP, MDK	short-term memory [BP], positive regulation of protein homodimerization activity [BP], dopamine neurotransmitter receptor activity [MF]
CG_h9laurent_promoter_p_RM_14_172_9			4	0.75	3.89E-04	SMO, SLC25A27, NOD2, DNAAF1, SLC50A1, CYP46A1	glucoside transmembrane transporter activity [MF], negative regulation of interleukin-18 production [BP], muramyl dipeptide binding [MF], otolith morphogenesis [BP], ventral midline determination [BP], detection of cell density by contact stimulus involved in contact inhibition [BP], glucoside transport [BP], positive regulation of dendritic cell cytokine production [BP], detection of muramyl dipeptide [BP], mesenchymal to epithelial transition involved in metanephric renal vesicle formation [BP], detection of biotic stimulus [BP], regulation of cilium beat frequency [BP], reduction of mitochondrial calcium ion concentration [BP], cholesterol 24-hydroxylase activity [MF], positive regulation of prostaglandin-E synthase activity [BP]
CG_h9laurent_promoter_p_RM_12_47_16			3	0.75	3.36E-04	ONECUT3, ZFPM1, CRTC3, IKZF1, ADIPOQ, MDK, LHX2, CHD7, TWSG1, TADA2B, UBC, PCF11, ZAR1, CBFB, CDK5R1, FOXF2, CREBRF, MSX2, IRX1, BMP8A, EVX1, ZNF33A, PHRF1, SGPL1, IRX5, COL4A2, PTPN6, LCOR, NFIC, PLXNA3, MAF1, HOXD11, DCAF7, PLEKHA1, SRRT, HLF, RBPJ, YY1	granulocyte differentiation [BP], palate development [BP], sequence-specific DNA binding transcription factor activity [MF], transcription, DNA-dependent [BP], sequence-specific DNA binding [MF], positive regulation of BMP signaling pathway [BP], negative regulation of fat cell differentiation [BP], multicellular organismal development [BP], transcription from RNA polymerase II promoter [BP], embryo development [BP], cell differentiation [BP]
CG_h9laurent_promoter_p_RM_12_165_10			4	0.75	3.02E-04	OAZ1, ADC	polyamine biosynthetic process [BP], polyamine metabolic process [BP]
CG_h9laurent_promoter_p_RM_12_391_18			3	0.5	3.77E-04	USP47, PAFAH1B1, MAPT, B3GNT5, NTN1	positive regulation of cell growth [BP], galactosyltransferase activity [MF], establishment of nucleus localization [BP], positive regulation of axon extension [BP]
CG_h9laurent_promoter_p_RM_12_178_10			3	0.5	3.80E-04	FGF2, HHAT, HOXD8, NANOS3, NR2F2, FOXO3, HOXC12, GRB7, UBR3, NFIX, FGFR3, FZD1	substantia nigra development [BP], positive regulation of phosphatidylinositol 3-kinase activity [BP], negative regulation of transcription from RNA polymerase II promoter [BP], epithelial cell fate commitment [BP], negative regulation of transcription, DNA-dependent [BP], fibroblast growth factor binding [MF], cytoplasmic stress granule [CC], multicellular organismal development [BP], embryo development [BP], negative regulation of endothelial cell migration [BP]
CG_h9laurent_promoter_p_RM_12_387_8			3	0.5	2.48E-04	INPPL1	inositol trisphosphate metabolic process [BP]
CG_h9laurent_promoter_p_RM_14_112_12			2	0.25	4.47E-04	MARC1, MARC2, PRDX5	molybdenum ion binding [MF], reactive nitrogen species metabolic process [BP], nitrate metabolic process [BP], detoxification of nitrogen compound [BP], nitrate reductase activity [MF], molybdopterin cofactor binding [MF]
CG_h9laurent_promoter_p_RM_12_44_19			2	0.25	3.48E-04	YEATS4, RUVBL2, RAC1	localization within membrane [BP], histone H2A acetylation [BP], NuA4 histone acetyltransferase complex [CC]
CG_h9laurent_promoter_p_RM_14_386_13			3	0.5	4.18E-04	TSPO, FOXF1, FOXP4, TGFBR1	pattern specification process [BP], negative regulation of glial cell proliferation [BP], anterior/posterior pattern specification [BP], embryonic foregut morphogenesis [BP]
CG_h9laurent_promoter_p_RM_12_455_9			5	0.75	2.93E-04	GALNT11, FOXF1, PTCHD2, GALNT16	polypeptide N-acetylgalactosaminyltransferase activity [MF], smoothened signaling pathway [BP]
CG_h9laurent_promoter_p_RM_12_280_11			4	0.5	3.03E-04	SYNM, ZBTB16, HOXD10, NAV2, OSR2, PAX2, HHEX	neurofilament cytoskeleton [CC], hindlimb morphogenesis [BP], pronephros development [BP], mesonephros development [BP], forelimb morphogenesis [BP], embryonic organ development [BP], optic nerve development [BP], camera-type eye development [BP]
CG_h9laurent_promoter_p_RM_20_15_2			1	0.25	1.44E-04	ALG1, EPHB3	chitobiosyldiphosphodolichol beta-mannosyltransferase activity [MF], palate development [BP]
CG_h9laurent_promoter_p_RM_12_169_13			2	0.25	2.82E-04	PKN1, IGFBP1, CDK5R1, PTPRM, FGF2, TRAF2	cadherin binding [MF], signal transduction [BP], negative regulation of endothelial cell migration [BP]
CG_h9laurent_promoter_p_RM_12_386_20			3	0.5	2.39E-04	FGF18, NAB2, BMP6	endochondral ossification [BP]
CG_h9laurent_promoter_p_RM_12_569_8			2	0.25	3.63E-04	PPIF	regulation of proton-transporting ATPase activity, rotational mechanism [BP]
CG_h9laurent_promoter_p_RM_14_7_6			2	0.25	2.81E-04	SMCHD1, GREM1	negative regulation of bone mineralization involved in bone maturation [BP], negative regulation of bone trabecula formation [BP], inactivation of X chromosome by DNA methylation [BP]
CG_h9laurent_promoter_p_RM_12_238_11			3	0.25	3.21E-04	PCSK9, BCL2L11, HOOK3, FOXO3, CYLD, SOX2, TRIM54, TPGS1, SARM1, DAPK1, TNFRSF19, DNAH2	neuronal stem cell maintenance [BP], microtubule [CC], induction of apoptosis [BP]
CG_h9laurent_promoter_p_RM_12_461_18			2	0.5	3.39E-04	TSC2, ADCY1, CREB1, GNAS, PDPK1	epidermal growth factor receptor signaling pathway [BP], adenylate cyclase activity [MF]
CG_h9laurent_promoter_p_RM_12_59_7			3	0.5	1.48E-04	GATA3, WNT1	negative regulation of fat cell differentiation [BP]
CG_h9laurent_promoter_p_RM_12_207_20			1	0.25	2.37E-04	NTRK1, OGG1, SLC2A4	response to ethanol [BP]
CG_h9laurent_promoter_p_RM_18_12_13			4	0.25	4.39E-04	PKP4, NDST1, RBPJ, MPP6, NTRK2, SIX3, ZSWIM6, RNF115, EEFSEC, MTMR3, CUL1, DHX9, TDRD3, SP2, ZNF362, PDS5B, AGFG1, URI1, LMTK2, ARID1A, DDX42, RBBP6, RUNX2, PLEKHA5, ATMIN, SLC7A6, NRSN1, SNX9, CARM1, FMN2, HABP4, SLAIN2, SEPT7, KLHDC2, HCCS, TTC3, PPM1A, EN2, ZIC2, TRAF3IP1, SIRT1, TSPYL2, UNC5B, ARPC2, CUX1, PAX2, PKNOX2, PRDM16, HOXD10, INSM1, ZNF292, YY1, AFTPH, DYRK2, NR2F2, BCR, ZBTB10, HIC1, FZD7, REPS2, LFNG, MVP, RAP2A, POMP, NLGN1, EPB41, ZNF696, RAB21, HIVEP1, BIRC7, FMR1, CPSF6, SOX1, CAND1, CATSPER4, BHLHE22, SLIT2, POU3F2, ARIH1, HSPB1, REST, CASC3, AR, PBX3, TBKBP1, SQSTM1, ZBED4, TAB2, RND2, WIPF3, WIPF2, MCU, COL6A2, GDF7	nucleus [CC], brain development [BP], compartment pattern specification [BP], multicellular organismal development [BP], cell fate commitment [BP], nervous system development [BP], 1-phosphatidylinositol binding [MF], corticospinal tract morphogenesis [BP], regulation of signal transduction [BP], sequence-specific DNA binding transcription factor activity [MF], sequence-specific DNA binding RNA polymerase II transcription factor activity [MF], neuron differentiation [BP], regulation of transcription from RNA polymerase II promoter [BP], cell differentiation [BP], neurogenesis [BP], protein binding [MF], positive regulation of transcription, DNA-dependent [BP], organ morphogenesis [BP], neuron projection morphogenesis [BP], camera-type eye morphogenesis [BP], protein complex assembly [BP], neuron development [BP], central nervous system development [BP], DNA binding [MF], negative regulation of transcription from RNA polymerase II promoter [BP], forebrain development [BP], sequence-specific DNA binding [MF], negative regulation of transcription, DNA-dependent [BP], positive regulation of gene expression [BP]
CG_h9laurent_promoter_p_RM_14_298_12			3	0.5	4.18E-04	ZNF333, PLK5, CHAF1A, SOX1, SKI, ADORA2A, KCNA5, CHD7, CACNA1D, WNK2, GPR124, CDK5R1, MARK1, ZNF551, MYRF, PKN3, TGFBR2, ACVR2B, ZNF362, PKN1, RUNX2, MDFIC, TSHZ1, NFIA, BRSK2, ZNF618, JDP2, INSM1, SLC2A4RG, RBCK1, ZMIZ1, PHF2, FOXC1, POLA1	central nervous system development [BP], palate development [BP], protein serine/threonine kinase activity [MF], regulation of transcription, DNA-dependent [BP], protein kinase activity [MF], regulation of atrial cardiac muscle cell membrane repolarization [BP], transcription, DNA-dependent [BP], alpha-actinin binding [MF], artery development [BP], regulation of ion homeostasis [BP], chromatin binding [MF], epithelial cell migration [BP], camera-type eye development [BP]
CG_h9laurent_promoter_p_RM_12_453_26			2	0.5	2.91E-04	PRRX2, KCNF1, BCR, KCNQ5, KCNQ4	inner ear morphogenesis [BP], delayed rectifier potassium channel activity [MF]
CG_h9laurent_promoter_p_RM_14_353_17			1	0.25	3.40E-04	SMO, STUB1, SOX2	cellular response to misfolded protein [BP], forebrain morphogenesis [BP], positive regulation of neuroblast proliferation [BP], adenohypophysis development [BP], misfolded or incompletely synthesized protein catabolic process [BP]
CG_h9laurent_promoter_p_RM_14_335_10			2	0.25	2.37E-04	USP10, CUL4A	ubiquitin-dependent protein catabolic process [BP]
CG_h9laurent_promoter_p_RM_12_98_29			3	0.5	3.85E-04	SPG7, AP1AR, LRP5, NTRK1, SOX8, NR2E1, SKI, PCSK9	neurogenesis [BP], early endosome [CC], adipose tissue development [BP], Sertoli cell development [BP], neuron differentiation [BP], retina development in camera-type eye [BP], nervous system development [BP]
CG_h9laurent_promoter_p_RM_14_5_3			2	0.25	2.86E-04	PLXNA1, FNTA, PLXNA3	positive regulation of tubulin deacetylation [BP], semaphorin receptor complex [CC], semaphorin receptor activity [MF]
CG_h9laurent_promoter_p_RM_14_113_5			2	0.25	3.21E-04	RPS21, RRP36	ribosomal small subunit biogenesis [BP]
CG_h9laurent_promoter_p_RM_12_465_14			3	0.5	3.84E-04	PSMD1, SOX2, MESP2, NCOA3, LHX2, SOX11, WWC1, EN2, SLC47A1, ATOH8, TCF7, SOLH, ZNF140, ATMIN, CUX2, SALL3, TP53INP2, INSM2, F2R, AATF, NSD1, PDPK1, ZMIZ1, POU2F3, ZNF771, HOXC8	nucleic acid binding transcription factor activity [MF], positive regulation of transcription, DNA-dependent [BP], regulation of transcription, DNA-dependent [BP], monovalent cation:hydrogen antiporter activity [MF], sequence-specific DNA binding transcription factor activity [MF], transcription, DNA-dependent [BP], regulation of gene expression [BP], regulation of RNA biosynthetic process [BP], regulation of hippo signaling cascade [BP], RNA metabolic process [BP], positive regulation of gene expression [BP], regulation of transcription from RNA polymerase II promoter [BP]
CG_h9laurent_promoter_p_RM_14_152_20			4	0.5	3.62E-04	PIM1, PKD2	positive regulation of cyclin-dependent protein kinase activity involved in G1/S [BP]
CG_h9laurent_promoter_p_RM_12_397_19			3	0.75	3.53E-04	SLC2A10, SLC35A3	sugar:hydrogen symporter activity [MF]
CG_h9laurent_promoter_p_RM_12_197_12			2	0.25	3.18E-04	BTRC, MARK1, SOX4, IDUA, DLX6	Wnt receptor signaling pathway [BP], skeletal system morphogenesis [BP], limb morphogenesis [BP], skeletal system development [BP]
CG_h9laurent_promoter_p_RM_12_534_15			5	0.75	1.69E-04	ID1, CDC73, SUPT5H	blood vessel endothelial cell migration [BP], positive regulation of DNA-dependent transcription, elongation [BP], positive regulation of transcription elongation from RNA polymerase II promoter [BP]
CG_h9laurent_promoter_p_RM_12_456_22			5	1.0	2.84E-04	NFATC3, TMSB4X, ZFPM1, KIF26A, SMO, TUBA8, TRIM54, ARNTL2, CBX2, ZNF7, NFE2L3, TADA2A, ASXL3, ZBTB8A, TPM1, PBX3, EN2, NF2, MAPRE2, CAPZA2, SPAG6, FLI1, TCEA2, RXRA, MLLT10, HOXD1, DYNC1H1, ZNF518A, ZEB1, PKNOX1, CXADR, TBL1X, PKD2, G3BP1, CXXC5, ARID1B, NFIX, ZNF575, NFATC1	microtubule cytoskeleton [CC], sequence-specific DNA binding transcription factor activity [MF], cytoskeleton [CC], cytoskeletal protein binding [MF], microtubule [CC], cortical cytoskeleton [CC], DNA binding [MF], heart development [BP], positive regulation of transcription from RNA polymerase II promoter [BP]
CG_h9laurent_promoter_p_RM_12_209_14			2	0.25	2.31E-04	SOX1	forebrain neuron development [BP]
CG_h9laurent_promoter_p_RM_16_67_6			1	0.25	5.04E-04	CEP164, BRSK2, ARID1B, PLXNA1, TACC3, EN2, RABL6, FBXO45	neurogenesis [BP], centrosome [CC], multicellular organismal development [BP], nervous system development [BP]
CG_h9laurent_promoter_p_RM_14_98_6			2	0.25	4.31E-04	GNGT1	cardiac muscle cell apoptotic process [BP]
CG_h9laurent_promoter_p_RM_16_52_6			1	0.25	4.08E-04	SMARCA4, SMARCB1	Tat protein binding [MF], positive regulation by host of viral transcription [BP], npBAF complex [CC], nBAF complex [CC], nucleosome disassembly [BP], SWI/SNF complex [CC]
CG_h9laurent_promoter_p_RM_16_1_10			1	0.25	4.84E-04	NTSR1, GPR50	G-protein coupled receptor signaling pathway [BP]
CG_h9laurent_promoter_p_RM_14_362_8			3	0.5	3.55E-04	SMARCA4, SMARCB1	Tat protein binding [MF], positive regulation by host of viral transcription [BP], npBAF complex [CC], nBAF complex [CC], nucleosome disassembly [BP], SWI/SNF complex [CC]
CG_h9laurent_promoter_p_RM_12_297_15			2	0.25	2.85E-04	LRP5, WNT10A, SOX17, TBX1, FOXF2, INSIG1, ARHGAP5, EPHB2	embryonic organ development [BP], positive regulation of mesenchymal cell proliferation [BP], axis specification [BP], palate development [BP]
CG_h9laurent_promoter_p_RM_18_4_32			1	0.25	4.37E-04	HOXC5, ZNF592, ZNF839, USP9X, POLR1D, MLL5, EXOSC2, BCORL1, SOX1, PHF2, EHMT1, CEBPB, CHD3, JMY, ZNF532, ASXL3, EGR1, NR2F1, KCMF1, MAP3K4, KLF2, FOXF2, CDC25B, SNRNP70, KCNIP3, ACVR2A, ABCG1, TRIM24, JARID2, ZNF362, WAC, GRIK2, TRRAP, PKNOX1, PKNOX2, POGK, MAP1LC3B, GNAS, PLXNA3, MAF1, ARID1A, NOG, ID2, SPEN, BMPR2, NAB1, HIVEP1, NELFB	intracellular [CC], positive regulation of osteoblast differentiation [BP], osteoblast differentiation [BP], RNA metabolic process [BP], regulation of transcription, DNA-dependent [BP], DNA methylation [BP], transcription, DNA-dependent [BP], negative regulation of transcription, DNA-dependent [BP], regulation of gene expression [BP], negative regulation of gene expression [BP], gene expression [BP], transcription from RNA polymerase II promoter [BP], erythrocyte differentiation [BP], regulation of transcription from RNA polymerase II promoter [BP]
CG_h9laurent_promoter_p_RM_14_329_8			2	0.25	3.47E-04	RARA, PPP1R1B, PLEKHG6, OXT, MYO6, PDS5B, ITM2C, RAN, PLEKHM2, MZT2B, DKC1, REPS2, SEPT11, HSD17B12	protein binding [MF], response to amphetamine [BP], response to electrical stimulus [BP]
CG_h9laurent_promoter_p_RM_12_84_26			2	0.25	2.50E-04	PDE4A, GATA4, KCNA5, PDE8A, SOX4, REST	core promoter binding [MF], cardiac ventricle morphogenesis [BP], RNA polymerase II transcription factor binding transcription factor activity [MF], atrial septum primum morphogenesis [BP], cAMP catabolic process [BP], core promoter sequence-specific DNA binding [MF], outward rectifier potassium channel activity [MF], transcription regulatory region sequence-specific DNA binding [MF], atrial septum morphogenesis [BP], ventricular septum development [BP], Sertoli cell differentiation [BP], 3',5'-cyclic-AMP phosphodiesterase activity [MF]
CG_h9laurent_promoter_p_RM_14_342_10			2	0.25	3.45E-04	PHF17, FOSB, LRRK1, ABL1, SKI, ZBTB10, ZBTB16, PPM1A, GADD45B, SS18L1, MAPK8IP1, CBFB, KDM6A, ZNF470, TRAF3, MAT2A, UBE2E1, RXRA, REST, SMYD2, IDUA, PACS2, TRIM41, CHAMP1, CHD7, BMP1, FZR1, PIAS4, PHF2, FGFRL1	limb development [BP], transcriptional repressor complex [CC], negative regulation of transcription from RNA polymerase II promoter [BP], limb morphogenesis [BP], cation binding [MF], regulation of transcription, DNA-dependent [BP], negative regulation of protein kinase activity [BP], negative regulation of transcription, DNA-dependent [BP], apoptotic process [BP], metal ion binding [MF], nose development [BP], negative regulation of gene expression [BP], nucleus [CC], zinc ion binding [MF], positive regulation of cartilage development [BP], skeletal system development [BP]
CG_h9laurent_promoter_p_RM_12_92_9			2	0.5	3.44E-04	FOXK2, TCERG1, SMO, SOX8, TBX1, HPCA, APCDD1, KCNA5, QKI, HIC1, ZHX2, CDK5R1, TCF25, KNDC1, FOXJ2, HHEX, TRIM24, EPN1, PHRF1, RPS28, PER3, SNAPC2, VEGFA, FOXL1, PTPN1, EP300, PROX1, NTN1, TAB1, NOM1, RPL10, CTHRC1, NFATC1	vasculogenesis [BP], positive regulation of osteoblast proliferation [BP], organ development [BP], coronary artery morphogenesis [BP], Wnt-protein binding [MF], ear morphogenesis [BP], lymph vessel development [BP], cerebellar granule cell differentiation [BP], venous blood vessel morphogenesis [BP], RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity [MF], regulation of signal transduction [BP], cerebellar cortex morphogenesis [BP], embryonic organ development [BP], positive regulation of branching involved in ureteric bud morphogenesis [BP], pattern specification process [BP], RNA metabolic process [BP], heart development [BP], regulation of sequence-specific DNA binding transcription factor activity [BP], transcription factor binding [MF], receptor binding [MF], organ morphogenesis [BP], heart morphogenesis [BP], positive regulation of neural precursor cell proliferation [BP], negative regulation of gene expression [BP], cerebellum development [BP], semicircular canal morphogenesis [BP], negative regulation of transcription from RNA polymerase II promoter [BP], inner ear morphogenesis [BP], sequence-specific DNA binding [MF], negative regulation of transcription, DNA-dependent [BP], inner ear development [BP], tissue development [BP], embryo development [BP], transcription from RNA polymerase II promoter [BP], DNA binding, bending [MF]
CG_h9laurent_promoter_p_RM_12_275_23			2	0.25	4.70E-04	SPHK1, TBCD, TUBA1C	'de novo' posttranslational protein folding [BP]
CG_h9laurent_promoter_p_RM_14_340_12			3	0.5	4.01E-04	ANGPTL4, APOC1, TGFBR1	negative regulation of lipoprotein lipase activity [BP], lens development in camera-type eye [BP]
CG_h9laurent_promoter_p_RM_12_28_13			2	0.25	2.13E-04	SLC18A2	insulin secretion [BP]
CG_h9laurent_promoter_p_RM_12_349_20			2	0.25	3.43E-04	CHRD, POR, RAC1, IGF2R	cerebral cortex radially oriented cell migration [BP], trans-Golgi network transport vesicle [CC], anatomical structure morphogenesis [BP], negative regulation of lipase activity [BP], forebrain development [BP]
CG_h9laurent_promoter_p_RM_14_253_16			3	0.5	3.68E-04	MLL, SETD1B	histone methyltransferase activity (H3-K4 specific) [MF], histone H3-K4 methylation [BP]
CG_h9laurent_promoter_p_RM_12_485_12			5	0.75	2.80E-04	RHOQ, MYO3A	positive regulation of filopodium assembly [BP]
CG_h9laurent_promoter_p_RM_12_203_9			2	0.5	1.76E-04	CCNE1, IRF9, SOX13, TFAP2E, HOXD1, PPARD, SOX9, TCF7, LHX2	cyclin-dependent protein kinase regulator activity [MF], transcription from RNA polymerase II promoter [BP], sequence-specific DNA binding transcription factor activity [MF]
CG_h9laurent_promoter_p_RM_14_148_16			3	0.5	3.77E-04	ZFAND6, AKAP1, TOMM6, PHLPP1, SAMD11, FOXF2, DRAP1, CDK5R1, SETDB2, IGF1R, HOXD4, PAFAH1B1, BRSK2, ADCY1, DR1, ARID1B, RUNX2, HUNK, ACSL3, FOXP4, CDKN1B, EPB41, SKI, CHD2, CHD7, SOX11, SOX12, EN2, ZIC2, GRM7, DLX1, DPYSL5, JAM3, SPATA18, C8orf40, CUX1, ZBTB10, PKNOX2, PRDM16, INSM1, PPP2R5D, ALKBH5, INA, FOXC1, YY1, WBSCR22, ONECUT3, SMAD1, RPS6KB2, CEP164, COASY, NAA20, RPS6KB1, PBX3, SUV420H2, DUSP5, BCL7A, FBXO45, NLGN1, PAQR5, RXRA, BAHD1, HTATSF1, TMEM57, EP300, PLXNA1, TACC3, AGPAT5, BABAM1, ZMIZ1, SPHK1, SPG7, PSMD1, S100P, SOX8, TNFAIP2, CEBPG, DMBX1, MLLT4, TAL2, KLF3, CNOT6, POU3F3, LTBP4, SSNA1, REST, E4F1, POGK, CTNS, RASA1, DAZAP1, RNF169, ZNF710, ZBTB42, ATF4, WBP4, HSF1	regulation of RNA metabolic process [BP], brain development [BP], multicellular organismal development [BP], nucleic acid binding transcription factor activity [MF], transcription factor complex [CC], nervous system development [BP], core promoter binding [MF], adult behavior [BP], regulation of transcription, DNA-dependent [BP], adult locomotory behavior [BP], neuron differentiation [BP], nucleic acid binding [MF], mitochondrial outer membrane [CC], transcription regulatory region DNA binding [MF], nucleus [CC], cell differentiation [BP], neurogenesis [BP], chromatin DNA binding [MF], transcription factor binding [MF], central nervous system development [BP], sequence-specific DNA binding transcription factor activity [MF], transcription regulatory region sequence-specific DNA binding [MF], core promoter sequence-specific DNA binding [MF], chromatin binding [MF], negative regulation of gene expression [BP], regulation of transcription from RNA polymerase II promoter [BP], DNA binding [MF], palate development [BP], negative regulation of transcription from RNA polymerase II promoter [BP], osteoblast fate commitment [BP], transcription, DNA-dependent [BP], sequence-specific DNA binding [MF], negative regulation of transcription, DNA-dependent [BP], establishment of cell polarity [BP], cerebral cortex radially oriented cell migration [BP], embryo development [BP], transcription from RNA polymerase II promoter [BP], ribosomal protein S6 kinase activity [MF], nucleoplasm [CC]
CG_h9laurent_promoter_p_RM_16_63_4			3	0.25	3.20E-04	PPARD	linoleic acid binding [MF]
CG_h9laurent_promoter_p_RM_12_492_10			4	0.75	3.83E-04	ADRA2C, PDPK1	activation of protein kinase B activity [BP]
CG_h9laurent_promoter_p_RM_16_15_7			3	0.25	4.11E-04	RGCC, E4F1	mitotic cell cycle arrest [BP]
CG_h9laurent_promoter_p_RM_12_587_11			4	0.5	2.19E-04	BCR, PLEKHA1	platelet-derived growth factor receptor signaling pathway [BP]
CG_h9laurent_promoter_p_RM_12_296_9			2	0.25	2.66E-04	SOX17	embryonic organ development [BP]
CG_h9laurent_promoter_p_RM_14_334_11			2	0.25	1.80E-04	CRHR1, POLR2A	RNA-directed RNA polymerase activity [MF], corticotropin-releasing hormone receptor activity [MF]
CG_h9laurent_promoter_p_RM_12_205_7			1	0.25	3.91E-04	SLC50A1	glucoside transport [BP]
CG_h9laurent_promoter_p_RM_14_39_6			2	0.25	2.05E-04	SLC5A2, GATA3, CRHBP, KAT8	negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation [BP], negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation [BP], negative regulation of cell proliferation involved in mesonephros development [BP], negative regulation of corticotropin-releasing hormone receptor activity [BP], regulation of histone H3-K27 methylation [BP], myeloid cell differentiation [BP], negative regulation of corticotropin secretion [BP], low-affinity glucose:sodium symporter activity [MF]
CG_h9laurent_promoter_p_RM_12_299_24			3	0.5	3.70E-04	DNAAF1, AK4, PPP4R4	tetracycline metabolic process [BP], regulation of cilium beat frequency [BP], regulation of protein serine/threonine phosphatase activity [BP], carbon tetrachloride metabolic process [BP]
CG_h9laurent_promoter_p_RM_14_85_22			2	0.25	4.43E-04	TRIM28, HIC1, ZNF236, FOXD3, MKL2, POU2F3, CUX1, MAFK, SOX2, PBX3, CBFB	sequence-specific DNA binding transcription factor activity [MF]
CG_h9laurent_promoter_p_RM_20_10_3			1	0.25	2.91E-04	TENC1	multicellular organism growth [BP]
CG_h9laurent_promoter_p_RM_14_255_3			1	0.25	3.29E-04	ACVR2A, TGFBR1, B3GALT6, AACS	response to cholesterol [BP], positive regulation of pathway-restricted SMAD protein phosphorylation [BP], acetoacetate-CoA ligase activity [MF], transforming growth factor beta-activated receptor activity [MF], galactosylxylosylprotein 3-beta-galactosyltransferase activity [MF], transmembrane receptor protein serine/threonine kinase activity [MF], pathway-restricted SMAD protein phosphorylation [BP]
CG_h9laurent_promoter_p_RM_12_394_22			3	0.5	4.11E-04	HINFP, TBL1X	histone binding [MF]
CG_h9laurent_promoter_p_RM_14_280_7			2	0.25	4.44E-04	BCL2L11, ATP2A2, SMAD5, EPN1, RXRA, IRX5, MSX1, ADM, NPR2	blood circulation [BP], bone development [BP], odontogenesis of dentin-containing tooth [BP], positive regulation of heart rate [BP], in utero embryonic development [BP], regulation of heart rate [BP], regulation of the force of heart contraction [BP]
CG_h9laurent_promoter_p_RM_12_389_15			3	0.75	1.55E-04	ATP2A2	regulation of cardiac muscle cell membrane potential [BP]
CG_h9laurent_promoter_p_RM_14_110_4			3	0.5	4.26E-04	CDT1, ADRB1, HIST1H2AH, CDC45, HIST1H2BO, SPTAN1	regulation of transcription involved in G1/S phase of mitotic cell cycle [BP], DNA replication checkpoint [BP], protein heterodimerization activity [MF], DNA replication initiation [BP], fear response [BP]
CG_h9laurent_promoter_p_RM_12_354_15			3	0.5	2.46E-04	FOXD2, CREB1, FOXB1	RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity [MF]
CG_h9laurent_promoter_p_RM_14_102_10			3	0.25	2.48E-04	CDC42, CLN8, WNT1	neuron fate determination [BP], protein catabolic process [BP]
CG_h9laurent_promoter_p_RM_14_295_2			1	0.25	2.93E-04	PPARA, SLC27A4	regulation of glycolysis by positive regulation of transcription from RNA polymerase II promoter [BP], fatty acid transport [BP], regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter [BP]
CG_h9laurent_promoter_p_RM_16_61_3			2	0.5	4.44E-04	CAD, EPO	response to testosterone stimulus [BP], dihydroorotase activity [MF], aspartate binding [MF], aspartate carbamoyltransferase activity [MF], carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [MF]
CG_h9laurent_promoter_p_RM_14_382_10			2	0.25	3.39E-04	LMX1B, BMPR1A	dorsal/ventral pattern formation [BP], dorsal/ventral axis specification [BP]
CG_h9laurent_promoter_p_RM_12_472_13			3	0.75	2.91E-04	TRIM71, WTIP	gene silencing by miRNA [BP], positive regulation of gene silencing by miRNA [BP], regulation of gene silencing by miRNA [BP]
CG_h9laurent_promoter_p_RM_12_426_18			3	0.5	2.95E-04	ZFX, ONECUT3, HOXC4, RIPK1, BMPR1B, FAM120B, GZF1, HNRNPM, CAMTA1, CNOT2, PABPN1, TRIM28, RPS21, TXLNG, ARID2, CUX1, TBX21, PBX3, IRF4, GEMIN2, SLC2A4RG, TARS, HIVEP1, PTH1R	transcription, DNA-dependent [BP], gene expression [BP], RNA metabolic process [BP], receptor complex [CC]
CG_h9laurent_promoter_p_RM_12_469_18			3	0.5	1.98E-04	MALT1, FARP1, ITSN1	B-1 B cell differentiation [BP], kinase activator activity [MF], CBM complex [CC], Rho guanyl-nucleotide exchange factor activity [MF]
CG_h9laurent_promoter_p_RM_12_25_25			3	0.5	4.31E-04	FGF2	C21-steroid hormone biosynthetic process [BP]
CG_h9laurent_promoter_p_RM_14_213_10			2	0.25	3.77E-04	FOXK1, CREB1, FOXG1	RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity [MF]
CG_h9laurent_promoter_p_RM_14_197_8			4	0.5	2.85E-04	GNA11, GNAI2	extrinsic to internal side of plasma membrane [CC], G-protein beta/gamma-subunit complex binding [MF], heterotrimeric G-protein complex [CC]
CG_h9laurent_promoter_p_RM_14_202_35			3	0.5	3.01E-04	FOXD3, NRTN, SEMA3F, EGR1	neural crest cell migration [BP], response to norepinephrine stimulus [BP]
CG_h9laurent_promoter_p_RM_12_383_17			2	0.25	2.92E-04	PRPF31, RHOQ, PRPF6, DNAJA3	assembly of spliceosomal tri-snRNP [BP], U4/U6 x U5 tri-snRNP complex [CC], actin filament [CC]
CG_h9laurent_promoter_p_RM_14_116_13			2	0.25	2.85E-04	ADAP2, ARFGAP1, EPHB2	camera-type eye morphogenesis [BP], regulation of ARF GTPase activity [BP], ARF GTPase activator activity [MF]
CG_h9laurent_promoter_p_RM_14_37_8			3	0.5	3.98E-04	ZMIZ1, HES1, PKD2	aorta development [BP], artery morphogenesis [BP], S-shaped body morphogenesis [BP], renal tubule morphogenesis [BP]
CG_h9laurent_promoter_p_RM_16_50_2			2	0.5	2.36E-04	GMPS, PDPK1	3-phosphoinositide-dependent protein kinase activity [MF], GMP synthase (glutamine-hydrolyzing) activity [MF], GMP synthase activity [MF]
CG_h9laurent_promoter_p_RM_14_137_12			2	0.25	2.76E-04	FOXE1, SHROOM2	camera-type eye morphogenesis [BP], lens morphogenesis in camera-type eye [BP]
CG_h9laurent_promoter_p_RM_12_395_19			3	0.5	4.44E-04	CAPN1, SOLH, PRDX5	calcium-dependent cysteine-type endopeptidase activity [MF], negative regulation of oxidoreductase activity [BP]
CG_h9laurent_promoter_p_RM_14_86_14			2	0.25	4.14E-04	PLK1, ZNF618, USP3, ZNF341, REST, ZNF696, ZSWIM6, ZMIZ2, NR2F2, ZNF292, ZBTB10	zinc ion binding [MF], negative regulation of cyclin-dependent protein kinase activity [BP]
CG_h9laurent_promoter_p_RM_12_535_19			5	0.75	3.75E-04	DUSP14, MAP1B, BCR, ZIC1, DUSP5	establishment of monopolar cell polarity [BP], inner ear morphogenesis [BP], MAP kinase tyrosine/serine/threonine phosphatase activity [MF]
CG_h9laurent_promoter_p_RM_14_268_6			2	0.25	3.09E-04	NFE2L1, FOXD3, HOXC4, SREBF2, HLF, NPAS2, IRX1, OLIG2	sequence-specific DNA binding [MF], axon extension involved in axon guidance [BP], HMG box domain binding [MF], sequence-specific DNA binding transcription factor activity [MF]
CG_h9laurent_promoter_p_RM_16_34_2			1	0.25	3.58E-04	IGF1R	inactivation of MAPKK activity [BP]
CG_h9laurent_promoter_p_RM_12_544_8			2	0.5	2.92E-04	PIAS3, KCNJ12	potassium channel regulator activity [MF]
CG_h9laurent_promoter_p_RM_16_41_2			2	0.25	2.82E-04	RNF5	ER-associated misfolded protein catabolic process [BP]
CG_h9laurent_promoter_p_RM_12_506_12			3	0.5	2.77E-04	PRDM16, STK11, PARD6B, VAPA, CNTNAP1, CABLES1, LAMC3, UCHL1, INHA	neurogenesis [BP], protein complex [CC], axonogenesis [BP], neuromuscular process [BP], neuron projection development [BP], neuron projection morphogenesis [BP], cell morphogenesis involved in differentiation [BP], nervous system development [BP]
CG_h9laurent_promoter_p_RM_16_58_4			2	0.25	4.06E-04	SSH3, RAC1, ICT1	regulation of lamellipodium assembly [BP], mitochondrial translational termination [BP], translation release factor activity, codon nonspecific [MF], lamellipodium assembly [BP]
CG_h9laurent_promoter_p_RM_12_405_11			5	1.0	3.17E-04	PLK5, CBFB, SH3GL3, SPEN, NFE2L3, ZFP42, NF2, FOSL2, IRX5, MTA1, FGD5, TGFBR1, HHEX, TRIM28, PKN3, RABEP1, CUX1, TCEAL1, DBI, NFIA, LDLR, KIT, SLC2A4RG, ZFPM1	regulation of phosphatidylcholine catabolic process [BP], early endosome [CC], mast cell degranulation [BP], megakaryocyte development [BP], mast cell differentiation [BP], protein kinase activity [MF], sequence-specific DNA binding transcription factor activity [MF], embryonic organ development [BP], lipid binding [MF]
CG_h9laurent_promoter_p_RM_12_257_15			2	0.25	2.73E-04	F2R, MDM2, TNFRSF11A, F2RL1, HMGA1, SMTNL1, TNFRSF19, ADRA2C	positive regulation of Rho protein signal transduction [BP], positive regulation of interleukin-8 secretion [BP], peroxisome proliferator activated receptor binding [MF], positive regulation of vasoconstriction [BP], tumor necrosis factor-mediated signaling pathway [BP], thrombin receptor activity [MF], G-protein beta-subunit binding [MF], positive regulation of interleukin-6 secretion [BP]
CG_h9laurent_promoter_p_RM_12_424_12			3	0.5	3.36E-04	CTNNB1, ORC6	DNA-dependent DNA replication [BP], renal vesicle formation [BP]
CG_h9laurent_promoter_p_RM_12_417_23			2	0.5	2.13E-04	TGFBR2, ASPSCR1, NUP50, IL4R, SYTL3, CDKN1A, HEXIM2, YKT6, NR2F2, AP4E1, SETD1B, SEC24B, KCNIP3, GATA3, EHMT1	response to estrogen stimulus [BP], positive regulation of T cell differentiation [BP], histone methylation [BP], negative regulation of cyclin-dependent protein kinase activity [BP], regulation of CD4-positive, alpha-beta T cell differentiation [BP], protein transport [BP], histone H3-K4 methylation [BP], lens development in camera-type eye [BP], intracellular protein transport [BP]
CG_h9laurent_promoter_p_RM_14_153_5			2	0.5	2.75E-04	TRAF3, CYFIP2, NANOS3, TSHZ1, CHSY3, OSR2, RXRA, AHR, CUX1, PPARD, UST, CDK5R1, BFAR, NOTO, SOX9, BCAN	prostate gland development [BP], dermatan sulfate biosynthetic process [BP], sequence-specific DNA binding [MF], ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity [MF], oogenesis [BP], notochord development [BP], negative regulation of transcription, DNA-dependent [BP], apoptotic process [BP], chondroitin sulfate metabolic process [BP]
CG_h9laurent_promoter_p_RM_14_45_10			3	0.25	2.93E-04	RPS6KA4, PIM3, ADRBK2, STK17A, GRK5	protein serine/threonine kinase activity [MF], histone phosphorylation [BP], G-protein coupled receptor kinase activity [MF]
CG_h9laurent_promoter_p_RM_12_365_17			2	0.5	2.97E-04	AP2M1, SLC6A1, STXBP1, REPS2, FOXO3, FOXN2, FOXL1, MLST8, RPS6KB2, SETD6, EHMT1	epidermal growth factor receptor signaling pathway [BP], peptidyl-lysine monomethylation [BP], negative regulation of synaptic transmission, GABAergic [BP], DNA binding, bending [MF]
CG_h9laurent_promoter_p_RM_12_478_11			3	0.5	4.05E-04	HHEX, RAB4A, ABL1	regulation of endocytosis [BP], embryonic organ development [BP]
CG_h9laurent_promoter_p_RM_12_571_13			3	0.5	4.37E-04	PNPO	pyridoxamine-phosphate oxidase activity [MF]
CG_h9laurent_promoter_p_RM_12_215_12			3	0.5	3.51E-04	TCF7, MTA3, SLC2A4RG, BAHCC1, ZNF710, ZBTB8A, CREB1, BLM, BANF2, ADNP2, KPNA2, ZNF236, ZBTB42, NFIX, FOXC1, TEAD4, NFATC1	G2 phase of mitotic cell cycle [BP], DNA binding [MF], RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity [MF], RNA polymerase II distal enhancer sequence-specific DNA binding [MF], sequence-specific DNA binding transcription factor activity [MF]
CG_h9laurent_promoter_p_RM_14_375_11			2	0.25	3.38E-04	NFIA, PSD2, MLLT4, CTNNB1, SYNGR1, PTPRM, P2RX4, PRDM16	cell junction [CC], cell adhesion molecule binding [MF], cadherin binding [MF], tongue development [BP], cell-cell adherens junction [CC]
CG_h9laurent_promoter_p_RM_14_119_7			2	0.25	2.68E-04	RIMKLB	acid-amino acid ligase activity [MF]
CG_h9laurent_promoter_p_RM_12_114_6			2	0.25	2.58E-04	KCNQ4, ITGA9	basal plasma membrane [CC]
CG_h9laurent_promoter_p_RM_14_231_9			2	0.25	3.59E-04	ITGA3, DAG1, CACNA1C	synapse [CC], alpha-actinin binding [MF]
CG_h9laurent_promoter_p_RM_14_72_4			3	0.25	4.71E-04	LDLRAP1, AP2A2, SLC5A3	myo-inositol:sodium symporter activity [MF], AP-2 adaptor complex [CC]
CG_h9laurent_promoter_p_RM_12_269_29			2	0.25	2.83E-04	ARHGAP26, BAIAP2	cytoskeletal adaptor activity [MF]
CG_h9laurent_promoter_p_RM_14_174_8			4	0.5	2.68E-04	ZDHHC18, ZDHHC13, KCNK3, EPO	cellular response to hypoxia [BP], palmitoyltransferase activity [MF]
CG_h9laurent_promoter_p_RM_14_79_13			3	0.5	2.55E-04	NFKB1, KLF11, YY1, CTCF, SOX2	transcription regulatory region DNA binding [MF], regulatory region DNA binding [MF]
CG_h9laurent_promoter_p_RM_12_236_12			2	0.5	4.53E-04	ADM, PTPRJ, CCNF	placenta development [BP], negative regulation of vascular permeability [BP]
CG_h9laurent_promoter_p_RM_16_36_2			3	0.25	5.16E-04	POU3F3	metanephric thick ascending limb development [BP], metanephric macula densa development [BP]
CG_h9laurent_promoter_p_RM_16_43_2			4	0.5	2.40E-04	IKZF1	positive regulation of neutrophil differentiation [BP]
CG_h9laurent_promoter_p_RM_12_211_17			5	0.75	3.27E-04	EGFR, KIAA1804	MAP kinase kinase kinase activity [MF]
CG_h9laurent_promoter_p_RM_12_516_30			3	0.5	2.98E-04	ZNF76, PRPF6, EIF3I, LHX4, BRPF1, CBFB, FOXF2, CLN8, BMP8A, HOXD4, SP5, MYLIP, SMARCD1, GTF2I, ACSL3, F2R, MRPL40, HUNK, PPDPF, CTCF, ZNF696, CYR61, SKI, JMY, SUB1, SOX11, PPM1L, EN2, DLX6, SLC25A10, EPHB2, DGCR8, PHRF1, TIPARP, INSIG1, PKNOX1, PRDM16, TBPL1, RPS6KA4, KCNH3, KDM3B, ACTR5, PRDM8, VAX2, FOSB, TP53INP2, SMO, SMPD2, POFUT1, MDK, HIC2, ENOPH1, CELSR2, PLXNA3, PLXNA1, RLF, LMO4, AK4, RPL10A, PSMB3, CDC42, BAHD1, CAV1, BMPR1A, BMPR1B, FMR1, TEAD1, CPSF3, GRHL1, SMARCA4, DAO, RAI1, YWHAH, KLF2, NACC1, SMARCB1, CNP, HOOK3, NR4A1, RXRA, RPL28, POGK, UPP1, RPL26L1, CCRN4L, ILF3, FGFRL1	brain development [BP], nitrogen compound metabolic process [BP], multicellular organismal development [BP], nervous system development [BP], nucleobase-containing compound metabolic process [BP], transcription coactivator activity [MF], negative regulation of neurogenesis [BP], regulation of transcription, DNA-dependent [BP], neuron differentiation [BP], nucleosome disassembly [BP], caveola [CC], RNA metabolic process [BP], cell differentiation [BP], skeletal system development [BP], neurogenesis [BP], anatomical structure morphogenesis [BP], positive regulation of transcription, DNA-dependent [BP], osteoblast differentiation [BP], organ morphogenesis [BP], central nervous system development [BP], ceramide biosynthetic process [BP], nBAF complex [CC], central nervous system neuron differentiation [BP], SWI/SNF complex [CC], regulation of transcription from RNA polymerase II promoter [BP], palate development [BP], camera-type eye development [BP], forebrain development [BP], transcription, DNA-dependent [BP], npBAF complex [CC], sphingolipid biosynthetic process [BP], ventricular septum development [BP], gene expression [BP], transcription from RNA polymerase II promoter [BP], cellular nitrogen compound metabolic process [BP], positive regulation of gene expression [BP]
CG_h9laurent_promoter_p_RM_14_226_9			2	0.25	2.92E-04	EED, SMARCA4, CDC73, SUV39H1	negative regulation of S phase of mitotic cell cycle [BP], histone methyltransferase activity [MF]
CG_h9laurent_promoter_p_RM_14_81_13			2	0.25	3.80E-04	PLXNA1, PLXNA3	semaphorin receptor complex [CC], semaphorin receptor activity [MF]
CG_h9laurent_promoter_p_RM_12_522_10			3	0.75	3.81E-04	HHIP, CTNNA2, PAX2, AOC3	quinone binding [MF], brain morphogenesis [BP]
CG_h9laurent_promoter_p_RM_12_553_16			3	0.5	3.15E-04	NGRN, LMX1B, CEBPB	neuron differentiation [BP]
CG_h9laurent_promoter_p_RM_14_277_7			2	0.25	3.82E-04	CHD7	nose development [BP]
CG_h9laurent_promoter_p_RM_12_119_12			4	0.5	3.48E-04	AGK, SPHK1	diacylglycerol kinase activity [MF]
CG_h9laurent_promoter_p_RM_12_208_4			2	0.5	2.92E-04	PPFIBP2, SLC39A14	integrase activity [MF], ferrous iron transmembrane transporter activity [MF]
CG_h9laurent_promoter_p_RM_12_222_18			3	0.5	3.44E-04	POLD1, TCF7, HHEX, CHD7, NLGN1, SMAD6, NCS1, BICC1, GDA, CYB5D2, DAG1, FGF18, SHMT2, CLSTN2, FBXO45	chromatin binding [MF], multicellular organismal development [BP], postsynaptic membrane [CC], nervous system development [BP]
CG_h9laurent_promoter_p_RM_16_25_30			8	0.5	4.79E-04	FBXO18, ZFX, ZFPM1, SETD1B, ZXDB, CERS6, FAM50A, RBPJ, MIB1, CBFB, RNF111, KDM2A, CDK5R1, IGF1R, TRIM28, TRIM24, SP2, ZNF362, KCNF1, URI1, DR1, ARID1B, ARID1A, DDX42, TCF7L1, PTEN, YBX1, CTCF, HCN2, KAT2B, POLR1C, SETBP1, ACSBG2, VANGL1, HCCS, XPO7, BICC1, ZIC2, NR4A3, SIRT1, XPOT, KCNQ5, MAN2A1, PAX1, MLLT10, PAX2, PRDM12, TLK2, ZNF618, HOXD10, POLE4, HES1, ALKBH5, GGNBP2, LCMT1, SMAD6, SMAD1, DLK1, UBAP2L, KCNC1, AFMID, FGF18, MAPK6, DUSP5, DUSP9, FBXO45, POMP, WAC, CARM1, EEFSEC, MNAT1, UCHL3, MAPK8IP3, ID4, ADRB1, BASP1, CXXC5, ZMIZ1, MVP, CAMK1D, BIRC7, SOX8, PRELID1, CPSF4, MID2, DGKZ, CAND1, BHLHE22, NPAS2, GPR124, UBE2Z, KCNS2, POU3F2, HSPB1, HOOK3, TTLL9, CASC3, FPGS, RTF1, CHD7, RNF169, ZNF711, KAT6B, NFIX, HSF1	nucleus [CC], brain development [BP], generation of neurons [BP], ureter morphogenesis [BP], multicellular organismal development [BP], positive regulation of heart growth [BP], regulation of fat cell differentiation [BP], nervous system development [BP], ligase activity [MF], chromatin modification [BP], negative regulation of neurogenesis [BP], metanephric nephron tubule morphogenesis [BP], sequence-specific DNA binding [MF], regulation of transcription, DNA-dependent [BP], negative regulation of catalytic activity [BP], nucleoplasm [CC], in utero embryonic development [BP], nucleic acid binding [MF], regulation of neuron differentiation [BP], regulation of dendrite development [BP], chromatin organization [BP], metanephric nephron tubule formation [BP], nuclear euchromatin [CC], neurogenesis [BP], anatomical structure morphogenesis [BP], positive regulation of transcription, DNA-dependent [BP], transcription regulatory region DNA binding [MF], fat cell differentiation [BP], organ morphogenesis [BP], central nervous system development [BP], locomotor rhythm [BP], positive regulation of transcription from RNA polymerase II promoter [BP], chromatin binding [MF], voltage-gated potassium channel complex [CC], regulation of transcription from RNA polymerase II promoter [BP], ureteric bud development [BP], protein complex [CC], DNA binding [MF], delayed rectifier potassium channel activity [MF], Ada2/Gcn5/Ada3 transcription activator complex [CC], cellular protein modification process [BP], transcription, DNA-dependent [BP], transcription cofactor activity [MF], negative regulation of transcription, DNA-dependent [BP], regulation of gene expression [BP], embryo development [BP], transcription from RNA polymerase II promoter [BP], positive regulation of gene expression [BP]
CG_h9laurent_promoter_p_RM_12_315_23			3	0.5	5.35E-05	GSTO1, B4GALT7, SPR	glutathione dehydrogenase (ascorbate) activity [MF], methylarsonate reductase activity [MF], sepiapterin reductase activity [MF], xylosylprotein 4-beta-galactosyltransferase activity [MF], positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [BP]
CG_h9laurent_promoter_p_RM_14_224_12			1	0.25	3.03E-04	MARCH9	trans-Golgi network [CC]
CG_h9laurent_promoter_p_RM_14_275_8			2	0.25	3.10E-04	RAB7A, PRKAR1A, GAB1, PDPK1	epidermal growth factor receptor signaling pathway [BP], epidermal growth factor catabolic process [BP], fibroblast growth factor receptor signaling pathway [BP], bone resorption [BP]
CG_h9laurent_promoter_p_RM_12_227_9			3	0.5	2.24E-04	ITPR3, PDHA1, RYR2, PDHX	intracellular ligand-gated calcium channel activity [MF], calcium-release channel activity [MF], acetyl-CoA biosynthetic process from pyruvate [BP], regulation of acetyl-CoA biosynthetic process from pyruvate [BP]
CG_h9laurent_promoter_p_RM_14_34_28			6	0.75	4.75E-04	PPP2R1A, PHF17, ZRANB1, FUS, ONECUT3, PSMD11, STK11, EIF5, HABP4, PIWIL4, ELF3, SAMD4B, IKZF1, ARNTL, NFX1, ZNF451, ZBTB10, CEBPG, CHD7, PPM1E, NFE2L3, WWC1, NPAS3, CCNF, BIRC7, BSN, GMCL1, ZIC2, FOXF1, MYRF, ZBTB34, KLF2, MVP, DGKZ, SMG7, ENDOG, EPN1, WTIP, SIVA1, HOXC11, CUX2, SKIL, SART1, PBX3, MAPK8IP3, THAP3, CDCA8, PTMA, ARID1B, PLXNA1, JDP2, USP10, CNOT6, BASP1, POLE4, ZNF276, PTF1A, ATF4, ZNF460, SOX12, HSF1	regulation of hippo signaling cascade [BP], regulation of transcription, DNA-dependent [BP], sequence-specific DNA binding transcription factor activity [MF], transcription, DNA-dependent [BP], sequence-specific DNA binding [MF], regulation of gene expression [BP], DNA binding [MF], in utero embryonic development [BP], gene expression [BP], RNA metabolic process [BP], nucleus [CC]
CG_h9laurent_promoter_p_RM_16_6_6			1	0.25	4.08E-04	KL, BMP6	positive regulation of bone mineralization [BP]
CG_h9laurent_promoter_p_RM_14_158_3			3	0.5	2.58E-04	ERBB2	RNA polymerase I core binding [MF]
CG_h9laurent_promoter_p_RM_12_17_9			3	0.5	2.67E-04	BMI1, SPHK1	positive regulation of fibroblast proliferation [BP]
CG_h9laurent_promoter_p_RM_12_259_13			4	0.5	1.53E-04	AGRN	positive regulation of synaptic growth at neuromuscular junction [BP]
CG_h9laurent_promoter_p_RM_14_273_9			3	0.25	3.82E-04	FCHO2, SNX18, ZFYVE9, SH2B3, IQSEC3, PLEKHG6	endocytosis [BP], membrane invagination [BP], phospholipid binding [MF]
CG_h9laurent_promoter_p_RM_12_234_15			3	0.5	9.83E-05	GRM2, B3GNT5	beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity [MF], lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity [MF], lipopolysaccharide N-acetylglucosaminyltransferase activity [MF], group II metabotropic glutamate receptor activity [MF]
CG_h9laurent_promoter_p_RM_14_19_7			2	0.25	3.71E-04	NAGS, LRRK2, ATP2A2, SMS	calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential [MF], acetyl-CoA:L-glutamate N-acetyltransferase activity [MF], spermine synthase activity [MF], GTP-dependent protein kinase activity [MF]
CG_h9laurent_promoter_p_RM_12_600_7			4	0.75	3.11E-04	TRAF4, MT2A, MAP3K4, AGRN, CDK5R1, SEC24B, NELL1, CASC3	G-protein coupled acetylcholine receptor signaling pathway [BP], perinuclear region of cytoplasm [CC]
CG_h9laurent_promoter_p_RM_14_68_5			2	0.25	3.56E-04	H6PD	glucose 1-dehydrogenase [NAD(P)] activity [MF]
CG_h9laurent_promoter_p_RM_14_2_4			1	0.25	3.67E-04	ARHGEF16, ADCY1, PRKAR1A, LMX1B, SPTBN4	nerve growth factor receptor signaling pathway [BP], axonogenesis [BP], neuron differentiation [BP], cellular response to glucagon stimulus [BP], activation of protein kinase A activity [BP]
CG_h9laurent_promoter_p_RM_16_4_4			3	0.5	1.08E-04	ZNF844, ZNF441, ZNF720, ZNF440	transcription, DNA-dependent [BP], regulation of transcription, DNA-dependent [BP], nucleic acid binding [MF]
CG_h9laurent_promoter_p_RM_16_38_3			4	0.5	4.45E-04	INHBB	negative regulation of hepatocyte growth factor biosynthetic process [BP], host cell surface receptor binding [MF]
CG_h9laurent_promoter_p_RM_12_69_19			3	0.5	3.56E-04	FOXO3, CRTC3, FOXF1, ID1, CRTC1	positive regulation of CREB transcription factor activity [BP], lung vasculature development [BP], cAMP response element binding protein binding [MF], regulation of sequence-specific DNA binding transcription factor activity [BP]
CG_h9laurent_promoter_p_RM_12_463_23			2	0.5	3.08E-04	ACE, EPHA8, PRPF4B, TUBB, SHROOM2, ADD3, DGKZ, CEBPB, LRRK1, INPPL1, WASF3, ITSN1, FZD9, EML6, EML4, TUBB6, VIL1, SUSD2, VWA1, IRAK2, NLK, DAPK1, POU3F2, IGF1R, HHEX, BNIP3L, PPP1R3F, FOS, SPAG6, ENPP1, FER, FES, EPB41, ASRGL1, PKNOX2, CEP170B, KIF1C, PKD2, EMX2, PICK1, CUL4A, PRDM6, RDH10, CEP72, PPP1R3G, PAK2, SKIL, SNTB2	lipid phosphorylation [BP], actin binding [MF], microtubule [CC], lamellipodium [CC], cell projection organization [BP], identical protein binding [MF], nervous system development [BP], primary lung bud formation [BP], cellular response to organic substance [BP], phosphorylation [BP], cytoskeletal protein binding [MF], response to growth factor stimulus [BP], neurogenesis [BP], neuron differentiation [BP], microtubule cytoskeleton [CC], polysaccharide binding [MF], regulation of protein metabolic process [BP], regulation of protein phosphorylation [BP], protein phosphorylation [BP], glycogen binding [MF], protein autophosphorylation [BP], actin cytoskeleton [CC]
CG_h9laurent_promoter_p_RM_12_407_16			3	0.5	3.92E-04	MEIS1, MERTK, TUB, SOX1, SKI, CAMK1D	positive regulation of phagocytosis [BP], camera-type eye development [BP], lens morphogenesis in camera-type eye [BP]
CG_h9laurent_promoter_p_RM_14_271_7			2	0.25	4.85E-04	ALDH1A3, FOXF2	embryonic camera-type eye morphogenesis [BP], embryonic eye morphogenesis [BP], nucleus accumbens development [BP]
CG_h9laurent_promoter_p_RM_12_40_28			3	0.75	2.67E-04	LRP5, NOG, PVRL3, GNA11, WTIP, LIMD1, FOXC1, FGFRL1	negative regulation of osteoblast differentiation [BP], retina morphogenesis in camera-type eye [BP], cardiac muscle cell proliferation [BP], negative regulation of hippo signaling cascade [BP], positive regulation of gene silencing by miRNA [BP], skeletal system development [BP]
CG_h9laurent_promoter_p_RM_12_353_26			3	0.5	3.30E-04	TCEA2, CTCF, ZIC2	transcription elongation factor complex [CC], chromatin DNA binding [MF], regulation of histone methylation [BP]
CG_h9laurent_promoter_p_RM_14_10_2			1	0.25	2.40E-04	CAMP, RALB, SDHAF1	cell wall [CC], regulation of exocyst localization [BP], regulation of exocyst assembly [BP], mitochondrial respiratory chain complex II assembly [BP], negative regulation of growth of symbiont on or near host surface [BP]
CG_h9laurent_promoter_p_RM_12_459_17			2	0.25	3.10E-04	CCNY, FOS, CCND1	cyclin-dependent protein kinase holoenzyme complex [CC], positive regulation of cyclin-dependent protein kinase activity [BP], cyclin-dependent protein kinase regulator activity [MF], response to corticosterone stimulus [BP]
CG_h9laurent_promoter_p_RM_16_44_13			4	0.5	2.97E-04	ACE, SPTAN1, ARPC5L, ILK, KHDRBS3, EPB41, SKI, ARHGAP10, ABL1, BAIAP2, GRIN1, TSPO, ABLIM3	cytoskeleton organization [BP], regulation of actin cytoskeleton organization [BP], actin cytoskeleton organization [BP], spectrin binding [MF], actin binding [MF], protein domain specific binding [MF], spectrin [CC], neurotransmitter binding [MF], negative regulation of glial cell proliferation [BP], SH3 domain binding [MF]
CG_h9laurent_promoter_p_RM_14_256_4			2	0.25	2.71E-04	BANF2, ZIC3, SUZ12, ZNF131, NFKB1, ZNF775, PBX3, LMX1B, PDS5B	sequence-specific DNA binding [MF], nucleic acid binding transcription factor activity [MF], DNA binding [MF], sequence-specific DNA binding transcription factor activity [MF]
CG_h9laurent_promoter_p_RM_14_327_3			1	0.25	3.14E-04	PAICS, SQSTM1, ALDH1A3, PDPK1	3-phosphoinositide-dependent protein kinase activity [MF], nucleus accumbens development [BP], regulation of I-kappaB kinase/NF-kappaB cascade [BP], protein serine/threonine kinase activity [MF], phosphoribosylaminoimidazole carboxylase activity [MF], phosphoribosylaminoimidazolesuccinocarboxamide synthase activity [MF], 5-(carboxyamino)imidazole ribonucleotide mutase activity [MF]
CG_h9laurent_promoter_p_RM_12_317_8			1	0.25	9.51E-05	CDC6	positive regulation of chromosome segregation [BP], regulation of mitotic anaphase [BP]
CG_h9laurent_promoter_p_RM_12_175_14			3	0.75	2.02E-04	CTCF	chromatin insulator sequence binding [MF]
CG_h9laurent_promoter_p_RM_14_30_7			2	0.25	4.41E-04	AGPAT6	glandular epithelial cell maturation [BP]
CG_h9laurent_promoter_p_RM_14_318_6			2	0.25	4.93E-04	ACSF3, P2RX4, SNX9	malonate catabolic process [BP], lipid tube assembly [BP], malonyl-CoA synthetase activity [MF], response to fluid shear stress [BP]
CG_h9laurent_promoter_p_RM_12_334_16			4	0.75	3.30E-04	HOXD4, TFAP2C, SMAD4	neuron fate commitment [BP], forebrain neuron fate commitment [BP], stem cell differentiation [BP], sebaceous gland development [BP]
CG_h9laurent_promoter_p_RM_12_498_21			2	0.5	3.80E-04	CACNG7	voltage-gated calcium channel complex [CC]
CG_h9laurent_promoter_p_RM_12_132_3			2	0.25	8.47E-05	GUCY1B3	guanylate cyclase complex, soluble [CC]
CG_h9laurent_promoter_p_RM_20_14_4			1	0.25	2.91E-04	OPRL1, NR4A3	nociceptin receptor activity [MF], vestibular reflex [BP]
CG_h9laurent_promoter_p_RM_14_305_16			4	0.75	3.88E-04	PTGS1, TMOD2, ZFAND6, RAD23B, TOMM6, SAMD11, RBPJ, CRAMP1L, FSTL3, MIB2, FOXF2, IRX5, CDK5R1, IGF1R, HOXD4, MDFIC, EDEM1, PAFAH1B1, AKAP1, BRSK2, DR1, ARID1B, RUNX2, HUNK, KPNA2, ACSL3, TBCD, HINFP, SNX9, EPB41, ORAI1, SKI, CHD2, CHD7, SOX11, SOX12, EN2, ZIC2, HOOK3, DLX1, DPYSL5, MAL2, EPN1, CUX1, MLL, PKNOX2, VSTM2L, USP11, INA, FOXC1, BAG3, EML1, YY1, RBM6, ONECUT3, SMAD1, RAP1A, CD4, ZNF839, CEP164, COASY, ZBTB10, FOXP4, RPS6KB1, SS18L1, PDE3B, MAPK6, SUV420H2, DUSP5, BCL7A, ATOH8, FBXO45, TGFBR1, TSSK3, TAL2, WAC, RXRA, SH2B3, HTATSF1, TMEM57, EP300, LLGL1, PLXNA1, TACC3, JDP2, AGPAT5, BABAM1, ZMIZ1, EPB41L1, STIM2, SNTB2, PTK7, SPG7, PSMD1, BAHD1, PSMD2, CNTNAP1, SOX8, ELF3, SPTBN4, CEBPG, DMBX1, MLLT4, NLGN1, KCNK3, MED11, EFR3A, CNOT6, POU3F3, SLC44A1, ZNHIT1, LTBP4, SSNA1, PAQR5, REST, GTF2H4, E4F1, POGK, DAZAP1, THAP6, RNF169, ZNF710, OAZ1, GNA11, ATF4, HSF1	neuron projection [CC], BMP signaling pathway [BP], multicellular organismal development [BP], nucleic acid binding transcription factor activity [MF], transcription factor complex [CC], nervous system development [BP], core promoter binding [MF], cortical actin cytoskeleton organization [BP], regulation of transcription, DNA-dependent [BP], sequence-specific DNA binding transcription factor activity [MF], embryonic organ development [BP], neuron differentiation [BP], in utero embryonic development [BP], mitochondrial outer membrane [CC], transcription regulatory region DNA binding [MF], nucleus [CC], heart development [BP], cell differentiation [BP], protein complex [CC], neurogenesis [BP], protein binding [MF], chromatin DNA binding [MF], positive regulation of transcription, DNA-dependent [BP], transcription factor binding [MF], organ morphogenesis [BP], brain development [BP], central nervous system development [BP], artery morphogenesis [BP], positive regulation of transcription from RNA polymerase II promoter [BP], transcription regulatory region sequence-specific DNA binding [MF], core promoter sequence-specific DNA binding [MF], chromatin binding [MF], negative regulation of gene expression [BP], DNA binding [MF], regulation of transcription from RNA polymerase II promoter [BP], camera-type eye morphogenesis [BP], intracellular [CC], guanyl-nucleotide exchange factor complex [CC], palate development [BP], camera-type eye development [BP], osteoblast fate commitment [BP], cardiac muscle cell proliferation [BP], transcription, DNA-dependent [BP], sequence-specific DNA binding [MF], negative regulation of transcription, DNA-dependent [BP], regulation of gene expression [BP], gamete generation [BP], cerebral cortex radially oriented cell migration [BP], embryo development [BP], transcription from RNA polymerase II promoter [BP], cellular nitrogen compound metabolic process [BP], positive regulation of gene expression [BP], nucleoplasm [CC]
CG_h9laurent_promoter_p_RM_12_184_13			2	0.5	4.36E-04	SQSTM1, PKDCC, RUNX2	positive regulation of chondrocyte differentiation [BP], protein localization [BP]
CG_h9laurent_promoter_p_RM_14_178_17			3	0.5	3.39E-04	MAG, ITSN1, PIK3CA, PQBP1, AP2B1, AATF, GRB7, PDPK1, PTPN6, RBM4	epidermal growth factor receptor signaling pathway [BP], T cell costimulation [BP], cytoplasmic stress granule [CC], nerve growth factor receptor signaling pathway [BP]
CG_h9laurent_promoter_p_RM_12_530_22			3	0.5	3.54E-04	SMYD2, ACVR1B, PSMD7, PPRC1, PSMD1, EPO, CHAF1A, EXOSC2, SOX4, DGCR8, CHD9, EIF3B, NPAS3, ING1, ACVR2A, ZFPM1, MLLT10, HMGA1, SNAPC2, SALL3, PAX2, ING5, ZEB1, PBX3, ING2, CLP1, WHSC1, HOXD11, NOTO, HES3, PHF2, SP100, NFATC1	methylated histone residue binding [MF], atrial septum primum morphogenesis [BP], chromo shadow domain binding [MF], positive regulation of transcription, DNA-dependent [BP], transcription, DNA-dependent [BP], mitral valve morphogenesis [BP], atrial septum morphogenesis [BP], inhibin binding [MF], positive regulation of activin receptor signaling pathway [BP], gene expression [BP], RNA metabolic process [BP]
CG_h9laurent_promoter_p_RM_20_16_3			1	0.25	2.96E-04	TUFT1	structural constituent of tooth enamel [MF]
CG_h9laurent_promoter_p_RM_14_169_10			3	0.25	2.61E-04	LRP5, PRKCA, TULP3, DRD4, MPZL1, SIVA1, CCNF, ADAP2, NDUFS7, VPS26A, MAVS, VRK1	mitochondrial envelope [CC], protein binding [MF], negative regulation of adenylate cyclase activity [BP], phosphatidylinositol-4,5-bisphosphate binding [MF], negative regulation of cAMP biosynthetic process [BP]
CG_h9laurent_promoter_p_RM_14_274_6			3	0.5	2.90E-04	DNAJC6, FAM20C, LLGL1, ACR	Golgi to plasma membrane transport [BP], cortical actin cytoskeleton [CC], acrosome matrix dispersal [BP], post-Golgi vesicle-mediated transport [BP], dentinogenesis [BP], osteoclast maturation [BP]
CG_h9laurent_promoter_p_RM_12_418_11			3	0.5	2.39E-04	RDH10, ST8SIA2, ALDH1A3, MMP15	nose development [BP], retinal metabolic process [BP], retinoic acid biosynthetic process [BP], cellular protein modification process [BP], retinol metabolic process [BP], retinoic acid metabolic process [BP]
CG_h9laurent_promoter_p_RM_14_339_8			4	0.5	3.35E-04	CDC34, CUL1, GNG10, GNAO1	heterotrimeric G-protein complex [CC], G1/S transition of mitotic cell cycle [BP]
CG_h9laurent_promoter_p_RM_14_118_11			3	0.5	2.80E-04	PINK1, TTLL9, TTL, HTR6	positive regulation of dopamine secretion [BP], tubulin-tyrosine ligase activity [MF]
CG_h9laurent_promoter_p_RM_14_370_27			4	0.5	2.88E-04	ACVR2B, MACF1, ANGPTL4, ABL1, WNT5B, SKI, WNT3A	myotube differentiation [BP], muscle cell differentiation [BP], axis elongation involved in somitogenesis [BP], BMP signaling pathway [BP], Wnt receptor signaling pathway, calcium modulating pathway [BP], repressing transcription factor binding [MF], convergent extension involved in axis elongation [BP], skeletal muscle cell differentiation [BP], positive regulation of Wnt receptor signaling pathway [BP], anterior/posterior pattern specification [BP], convergent extension [BP], cell differentiation [BP], frizzled-2 binding [MF]
CG_h9laurent_promoter_p_RM_12_65_28			2	0.5	2.41E-04	KDM4C, BMPR1A, BMPR1B, TBX1, GATA4, KDM3A, SKI, YAP1, ZFPM1	SMAD binding [MF], atrioventricular valve morphogenesis [BP], lateral mesoderm development [BP], heart morphogenesis [BP], BMP signaling pathway [BP], atrial septum morphogenesis [BP], histone H3-K9 demethylation [BP], heart formation [BP]
CG_h9laurent_promoter_p_RM_14_188_18			4	0.5	3.66E-04	SMAD6, CREB1, TLE4, FOXF1, PROX1, FOXK2	RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity [MF], positive regulation of S phase of mitotic cell cycle [BP]
CG_h9laurent_promoter_p_RM_12_124_10			4	0.75	3.79E-04	PIWIL4, HINFP, ZAR1, FOXQ1, CARM1, MSRB2, MAFK, FYTTD1, TRIM54, TEAD1, SPTBN4, SKI, MAFF, CERS4, SOX1, PPM1A, NFE2L3, TULP3, RBPJ, NPAS1, PKNOX1, KDM4C, ONECUT3, DRAP1, LCOR, LBH, SNRNP70, MTA1, LONP2, CDC25B, SCN8A, RXRA, IRX5, DAG1, SART1, PTPN6, NFIC, KIAA1967, PLXNA3, CCND1, AATF, HES1, NFIX, FOXC1, AGFG1, ZNF277	node of Ranvier [CC], enzyme binding [MF], sequence-specific DNA binding transcription factor activity [MF], sequence-specific DNA binding [MF], nucleoplasm [CC], multicellular organismal development [BP], cell differentiation [BP]
CG_h9laurent_promoter_p_RM_14_245_22			3	0.25	3.23E-04	SFT2D3, BCAP29, RINT1, PAX2, TSC2, VPS18	optic cup morphogenesis involved in camera-type eye development [BP], vesicle-mediated transport [BP]
CG_h9laurent_promoter_p_RM_14_8_9			2	0.25	3.23E-04	ATAD3B, ATAD3A, CACNA1B, FBXO18, PBX3, EPO, P2RX4, IGF1R	positive regulation of DNA replication [BP], inactivation of MAPKK activity [BP], anterior compartment pattern formation [BP], regulation of sodium ion transport [BP], ATP binding [MF], posterior compartment specification [BP]
CG_h9laurent_promoter_p_RM_12_454_24			4	0.75	2.73E-04	RPS6KA1, LMO4, TCEA2, SMAD1, RET, TLX1, SMO, MAP2K3, STAT5A, PRPF6, BMP6	kidney development [BP], Peyer's patch development [BP], positive regulation of transcription from RNA polymerase II promoter [BP], midgut development [BP], positive regulation of transcription, DNA-dependent [BP]
CG_h9laurent_promoter_p_RM_12_52_9			2	0.25	2.85E-04	KIT, CUX1	retrograde transport, vesicle recycling within Golgi [BP], mast cell chemotaxis [BP]
CG_h9laurent_promoter_p_RM_12_555_28			2	0.5	1.97E-04	DAG1	nerve maturation [BP]
CG_h9laurent_promoter_p_RM_12_333_9			4	0.75	3.15E-04	SIRT1, SMARCB1, NPM1	Tat protein binding [MF], regulation of endodeoxyribonuclease activity [BP], chromatin remodeling [BP]
CG_h9laurent_promoter_p_RM_14_317_8			1	0.25	2.77E-04	TNFRSF11A, F2RL1	tumor necrosis factor-mediated signaling pathway [BP], interleukin-1 beta secretion [BP]
CG_h9laurent_promoter_p_RM_12_18_13			2	0.25	2.82E-04	ESR1, DOCK1, INSM1, ELK3, CAPN5, GABRD, PDPK1, KCNIP3, P2RX4, AKAP5	positive regulation of calcium-mediated signaling [BP], signal transduction [BP], type B pancreatic cell development [BP]
CG_h9laurent_promoter_p_RM_12_558_20			3	0.5	2.65E-04	HSPB1, RALGPS2, LIMK1, ATP1B2, ANO1, SH3GLB1, AHR, KLHL2, HNRNPAB, KIF19, RNF213, CEBPB	cytoplasm [CC]
CG_h9laurent_promoter_p_RM_14_262_11			1	0.25	2.19E-04	GADD45B, UBA2, TRAF7, STXBP1	ligase activity [MF], positive regulation of calcium ion-dependent exocytosis [BP], activation of MAPKKK activity [BP]
CG_h9laurent_promoter_p_RM_12_560_17			3	0.25	2.57E-04	IQSEC3, DIO3, MAF1	thyroid hormone generation [BP], inhibitory synapse [CC]
CG_h9laurent_promoter_p_RM_16_10_2			1	0.25	2.56E-04	VIL1	cytoplasmic actin-based contraction involved in cell motility [BP], lysophosphatidic acid binding [MF], regulation of lamellipodium morphogenesis [BP]
CG_h9laurent_promoter_p_RM_14_141_10			3	0.5	3.35E-04	SMAD6, CUL4A	positive regulation of S phase of mitotic cell cycle [BP]
CG_h9laurent_promoter_p_RM_12_188_12			5	0.75	2.45E-04	CNP, BRSK1, GNAS, ACR, RINT1, GNAL, TAOK1, TMOD1	G2/M transition DNA damage checkpoint [BP], activation of adenylate cyclase activity [BP], adult locomotory behavior [BP]
CG_h9laurent_promoter_p_RM_14_259_3			2	0.25	2.54E-04	PAX2	positive regulation of optic nerve formation [BP], optic chiasma development [BP], vestibulocochlear nerve formation [BP]
CG_h9laurent_promoter_p_RM_14_4_6			2	0.25	2.00E-04	ING2, NFYA	CCAAT-binding factor complex [CC]
CG_h9laurent_promoter_p_RM_12_593_18			3	0.5	2.07E-04	IGF1R, IGFBP2	insulin-like growth factor I binding [MF]
CG_h9laurent_promoter_p_RM_14_371_13			2	0.5	3.71E-04	ERBB2IP, ADORA2A, GNAS, MOCOS, ILK, RAC1, PLCG1, MAG, GPR26, MARC1, NRBP1, ADCY1, MMP15	glutamate receptor binding [MF], cellular response to catecholamine stimulus [BP], establishment or maintenance of epithelial cell apical/basal polarity [BP], nerve growth factor receptor signaling pathway [BP], cAMP biosynthetic process [BP], adenylate cyclase-modulating G-protein coupled receptor signaling pathway [BP], neuron projection morphogenesis [BP], adenylate cyclase activity [MF], positive regulation of catalytic activity [BP], lamellipodium [CC], molybdenum ion binding [MF], adenylate cyclase-activating G-protein coupled receptor signaling pathway [BP], transmembrane receptor protein tyrosine kinase signaling pathway [BP]
CG_h9laurent_promoter_p_RM_14_162_18			3	0.5	4.06E-04	TRAF3, YY1, ADD1, GNAS, AEBP2, RXRA, SLC12A5, NCAPH2, ZC3H12A, NSD1, IRAK3, WTIP, PROX1, SUV420H2, SIRT1	multicellular organism growth [BP], negative regulation of sequence-specific DNA binding transcription factor activity [BP], regulation of bile acid biosynthetic process [BP], PcG protein complex [CC], transcription corepressor activity [MF], chromosome [CC], histone H4-K20 methylation [BP], negative regulation of NF-kappaB transcription factor activity [BP], histone methyltransferase activity (H4-K20 specific) [MF], peroxisome proliferator activated receptor signaling pathway [BP], ESC/E(Z) complex [CC]
CG_h9laurent_promoter_p_RM_12_446_14			5	0.75	2.98E-04	ZNF358, TWIST2, PSMD1, PSMD13, KIT, PLEKHA1, SKI, DGKZ	proteasome regulatory particle [CC], face morphogenesis [BP], stem cell maintenance [BP], lipid kinase activity [MF]
CG_h9laurent_promoter_p_RM_12_230_17			3	0.5	3.18E-04	STK4, FXN	negative regulation of organ growth [BP]
CG_h9laurent_promoter_p_RM_12_399_16			4	0.5	2.63E-04	ADCY2, ITSN1, PSEN2, SMO, GRIN1, CHD7	semicircular canal morphogenesis [BP], membrane raft [CC], neuron projection [CC], dorsal/ventral neural tube patterning [BP], negative regulation of epithelial cell differentiation [BP]
CG_h9laurent_promoter_p_RM_16_12_8			2	0.25	3.38E-04	F2R, ADRA2C, OXT	regulation of sensory perception of pain [BP]
CG_h9laurent_promoter_p_RM_12_97_8			3	0.5	2.42E-04	WWC1, FES, HCK, PDE4A, PDE8A, RAC1	extrinsic to plasma membrane [CC], ruffle membrane [CC], cAMP catabolic process [BP], 3',5'-cyclic-nucleotide phosphodiesterase activity [MF], positive regulation of actin cytoskeleton reorganization [BP], 3',5'-cyclic-AMP phosphodiesterase activity [MF]
CG_h9laurent_promoter_p_RM_16_46_11			2	0.25	3.08E-04	CREB1, PPARD, PALM, MSH6, PDE4A, ZC3H12A, VASP, ING2, CIDEA, HDAC1	positive regulation of fat cell differentiation [BP], intrinsic apoptotic signaling pathway in response to DNA damage [BP], filopodium membrane [CC], Sin3 complex [CC], regulation of protein kinase A signaling cascade [BP]
CG_h9laurent_promoter_p_RM_14_357_19			2	0.25	4.03E-04	TRIM24, CENPF, SMAD6, GABRG2, ATL1, AK4, AGRN, TDRD3, GNA11, NSD1, SPTBN4, TSPO, TADA2B, PPM1A	GTP metabolic process [BP], benzodiazepine receptor activity [MF], clustering of voltage-gated sodium channels [BP], negative regulation of SMAD protein complex assembly [BP], GTP catabolic process [BP], chromatin binding [MF]
CG_h9laurent_promoter_p_RM_16_14_7			3	0.25	3.67E-04	MGMT, MPG	DNA dealkylation involved in DNA repair [BP]
CG_h9laurent_promoter_p_RM_12_73_9			6	0.75	3.13E-04	PKD2, PAX2, YAP1, ZHX2	metanephric collecting duct development [BP], somatic stem cell maintenance [BP], mesonephric duct development [BP], mesonephric tubule development [BP], metanephric distal tubule development [BP]
CG_h9laurent_promoter_p_RM_12_515_12			3	0.5	2.94E-04	JMY, CYR61, ACSL3, BNIP3L, ID2, PPDPF, LMO4, DAO, PSMB3, SMPD2, EN2, CBFB, SMARCD1, TP53INP2, BCL2L11, EP300, ZNF76, DIO3, TFDP1, SLC25A10, POGK	osteoblast differentiation [BP], regulation of lipid metabolic process [BP], mitochondrial outer membrane [CC], ceramide biosynthetic process [BP], multicellular organismal development [BP], regulation of transcription from RNA polymerase II promoter [BP], transcription from RNA polymerase II promoter [BP], cellular nitrogen compound metabolic process [BP], nervous system development [BP]
CG_h9laurent_promoter_p_RM_20_5_20			1	0.25	3.81E-04	ACVR2A, PRMT8, SLC6A8, GNAS, TRIM24, NOG, SLC44A1, HTT, MLL5, EHMT1	histone methylation [BP], DNA methylation [BP], activin-activated receptor activity [MF], p53 binding [MF], mesoderm development [BP], choline transmembrane transporter activity [MF], neural plate morphogenesis [BP], S-adenosylmethionine-dependent methyltransferase activity [MF]
CG_h9laurent_promoter_p_RM_12_435_17			3	0.5	2.40E-04	NT5M, NR2F2, MINPP1	inositol hexakisphosphate 2-phosphatase activity [MF], radial pattern formation [BP], dUMP catabolic process [BP], polyphosphate metabolic process [BP], bisphosphoglycerate 3-phosphatase activity [MF]
CG_h9laurent_promoter_p_RM_14_214_5			1	0.25	3.04E-04	UBC, IRX5	gonad development [BP], female gonad development [BP]
CG_h9laurent_promoter_p_RM_14_177_16			8	0.5	3.56E-04	BLOC1S3, CAV1, PPP2R1A	inactivation of MAPK activity [BP], negative regulation of JAK-STAT cascade [BP], cellular membrane organization [BP]
CG_h9laurent_promoter_p_RM_14_368_11			3	0.5	3.34E-04	CORO1A, AACS, FZD10, SPTBN4, EXOSC4, DGKZ, KCNS3, GPR142, TBC1D24, SNX30, LYN, ULK1, ATXN2L, SPAG6, SPATA18, RXRA, MLLT10, TRAF3, FOXL1, SBK1, CSGALNACT2, PKNOX1, CAPZA2, ESR1, TACC1, EIF2AK4, G3BP1, SSTR4, CXXC5, PHF7, YBX1, CDC42, NFATC1	regulation of actin filament polymerization [BP], intracellular [CC], regulation of actin cytoskeleton organization [BP], negative regulation of protein complex assembly [BP], thioesterase binding [MF], proteoglycan biosynthetic process [BP], cytoplasm [CC], regulation of branching involved in prostate gland morphogenesis [BP], cellular response to extracellular stimulus [BP], response to starvation [BP], cytoplasmic stress granule [CC]
CG_h9laurent_promoter_p_RM_14_297_6			2	0.5	3.37E-04	ACVR2A, PPP1CB, TFDP1, DGKE, DGKZ	transmembrane receptor protein serine/threonine kinase signaling pathway [BP], diacylglycerol kinase activity [MF], transforming growth factor beta receptor signaling pathway [BP]
CG_h9laurent_promoter_p_RM_14_301_18			2	0.25	3.24E-04	FGFRL1	heart valve morphogenesis [BP]
CG_h9laurent_promoter_p_RM_16_3_2			3	0.5	2.46E-04	PDPK1, HTRA1, PINK1	negative regulation of transforming growth factor beta receptor signaling pathway [BP], 3-phosphoinositide-dependent protein kinase activity [MF], C3HC4-type RING finger domain binding [MF]
CG_h9laurent_promoter_p_RM_16_16_5			1	0.25	4.44E-04	SLC6A8, SLC44A1	choline transmembrane transporter activity [MF]
CG_h9laurent_promoter_p_RM_14_18_6			2	0.25	2.47E-04	FOXC1, MAEL	regulation of organ growth [BP]
CG_h9laurent_promoter_p_RM_16_40_16			4	0.5	4.44E-04	PKP4, GTF3C4, SOX2, CEP164, CHD2, TRIM71, FZD7, RAN, RBPJ, NR2F2, FLYWCH1, IGF1R, HSPB1, HOXC11, CUX1, EBF4, LLGL2, ARID1B, ARID1A, TLX1, HOXD10, ZNF618, NSD1, FOXP4	positive regulation of cytokinesis [BP], miRNA binding [MF], positive regulation of transcription, DNA-dependent [BP], cell fate commitment [BP], SWI/SNF complex [CC], sequence-specific DNA binding [MF], regulation of gene expression [BP], chromatin binding [MF], DNA binding [MF], RNA metabolic process [BP], chromatin-mediated maintenance of transcription [BP], positive regulation of gene expression [BP], cell division [BP]
CG_h9laurent_promoter_p_RM_20_13_4			1	0.25	4.74E-04	CSF1	mammary gland fat development [BP], macrophage colony-stimulating factor receptor binding [MF], positive regulation of odontogenesis of dentin-containing tooth [BP]
CG_h9laurent_promoter_p_RM_14_304_5			2	0.25	5.30E-04	SLC25A27	reduction of mitochondrial calcium ion concentration [BP]
CG_h9laurent_promoter_p_RM_14_350_8			2	0.5	3.49E-04	SMARCB1, SMARCA4	positive regulation by host of viral transcription [BP], Tat protein binding [MF], npBAF complex [CC], nBAF complex [CC]
CG_h9laurent_promoter_p_RM_12_470_27			3	0.5	2.96E-04	TDRD9, C12orf52, TRIM24, FOXD3, MAEL, CUX1, ZBTB42, SKIL, SOX2, SYNGR1, SHISA9, DNAJA3	lymphocyte homeostasis [BP], piRNA metabolic process [BP], negative regulation of transcription from RNA polymerase II promoter [BP], DNA methylation involved in gamete generation [BP], male meiosis [BP], regulation of short-term neuronal synaptic plasticity [BP], negative regulation of transcription, DNA-dependent [BP], P granule [CC], piP-body [CC]
CG_h9laurent_promoter_p_RM_14_237_2			1	0.25	3.50E-04	TCF7L1, JPH3	positive regulation of transcription from RNA polymerase II promoter during mitosis [BP], regulation of neuronal synaptic plasticity [BP]
CG_h9laurent_promoter_p_RM_12_329_8			3	0.25	3.64E-04	NAB2, MTRR, MAF1	methionine biosynthetic process [BP], negative regulation of transcription from RNA polymerase III promoter [BP]
CG_h9laurent_promoter_p_RM_14_107_7			3	0.25	3.80E-04	LAMC3	astrocyte development [BP]
CG_h9laurent_promoter_p_RM_12_112_7			5	0.75	3.08E-04	FAM21B, FAM21C	retrograde transport, endosome to Golgi [BP], WASH complex [CC]
CG_h9laurent_promoter_p_RM_14_76_11			2	0.25	4.53E-04	FOXL1, SALL3	forelimb morphogenesis [BP]
CG_h9laurent_promoter_p_RM_14_299_6			5	0.5	2.09E-04	PDK3, ADRA2C, RXRA, RAC1, PDPK1	activation of protein kinase B activity [BP], peroxisome proliferator activated receptor signaling pathway [BP], hyperosmotic response [BP]
CG_h9laurent_promoter_p_RM_14_191_12			3	0.5	3.75E-04	DMBX1, RAC1, GPR124, SOX9, SSH3, FGF2, TCF7	regulation of lamellipodium assembly [BP], neurogenesis [BP], cochlea morphogenesis [BP], central nervous system development [BP], generation of neurons [BP], nervous system development [BP]
CG_h9laurent_promoter_p_RM_18_3_3			1	0.25	4.32E-04	WAC, PKNOX1, FOXF2, ZFPM1	histone H2B conserved C-terminal lysine ubiquitination [BP], negative regulation of interleukin-4 biosynthetic process [BP], transcription factor complex [CC], negative regulation of mast cell differentiation [BP]
CG_h9laurent_promoter_p_RM_14_38_3			2	0.5	4.13E-04	PTPN11, KHDRBS1, PDPK1	3-phosphoinositide-dependent protein kinase activity [MF], SH3/SH2 adaptor activity [MF], Grb2-Sos complex [CC], negative regulation of growth hormone secretion [BP], insulin receptor binding [MF], negative regulation of cortisol secretion [BP], T cell costimulation [BP]
CG_h9laurent_promoter_p_RM_14_315_8			1	0.25	3.01E-04	PXK	regulation of synaptic transmission [BP]
CG_h9laurent_promoter_p_RM_14_352_3			3	0.5	1.47E-04	PTGS1, ESRRA, LRP5, BMP6	osteoblast differentiation [BP], bone morphogenesis [BP], regulation of osteoblast differentiation [BP], regulation of cell proliferation [BP]
CG_h9laurent_promoter_p_RM_14_124_12			2	0.25	3.41E-04	TCF7, ID1, CLIC4	cellular response to interleukin-4 [BP], endothelial cell morphogenesis [BP]
CG_h9laurent_promoter_p_RM_12_20_23			3	0.5	2.47E-04	POU3F2	myelination in peripheral nervous system [BP]
CG_h9laurent_promoter_p_RM_14_17_15			1	0.25	2.81E-04	NPAS1, CHST13, CHST12, CACNA1I, CRAMP1L, MXI1, MGMT, ZFPM1, LIN28B, RASSF7, FOXO3, ZNF618, CACNA1H, PPP2R4, ZBTB47, ZNF775, KCNIP3, ZNF517, PAX2, NFIC	low voltage-gated calcium channel activity [MF], DNA binding [MF], chondroitin 4-sulfotransferase activity [MF], calcium channel complex [CC]